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Abstract
The hydrodynamics of magnetic fluids, often termed ferrofluids, has been an active
area of research since the mid 1960s. However, it is only in the past twenty years
that these fluids have begun to be used in magnetic resonance imaging (MRI) where
they have found application as contrast agents, improving the contrast to noise ratio
of the received MR intensity.
The major goal of this work was to assess the feasibility of modulating the signal
intensity in MRI in regions near superparamagnetic iron oxide contrast agents by
applying a rotating magnetic field. Analytical study and numerical simulations of
the effects of such a rotating magnetic field are presented. Simulated variations in
fluid magnetization are achieved by changing the frequency of the rotating magnetic
field. A linearization of the equilibrium magnetization Langevin relation results in a
small signal magnetic susceptibility tensor that can be used to influence fluid flow.
The feasibility of the approach under the real-life constraints of MR imaging are
assessed. Also examined is the potential for coupling changes in magnetization due
to rotating fields with hyperthermia treatment of cancerous tissue.
In addition to theoretical and simulated analysis, considerable experimental work
was undertaken at the MRI systems of the HST Athinoula A. Martinos Center for
Biomedical Imaging at Massachusetts General Hospital, Charlestown, Massachusetts.
This work evaluated the passive behavior of both commercial ferrofluids and MRI
contrast agents. The ability of MRI to serve as a highly accurate indicator of the
fluid's physical and magnetic properties is shown. The thesis represents the first
investigation into the use of the hydrodynamic properties of magnetic fluid in the
presence of a rotating field as a mechanism for contrast in MRI. The results show the
possibility of varying MR image intensity under careful selection of field conditions.
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ogy and Robert J. Shillman Career Development Assistant Professor of Electrical
Engineering
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Note on the Outline of the Thesis
1. Chapter 1 presents the basics of ferrofluids and MRI. This chapter represents a
bridging of the fields of ferrohydrodynamics and MRI.
2. In chapter 2, the theoretical work is begun with an examination of the effect
on fluid magnetization in regions near a compartment of SPIO contrast agent
by applying a rotating magnetic field transverse to the main DC field that
characterizes MRI. Analytical study and numerical simulations of the effects of
such a rotating magnetic are included.
3. Chapter 3 expands the work of the preceding chapter to account for a rotating
magnetic field where one of the components is parallel to the main field. Again,
analytical and numerical results are presented in some detail.
4. Chapter 4 includes a brief examination of the feasibility of mechanical rota-
tion of a vial of contrast agent as a means for modulating the magnetic fluid's
magnetization which, in turn, would change the MRI intensity.
5. In chapter 5, experimental results from MRI investigations at the Martinos Cen-
ter are presented. These include measurements of contrast agent magnetization
at 3T and comparison with results from vibrating sample magnetometry as
well as investigations of the effects of gradients in the magnetic field, ferrofluid
nanoparticle chaining and sensitivity of the contrast agent to transverse field
components.
6. Chapter 6 examines the experimental results for magnetic fluid flow in the
presence of the MRI's Bo field gradient at the magnet's edge. The effects are
investigated for various dosages of commercial MRI contrast agents.
7. Chapter 7 details the application of RF fields in MRI in the presence of magnetic
nanoparticles. The application of RF fields causing non-ohmic heating due to
the magnetic nanoparticles is presented.
8. The thesis ends with chapter 8 which includes a summary of the major contri-
butions from the work as well as suggestions for future work.

Chapter 1
Introduction to Magnetic Fluids
and MRI
Magnetic Resonance Imaging (MRI) is an investigative and diagnostic tool used to
visualize the structure and function of tissue in living organisms. The image contrast
associated with MRI is due to the response of water protons in the presence of exter-
nal magnetic fields. Exciting water protons and observing their relaxation behavior
enables the clinician to make diagnosis. Due to similarities between many bodily cells
and tissues, it is sometimes difficult to achieve this goal with traditional MRI. The
use of contrast agents can reduce this problem. Examples include the investigation
of vascular tissues (e.g., tumors), the assessment of brain perfusion (e.g., in stroke),
imaging of the gastrointestinal tract and liver and, most recently, cancer imaging
by cell-labelling [1-5]. Contrast agents seek to aid the clinician by enhancing the
variability across an MR image. However, once contrast agent is administered to the
patient, it is beyond the control of the clinician to influence the image intensity in
the neighborhood of the agent. A highly desirable property of contrast agent would
be active in vivo control so that the clinician might direct and manipulate MR image
intensity even after it has been administered to the patient. This would place MRI
on a more even footing with emerging imaging technologies, in particular Positron
emission tomography (PET). PET has a unique ability to not only provide images
but also to do so with high sensitivity and to provide both relative and absolute
quantification [6].
The goal of this work is to propose a means to modulate MR image intensity
by application of a rotating magnetic field in addition to the usual magnetic fields
present in MRI. This would be achieved by applying the fields in the neighborhood of
iron oxide nanoparticles and the effect of image modulation would be seen in nearby
water compartments.
The thesis begins by describing the salient properties of superparamagnetic iron
oxide (SPIO) particles in high-concentration suspensions and a brief introduction to
the basics of MRI. The particle properties are coupled to the governing constitutive
relations and boundary equations of physics to solve the particular problem of MR
image intensity in water located in the macroscopic vicinity of a compartment of
SPIO particles in a water suspension, referred to as a "ferrofluid". The system is
investigated by means of Comsol Multiphysics software simulations. In addition to
the main z-directed Bo magnetic field, which is a very strong static field, a weak
rotating field, Brot, is applied in the transverse {xy} and longitudinal {yz} planes. It
is shown that the frequency of Brot, denoted Q, can be used to modulate the MR image
intensity in the vicinity of the compartment under strict constraints by introducing
an additional source of rotating field, not currently found on the conventional MRI
system. The theoretical effect is investigated and found to be present when the "spin-
velocity" of the ferrofluid is significant and the value of Q approaches the reciprocal
of the ferrofluid's characteristic time constant, T.
1.1 Prior Work on Ferrofluids in MRI
The ferrohydrodynamics of suspensions of iron-oxide (usually consisting mainly of
magnetite, Fe 30 4) in carrier liquids such as oil or water, commonly termed ferroflu-
ids, is well-understood [42,48, 50, 51]. Following the analysis of Shliomis [48], much
work has sought to validate his theory through experiment [49, 52, 53] and these
efforts have proven convergent with the established theory, at least while the fer-
rofluid remains well outside the region of complete magnetic saturation. Iron oxide
nanoparticles were first proposed as a contrast agent in MRI by Weissleder [59] with
subsequent application by many other investigators [63,64]. Water-based ferroflu-
ids have found application as imaging contrast agents [59], particularly in tumor
imaging [1]. Scientists and clinicians in the MRI field preferred the term superpara-
magnetic iron oxide (SPIO) agents, rather than ferrofluids. In 2002, Feridex' became
the first FDA-approved SPIO agent for clinical studies. While much important work
has been undertaken to characterize the biomedical, physical and passive magnetic
properties of such SPIO agents [57, 58], including the relaxivity critical to contrast
in MRI [8-10,25], there has yet been no attempt, until now, to analyze the effect
of ferrofluid spin-velocity on MR imaging. This work, the subject of a filed patent
application [7], investigates the use of the spin velocity of magnetic nanoparticles in
presence of a rotating magnetic field as a possible source of image contrast in MRI.
Contrast agents fall under two categories: positive and negative agents. Positive
contrast agents increase signal intensity and usually refers to Gadolinium-based agents
(also called T1 agents). Negative contrast decreases signal intensity and this usually
'Feridex is manufactured by AMAG Pharmaceuticals, Cambridge, Massachusetts and distributed
by Bayer Pharmaceuticals under a licensing agreement. Up until 2007, AMAG was known as Ad-
vanced Magnetics. Feridex is sold in Europe under the brandname of Endorem and is licensed to
Guerbet, a French pharmaceutical firm.
refers to SPIO agents (also called T2 agents). One novel work has proposed SPIO
as a positive contrast agent (rather than a negative agent as it is usually employed)
by means of spectrally selective RF pulse excitation and subsequent off-resonance
readout of the surrounding water spins [66]. A separate technique [67] involves the
use of Oxygen-17 as an effective T2 relaxation2 agent where the additional T2 re-
laxation associated with 170 can be suppressed at will by irradiation of the oxygen
resonance before the signal is collected for image reconstruction. Reported results
suggest comparable contrast to noise ratios (CNR) to diffusion and Gadolinium con-
trast mechanisms. However, it would appear that no prior work investigates the
application of the spin velocity associated with SPIO particles such as magnetite to
the field of MRI contrast enhancement.
1.2 Physical Properties of Ferrofluids
Iron-oxide particles, often referred to as SPIO particles, are a commonly used MR
contrast agent [27, 59, 63, 64] as discussed in the previous section. The particles, of-
tentimes magnetite (Fe304), usually measure between 5 and 15 nm in diameter and
are contained in a carrier liquid such as water as depicted in Figure 1-1. To prevent
the particles agglomerating, a thin surfactant coating surrounds each particle [65].
Oleic acid is a common surfactant in oil-based ferrofluids while dextran became the
preferred surfactant in the early development of iron-oxide particles for MRI [59].
SPIO particles represent an enormous disturbance of the local magnetic field in an
MRI environment. Single-domain magnetite particles have a typical local magneti-
zation equal to 0.56 T (although this varies with volume). This field disturbance
will fall off inversely proportional to the cubic distance from the nanoparticle [35,42],
2T1 and T2 are the usual MRI relaxation time constants, discussed in detail in Section 1.4.3
so that, for typical imaging fields of 1.5 T, the effect due to a single nanoparticle
will not extend radially beyond approximately 10 pm from the particle's center. In
reality, each MRI imaging voxel3 contains many thousands or tens of thousands of
nanoparticles. Therefore, the voxel's image intensity is a smeared or averaged ef-
fect due to all the nanoparticles within the voxel. Even with this averaging effect,
SPIO agents are a potent MR contrast agent. In order to produce MR images with
sufficient signal to noise ratio4 (SNR) to allow the region where the contrast agent
is present to be differentiated from background noise, typical solid volume fractions
lie in the ppm range. However, it should be noted that magnetite volume fractions
of 0.008 have been tested on live rat brain [69] investigating capillary diffusion in
the dorsal hippocampus. The work of this thesis uses solid volume fractions varying
from 0.01 to 0.03 in order to achieve a perceptible effect due to spin-velocity effects.
Although the effects of nanoparticle spin-velocity persist at lower particle concen-
trations, they are not significant enough to impact the MRI environment. At such
high concentrations, the SPIO solution is referred to as a ferrofluid, in keeping with
physics parlance [42,68].
3Typical MRI imaging voxels are cubes on the order of 2 to 4 mm in length for high resolution
imaging.
4SNR compares the level of a desired signal to the level of background noise. SNR is optimal
for low concentrations of ferrofluid with all other MR parameters fixed. However, at very low
concentrations (solid fractions less than 10-s), the effect of the magnetic nanoparticles will cease
to be apparent in MRI. Conversely, at very high concentrations (solid fractions greater than 10-4),
regions containing nanoparticles become indistinguishable from the background noise. This latter
phenomenon is not critical if the tissue surrounding the highly concentrated agent has a relatively
high image intensity, yielding good contrast to noise ratio (CNR) in the resultant MRI. Thus arises
the distinction between SNR and CNR.
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Figure 1-1: Each ferrofluid particle consists of a superparamagnetic core surrounded
by a surfactant (also called dispersant) layer. This has a dual purpose in MRI: to
avoid agglomeration and to render the particle biocompatible.
1.3 Ferrofluid Time Constant, T
In the absense of an external magnetic field, a superparamagnetic ferrofluid suspension
has no net magnetization due to the random orientation of the nanoparticles in the
suspension. Upon the application of an external DC magnetic field to a ferrofluid
suspension, some fraction of the particles will rotate to align themselves with the
applied field. The time for this alignment to occur is characterized by the ferrofluid
relaxation time, 7, given by Eq. (1.1) and shown in Fig. 1-2 as a function of the
magnetic core radius.
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Figure 1-2: The ferrofluid time constant, 7, is usually dominated by either the Neel
(rN) or Brownian (TB) relaxation times, depending on the particle's radius.
As seen from Eq. (1.1), the ferrofluid relaxation time, T, is due to two distinct
contributions. These are the Brownian (TB) and Neel (rN) relaxation times. For
Brownian relaxation, which dominates at larger particle sizes, relaxation is due to
particle rotation in the carrier liquid. For Noel relaxation, which is the dominant
mechanism for smaller particle sizes, the mechanism is due to rotation of the mag-
netic vector within the particle. If the ferrofluid particle is constrained, for example
by attaching it to a surface, N6el relaxation is still operative although Brownian is
not. The relative expressions for TB and TN are given by Eq. (1.2) and Eq. (1.3)
where:
Vh = Particle hydrodynamic volume in m3 (includes surfactant contribution)
r- = Dynamic viscosity of the carrier liquid (assumed that of water) in Pa. s
Ka in MJ m"3 Anisotropy Constant, Ka
0.15
0.1
0.05
n
1 2 3 4 5 6 7
Particle radius in nam
Figure 1-3: Recorded values of Ka are plotted along with an interpolated expression
which is an excellent fit to the recorded results of Lehlooh et al. [55], [56] over the
range of nanoparticles considered; magnetic core radii between 1.5 nm and 6.3 nm.
k = Boltzmann's constant = 1.38x 10- 23 in m2.kg.s-2-K - 1
T = absolute temperature in K, assumed 295 K unless stated.
V, = Particle volume in m3 (excludes surfactant contribution)
Ka = Anisotropy constant in J m- 3
ro = Characteristic N6el time given by Rosensweig [42] as 1 ns
3 Vhr
TB =B kT
Se TV
TN = r0 e kT
(1.2)
(1.3)
The value of the anisotropy constant, Ka, follows from the analysis of Lehlooh
et al. [55, 56] who used collective magnetic excitation (CME) techniques to obtain
0
U.2Z
the values for Ka listed in Table 1.1. The analysis leading to the plot of Fig. 1-2
uses a third-order polynomial interpolation based on the values of Table 1.1, given
by Eq. (1.4), to estimate the value of Ka for the entire range of feasible particle radii,
R, given in meters, in the interpolated expression.
Ka = -4.47 x 1029R3 + 9.24 x 1021 R 2 - 7.46 x 1013R + 2.93 x 105 (1.4)
The interpolated expression is plotted in Fig. 1-3 along with the recorded values
for Ka from Table 1.1. For the plot of Fig. 1-2, surfactant thicknesses of 0, 1 and 2
nm are assumed and the temperature is 298 K.
Particle Radius in nm Ka in J m-3
6.3 0.78 x 105
5.0 0.95 x 105
3.0 1.40 x 105
1.5 2.00 x 10s
Table 1.1: The anisotropy energy constant, Ka,
lated by Lehlooh [56] using CME.
for different particle radii, as calcu-
1.3.1 Ferrofluid Langevin Parameter, L(a)
The fraction of magnetic nanoparticles in the ferrofluid that align with a static, ex-
ternal, magnetic flux density, B0 , with associated magnetic field5 Ho, is determined
5In general B0o = yo (Ho + Mo) where Ao is the magnetic permeability of free space and Mo is the
magnetization of the sample. However, many times in MRI, where Bo is 1.5 T or 3 T, Ho > Mo
by the Langevin function, L(a), shown in Fig. 1-4 and described by Eq. (1.5) where:
Meq = equilibrium magnetization in A m- 1
M8 = saturation magnetization = 0 Md in A m- 1
Md = single domain saturation magnetization for Fe 30 4 (- 446 kAm - 1)
¢ = unitless volume fraction of solids in the suspension6
a = unitless Langevin parameter = IOV Md HokT
V, = magnetic volume of each particle in m3 (excluding surfactant)
Bo = f 0oHo = applied external field in T
Meq = MsL(a) = M,(coth(a) - 1/a) (1.5)
The Langevin parameter, a, describes the ratio of magnetic to thermal energy
densities in the suspension [42]. If a > 1, then the Langevin function approaches
unity and practically all the particles are aligned with the applied field, Bo. The
ferrofluid is referred to as "saturated". This is the typical operating domain for
conventional SPIO contrast-agents in conventional, clinical MRI albeit at reduced
particle concentrations.
Shliomis [48] has shown that if the external magnetic field is rotating, then the
ferrofluid's equilibrium magnetization, Meq (given by the Langevin function) will lag
behind the time-varying magnetic field intensity, H, that is applied, resulting in a
body-torque density on the ferrofluid given by poM x H where po is the permeability
since the applied field due to the magnet is dominant over the magnetization of the sample under
investigation, even for ferrofluids. In this scenario, Bo M- oHo.
6Refer to Appendix B for an explanation of the various concentration units of relevance to MRI
contrast agents.
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Figure 1-4: The equilibrium magnetization associated with each particle radius is
determined by the Langevin function.
of free space in H-m - 1 and M is the instantaneous magnetization in Am - 1. The
fluid exhibits a spin velocity vector, w, and its value is related to the other critical
parameters by Shliomis' Relaxation Equation, given for an incompressible fluid' by
Eq. (1.6) where:
v = fluid flow velocity vector in ms - 1
w = fluid spin flow velocity vector in s- 1
7 = relaxation time constant in s
7For an incompressible fluid, the divergence of the fluid flow velocity is identically zero, V . v = 0
a M + v -VM - w x M - (1/r)(M - Meq) = 0 (1.6)
While in the most general case, the equilibrium magnetization, Meq, is given by the
Langevin function, for very low driving fields (a <« 1), L(a) might be approximated
by the initial linear portion of the curve in Fig. 1-2. In this case, Meq=XoH where Xo
is the initial8 susceptibility as given in Equation (2.28) of reference [42] and repeated
in Eq. (1.7).
Xo 0 = Md2 VP (1.7)3 kT
The following analysis follows a more general case applicable to the MRI envi-
ronment. The equilibrium magnetization is estimated as Meý=XeqH where Xeq is
the incremental susceptibility found from a small-signal linearization of the Langevin
relation about an operating point defined by a large DC z-directed magnetic field
intensity, Ho, with a corresponding equilibrium DC magnetization component, Mo,
also z-directed, and given by the Langevin function evaluated at the operating point.
Perturbations in the magnetic field intensity about this operating point can be repre-
sented by small-signal magnetic fields along the x, y and z axes, denoted Ih, hy and
hh. The corresponding small-signal magnetization, denoted hzx, riy, and fn,, will be
related to the small-signal magnetic field by the linearized Langevin relation. The
full analysis is included in Appendix A and the final results are given in Eqs. (1.8)
through (1.11), where ao = Md Vp po HokT
8In this context, initial refers the presence of low field strengths, where the Langevin function
can be approximated by its initial linear relation between the magnetization and the applied field.
Mo = M, (coth(ao) - 1/ao) (1.8)
in' = X ih = MS(coth(ao) - 1/ao) hx = o (1.9)HW H(
fn, = XYhhy = MS (coth(,ao) - 1/Io) hy = Ho hy (1.10)
Az8 = XZ 0 Z + - =(
It should be noted that for the case of a saturated ferrofluid, the Langevin function
approaches unity, as already stated. In this case, the susceptibility tensor solvable
from Eq. (1.6) approaches zero because H and M are increasingly decoupled and the
slope of the Langevin curve approaches zero, although this is only important for the
h_ term. Shliomis has postulated that the formulation of Eq. (1.6) only remains valid
when the excitation frequency Q2 is maintained in the range 6Qr < 10 [51]. Beyond
this range, it is unclear that the formulation still holds validity.
Finally, the analysis in this work induces spin velocity in the ferrofluid primarily
by application of external rotating magnetic fields. It should be noted that spin
velocity will also be observed in ferrofluid for flows with vorticity [42].
1.4 Magnetic Resonance Imaging
1.4.1 Introduction
Bo
Bo
Bo
.1I
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Axial Slice
Figure 1-5: The fundamental elements of MRI are (a) dipole alignment, (b) RF
excitation, (c) slice selection and (d) image reconstruction. The axial image slice is
shown with grateful thanks to Divya Bolar (MIT/HST).
The purpose of this section is to introduce the reader to the fundamental principles
of MRI in order to appreciate the work which follows. The interested reader is referred
to reference texts such as Haacke's [35] or Bushong's [36] for further elaboration of the
principles introduced in this work. In addition, Professor Dwight Nishimura's brief
introductory text [37] is a superb "light" introduction to MRI. The online resources
at the MRI tutor9 as well as the personal websites of Professors Joseph P. Hornako°
(Rochester Institute of Technology) and Brian Hargreaves"' (Stanford University) are
9http://www.mritutor.org/mritutor/
10http://www.cis.rit.edu/htbooks/mri/inside.htm
11http://www-mrsrl.stanford.edu/,-brian/intromr/
G(1
excellent additional resources. What follows represents an incomplete synopsis drawn
from these and other resources.
1.4.2 Excitation
Magnetic Resonance Imaging, in the clinical environment, is usually used to detect
signal from water molecules in the body. The dominant magnetic field associated
with each of these molecules is that of the hydrogen proton, which has a dipolar
magnetic field. In general, the hydrogen dipoles in the body are randomly oriented.
In the presence of a large DC magnetic field, Bo, aligned along the z axis, some
small net fraction of the dipoles align with the applied field, as shown in Fig. 1-5(a).
If a radio-frequency (RF) source is now brought to bear on the aligned dipoles, it
is found that at one particular frequency (the Larmor frequency, denoted wo) the
dipoles will precess about their equilibrium orientation, lagging the RF field, denoted
B 1, by 900 in space. If B1 is orthogonal to Bo (as is oftentimes the case in MRI), the
dipoles will be tipped into the plane perpendicular to Bo, as depicted by Fig. 1-5(b).
Typically, B1 (which is only a small fraction of Bo) is applied in the {xy} plane so
that upon excitation, each dipole is "flipped" by 90'. In fact, the hydrogen proton's
magnetization vector experiences nutation at wo = 21ry Bo as it tips away from Bo,
where y is referred to as the proton gyromagnetic ratio and its value for hydrogen is
42.58 MHz T- 1. When this tipping occurs, the component of the hydrogen magnetic
dipole field moves from being aligned with the z axis to the { xy} plane.
1.4.3 T1 and T2 Relaxation
After the B1 excitation field is turned off, the dipole's magnetization vector relaxes
back to align with Bo. As this occurs, the magnitude of the EMF that is induced in a
coil positioned perpendicular to the {xy} plane is found to decrease from its value at
the instant when the dipoles magnetization vector is aligned with B1. The relaxation
is characterized by two different time constants: T1 and T2. T1 relaxation, also re-
ferred to as longitudinal relaxation, is due to interactions between the dipole spins1 2
and the lattice while T2 relaxation, also referred to as transverse relaxation, is due
to interactions between the spins. T1 characterizes the return of the z component
of magnetization back to its equilibrium value after excitation. T2 characterizes the
decay of the transverse {xy} component after excitation. Due to fluctuations in the
magnetic field across a sample, T1 is always longer than T2. The Bloch equation
which governs spin behavior in MRI is found in many texts, including equation (4.19)
of reference [37] and is repeated in Eq. (1.12). M0o is the equilibrium sample magneti-
zation due to the Bo field. However, in this case, M0 is the equilibrium magnetization
due to the water protons used for imaging and not the magnetization of the ferrofluid
suspension.
M = M x 2ryB- (M - Mo) (1.12)ST2 T1
In order to compile a coherent MR image, it is necessary to vary the Larmor
frequency across the sample of interest, so that the signal corresponding to each
spatial position is mapped to a particular temporal frequency. This variation is
accomplished by means of gradient coils, highlighted in the example of Fig. 1-5(c) as
G(z), where G is a linear gradient in the z component of magnetic field along the
z axis. The local Larmor frequency is then related to the local magnetic field by
12A nuclear spin refers to a non-classical kind of angular momentum intrinsic to a body, as opposed
to orbital angular momentum, which is the motion of its center of mass about an external point.
This quantum-mechanical spin is quantized in units of half or full integers. The proton is a spin-1/2
particle. In MRI, a spin is oftentimes (somewhat inaccurately) used to refer to the 1H proton.
Eq. (1.13).
o = 21ry(Bo + G(z)) (1.13)
Adding further gradients in the x and y directions now allows for a three-dimensional
array of frequency bins to be collected. This array is termed k space and the magni-
tude of each frequency bin corresponds to the MR signal strength from a particular
voxel in the spatial domain. Mapping between the spatial and frequency domains is
performed by a Fourier analysis. The final image, typified by Fig. 1-5(d), is usually
multi-sliced although only one image is shown (in this case along the {xy} or axial
plane). Three-dimensional imaging is also possible.
1.4.4 Spin Dephasing and Compensation
In perfectly pure water, the values of the characteristic time constants, T1 and T2,
would be identical. As noted previously, due to inhomogeneities occurring in all
practical experiments, this is not the case. In fact, the decay of the magnetization
in the { xy} plane is rapid due to "spin dephasing". Due to inhomogeneities in the
Bo field, each spin will experience slightly more or slightly less dephasing as time
goes by. Spins which were initially coherently aligned (usually along the x axis) by
excitation, rapidly fall out of coherence once the B 1 field is turned off. The net signal
associated with their magnetization vector within a given voxel gradually falls away.
This intrinsic decay is characterized by the T2* time constant.
The rapid effect of T2* decay limited the use of conventional MR imagery until
Hahn [35] developed a compensating procedure that mitigates against rapid decay of
the signal in the {xy} plane: the "spin-echo" technique. The approach, highlighted
in Fig. 1-6 is to flip all the spins at a time half-way between excitation and read-
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Figure 1-6: A typical "spin-echo" sequence includes a refocusing flip at half the time
between excitation and read-out, TE. Representative gradient fields, Gx, and Gy are
also included. In general, the slice selection gradient, GY, is varied during each TR
to select a given slice along the y axis, as indicated in the figure.
out, denoted TE, thus causing the coherence to be reestablished at read-out. The
rephased envelope of signal decay, shown in Fig. 1-7, has a new characteristic decay
time termed T2. In fact, the intrinsic T2* time constant can be decomposed into
two distinct contributions [35], as given by Eq. (1.14). T2' is due to external field
induced relaxation while T2 is due to thermal and diffusion effects in the material.
The spin-lattice time constant, T1, is a mono-exponential rise back to the equilibrium
value, as shown in Fig. 1-7.
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Figure 1-7: T2 decay is characterized by the exponential decay envelope of the mag-
netization signal in the {xy} plane after excitation. T1 recovery is characterized by
the exponential growth of the magnetization along the z axis as the vector returns to
the equilibrium magnetization.
The time constants, T1 and T2 are unique for any material. The image contrast
between tissue types in living humans which is so important to medical diagnosis and
afforded by MRI is due mostly to T1 and T2 signal decay, in addition to factors such
as spin density, tissue density etc. Typical values of T2 are 100 ms for gray matter
deceasing to 40 ms for human liver [37]. T2 values in pure water typically range
between 1 s and 3 s. T1 values in vivo can be significantly longer, reaching the order
of several seconds.
Figure 1-8: T1 weighted MRI of the brain (A) before and (B) after Gadolinium
contrast enhancement, showing a metastatic deposit involving the right frontal bone
with a large extracranial soft tissue component and meningeal invasion. This figure
comes from a case report of suspected dormant micrometastasis in a cancer patient
[75]. (Reproduced with the kind permission of Dr. Nagi S. El Saghir, Clinical Professor
of Medicine Hematology-Oncology, American University of Beirut Medical Center.)
1.5 Contrast Agents
1.5.1 T1 and T2 contrast
Oftentimes when using MRI for diagnosing medical conditions in vivo, there is insuffi-
cient inherent contrast between adjacent human tissues to allow for medical personnel
to reach a definitive clinical prognosis. This is often the case for stomach and small
bowel imaging as well as for detection of vascular tissues (e.g., tumors) and the as-
sessment of brain perfusion (e.g., in stroke victims). In such cases, it is common to
administer a contrast-enhancing agent to the patient, either orally or by injection.
Contrast-agents are effective when neighboring tissues have similar MRI relaxation
times but absorb the contrast agents to varying degrees. Although there has been
some work in the field of positive contrast agents using off-resonance refocussing ef-
fects in the presence of SPIO nanoparticles [66], almost all current contrast agents
decrease the effective time constant (either T1, T2 or a combination of both, depend-
ing on the particular agent) resulting in a time constant that is shorter for the tissue
where absorption occurs. This is highlighted in Fig. 1-8 which shows a Ti-weightedl3
MRI of the brain (A) before and (B) after positive Gadolinium contrast enhancement.
Since the presence of the gadolinium agent primarily affects T1 relaxation, causing
the imaging spins in the vicinity of the contrast agent to recover more quickly to
their equilibrium position, a Tl-weighted image will show increased image intensity
or "positive" contrast enhancement in the presence of the agent. Hence, the referral
to gadolinium agents as positive contrast agents. Alternately, SPIO agents primarily
affect T2 relaxation. Imaging spins in the vicinity of the contrast agent exhibit more
rapid dephasing in the presence of the agent and therefore, a T2-weighted image will
show reduced or "negative" contrast compared to when the SPIO agent is absent.
Hence, SPIO agents are often referred to as negative contrast agents.
The new time constants after either positive or negative contrast enhancement are
approximated by Eqs (1.15) and (1.16) where C is concentration of agent, usually ex-
pressed in mol 1-1 and R, and R2 refer to the longitudinal and transverse relaxivities
of the agent respectively, with units of 1.s-l.mol - 1. Contrast agents are usually se-
lected so that either the longitudinal or transverse relaxivities are dominant, resulting
in T1 (eg., Gadolinium-based) and T2 (eg., SPIO) contrast agents.
1/Tlafter = 1/Tlbefo, + RIC (1.15)
1/T2after = 1/T2fore + R 2C (1.16)
13MR images can be defined as either Tl-weighted or T2-weighted, depending on the parameters
TE (read-out time) and TR (repetition time between excitations). This analysis follows from the
Bloch Equation and is found in reference [35]. Generally, for T2-weighted images TR>T2 with a
long TE time and for Tl-weighting, TE<T1 with a short TR time.
1.5.2 Predicting T1 and T2 Relaxation Times
As evident from Eqs (1.15) and ( 1.16), the altered relaxivity'4 associated with con-
trast agents is necessarily longer due to the inverse addition relation. T1 contrast-
agents are generally paramagnetic and their magnetization is usually a linear function
of the applied Bo field. This is not always the case for T2 contrast agents, which are
usually superparamagnetic materials and often operate at or near to magnetic sat-
uration (as determined by the Langevin function of Fig. 1-4). Most T1 agents are
gadolinium-based [28] and all act to decrease T1. Most commercial T2 agents are
superparamagnetic suspensions, such as MION-46L [16] and Feridex [62], and these
agents act to decrease T2.
Aqueous Solution Relaxation
In pure aqueous solutions, the dominant mechanism of T2 relaxation is dipole-dipole
interactions. Dipole-dipole interactions refer to the spatially varying magnetic fields
associated with the hydrogen protons of each water molecule. Since the dependence
falls off as the sixth power of the distance from the dipole [34], the effect on any
given hydrogen proton is only due to the other hydrogen proton of the same water
molecule. Due to thermally-induced tumbling, there will be a spatial variation in
the local B field experienced by each dipole, resulting in an exponentially decaying
magnetization recorded by a receiver coil and characterized by the T2 time constant.
Analytical expressions for intrinsic T1 and T2 of pure water are included as Equations
(2.28) and (2.29) of reference [34] as well as in numerous other sources.
14The relaxivity of a contrast agent is defined as the inverse of relaxation time associated with
the agent acting alone and has units of mol- s - 1. However, it is often expressed in units of s- 1,
so that the final time constant (in seconds) is the result of adding the inverse of the time constant
before contrast enhancement (sometimes called the "intrinsic relaxivity") to the contribution from
the agent's relaxivity.
Outer and Inner Sphere Relaxation
Contrast agent electrons interact with the hydrogen spins of nearby water molecules in
two ways and these are referred to as inner-sphere and outer-sphere relaxation. Inner-
sphere relaxation refers to the direct exchange of energy between the proton spins and
the electrons of the contrast agent and, in general, involves binding between the water
molecules and the contrast agent. Inner sphere relaxation accounts for up to 50% of
the relaxation effect in gadolinium-based agents [28]. Outer sphere relaxation occurs
due to the movement of water molecules in the vicinity of the field inhomogeneities
arising from the agent particles and usually does not involve binding. Inner sphere
relaxation is modulated over frequency by a time constant which depends on proton
exchange rate, ion rotation and electron spin relaxation. In outer sphere relaxation,
this modulation is usually approximated by the diffusion time constant of the solution
in the absence of contrast agents.
The relaxation of superparamagnetic suspensions in water is described by the
theory of Outer Sphere Relaxation. This theory owes its derivation to quantum
mechanical spin theory. After much debate within the literature, it appears that a
correct formulation for the additional contribution to T1 and T2 relaxation due to
superparamagnetic agents in water is given by equations (23a) and (23b) of Gillis'
publication [10].
1.5.3 Superparamagnetic Relaxation
In the presence of superparamagnetic contrast agents, relaxation mechanisms other
than dipole-dipole interactions become important. The theory of MRI relaxation in
the presense of magnetic particles owes its beginnings to the Solomon-Bloembergen
equations for diffusion [20] and has been subject to much revision and debate since
[8-10, 25]. It now appears that Gillis et al. [11, 13] have formulated a complete and
experimentally verifiable theoretical prediction for the additional contribution to T2
in the presence of superparamagnetic particles. Their approach, relying heavily on
a quantum derivation, is based on extending the analysis of paramagnetic agents to
include the additional characteristics of superparamagnetic particles. The final ana-
lytical expressions given by Eqs. (23a) and (23b) of reference [10] for the additional
contributions to T1 and T2 (expressed here in SI units) due to magnetic nanoparti-
cles are given by Eqs. (1.17) and (1.18) in the high field15 limit where "Re" denotes
the real component of a complex quantity and where:
NA = Avogadros' constant = 6.022x 1023 mol-1
Po = magnetic permeability of free space = 4r x 10- 7 T.m.A- 1
C = molar concentration 16 of contrast agent in mol-m - 3
pm = magnetic dipole moment = VpMd from Eq. (1.5)
Td = diffusion time constant in s from Eq. (1.21)
d = closest distance of approach of water molecule to SPIO particle in m
Jo = power spectral density function from Eqs. (1.19) and (1.20)
T = ferrofluid time constant from Fig. 1-2 and Eq. (1.1)
= unitless Langevin parameter = ,oV' Md Ho
V, = magnetic volume (excluding surfactant) of each particle in m3
Bo = applied external field in T
k = Boltzmann's constant = 1.38 x 10-23 m2.kg.s-2.K - 1
15Gillis' high field limit corresponds to a high spin limit, where S>1 in the quantum-based ex-
pressions he establishes. Since this is true of superparamagnetic particles over the entire range of
Larmor frequencies, we can consider the expressions to be complete for superparamagnetic particles
over all frequencies.
16A full discussion on the various terminologies employed to describe contrast agent concentration
is included in Appendix B
T = absolute temperature in K
NA c,2 7Td 2 (a) jo(WO, rd, - __ 00) +
1/T 1 = 0 2 "NA C { 3 L2(a) 0( d, T ) +
1357r m d3
3 [1 - 2L(a) - L2(a) Jo(wo, d, ) } (1.17)
1/T2 - 104 72 NA C 2 { L2(a) [3 Jo(wo, 7d, 7 -- 00) + 4 Jo(O, d, T, - oc)]
1357r -d3
+ [1 - 2 L (a ) - L2 (a)] [3 Jo(wo, Td, T) + 4 Jo(O, d,- )1 } (1.18)
1 + 0.25 To.5
Jo (w, 7d, 7) R= 1e + (1.19)
1 + To.5 + 4 T/9 + 1/9 T1.5
T = (yw + 1/-) rd (1.20)
While the expressions seem unwieldy at first, it should be noted that these are
general equations governing T1 and T2 over the entire spectrum of Larmor frequen-
cies. The expressions for 1/T1 and 1/T2 are the analytical equivalents to the usually
experimental values for the R 1,2 C terms in Eqs. (1.15) and (1.16). In reality, one
is generally interested in the time constant at a particular frequency, corresponding
to Bo for the MRI system in question. However, since these expressions have been
experimentally validated over a large range of wo [8,16], the theory of the approach
merits discussion. For this work, the additional contribution from superparamag-
netic particles to the T1 and T2 relaxation times is shown in Figures 1-9 and 1-10
respectively when the solid magnetic volume fraction is 1.38 x 10-6.
01
e
I-
03
Larmor Frequency [MHz]
Figure 1-9: Theoretical contribution to T1 predicted by Equation 1.17 for super-
paramagnetic particles of magnetite with varying radii and a solid magnetic volume
fraction of 1.38 x 10-6.
Outer Sphere Relaxation Discussion
The power spectral density term, given by Eqs. (1.19) and (1.20), represents the corre-
lation between wo and the electron-proton modulation [28] and for superparamagnetic
particles is dependent on two time constants: 7d and r, where r is the previously de-
fined ferrofluid time constant. The diffusion time constant Td is dependent on the
"closest distance of approach", d, as given by Eq. (1.21) where D is approximated
as the self-diffusion time constant of water at 250C. Mills [29] has estimated D to be
2.4 x 109 m2.s- 1 using an activation energy of 17.6 kJ/mol at room temperature.
rd = - (1.21)D
While Gillis et al. approximate d as the effective radius of the magnetic nanopar-
ticle [8], the approach of Bulte et al. [16] is to approximate it from experimental
results of MION-46L1 7 as 7.9 nm. Bulte's approach and approximation has been
adopted in this analysis for convenience. Furthermore, the approximation of D as
the self-diffusion time constant of water at 250C is wholly justified given the very
low superparamagnetic particle concentrations that are practical for imaging and the
negligible variation of the Langevin function over the clinical temperature range. The
analysis here is conducted assuming a temperature of 25 0C.
Gillis notes that his expressions for T1 and T2 are only valid for small particle
radii (up to 6.5 nm, from Fig. 1-4), when the Neel time constant dominates [II]. This
follows from an earlier assumption made in his analysis concerning the anisotropic
energy density [10].
It is evident that the expression for 1/T2 carries an additional DC term which does
not arise in the T1 expression. It is the DC term that gives rise to net phase shifts in
the {xy} plane [34]. Terms containing an infinite T term correspond to the relaxation
effect due to the time-averaged component of the spin aligned with Bo, since the
time-average is not affected by electron spin fluctuations [11]. The remaining terms
result from the AC or fluctuating components of the spins aligned with Bo and these
terms do show a dependence on 7, as expected. A factor of 3, which was omitted in
previous analysis [10] and now appears in the fluctuating (i.e., wo-dependent) terms
of both the expressions for 1/T1 and I/T2, Eqs. (1.17) and (1.18), accounts for the
alignment of superparamagnetic moment with the applied Bo field.
In comparing Gillis' expressions to experimental results, it is important to consider
the conversion of all quantities to SI units and to carefully consider the units of molar
17MION-46L is an ultrasmall monocrystalline superparamagnetic iron oxide believed to consist
mainly of maghemite or magnetite crystals.
concentration, C. The theoretical work outlined here follows the approach of Bulte
et al. [16] in applying Gillis' results to MION-46L particles in solution, where we
only consider the superparamagnetic contribution detailed in [16]. Following this
approach, the contributions from a ferrofluid dilution containing 1.38 x 10-6 solid
volume fraction to the overall relaxation time constants, as given by Eqs. (1.15) and
(1.16), are plotted in Fig. 1-9 and Fig. 1-10.
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Figure 1-10: Theoretical contribution to T2 predicted by Equation 1.18 for super-
paramagnetic particles of magnetite with varying radii and a solid magnetic volume
fraction of 1.38 x 10-6.
Susceptibility Effects in vivo
While Gillis' theory of outer sphere relaxation is an accurate model for the re-
laxation of water molecules in aqueous solutions of superparamagnetic particles, the
model does not account for the restrictions imposed on water diffusion in vivo. Instead
Z - ------- ~ - ·---- · · ~ ----- · ·- ~~ - --- ·--- ~ - ----.- ·- ~ · -1-----·
J .J..., .1.... .... I
of the implicit assumption of unlimited diffusion which is true in the phenomenologi-
cal model, diffusion is restricted in the body by compartmentalization of the contrast
agent in various tissues and cells [28]. Consequently, the transverse relaxation time,
T2, is considerably shorter in vivo than that predicted by the model and will be a
function of the echo-time, TE [12,14,15,17]. The literature refers to this phenomenon
of T2-shortening in vivo as susceptibility effects.
The longitudinal relaxation time, T1, is affected to a lesser extent since the local
magnetic fields generated in vivo are large enough that T1 relaxivity due to the
contrast agent has dispersed and the T1 decay is due mostly to the contribution from
the solvent, which is usually water.
In spin-echo sequences, susceptibility effects are minimized since the phase of each
individual spin is refocused in every echo with a consequent reduction in the total
dephasing observed at the echo time, TE. This means that susceptibility effects are
only of interest for the case of T2* imaging.
1.6 Results
1.6.1 T1 and T2 Estimation
In order to validate the model described in the previous section, a series of experiments
were conducted to establish the T1 and T2 relaxivities due to an aqueous solution
containing superparamagnetic particles. This work continued the initial evaluations
of Professor Adalsteinsson which are included in Appendix C. Since the ferrofluid
concentrations and imaging parameters varied considerably from his work to this, a
meaningful comparison is difficult. However, the work is included for the interested
Figure 1-11: Various ferrofluid concentrations were examined at 1.5 T with reference
to a deionized water control. The white vial W outlines indicate the regions of interest
for quantification of T1 and T2 relaxation times.
reader. Various concentrations of MSG Wll s ferrofluid in deionized water were
placed in sealed cylindrical vials (11 cm in length, 2.8 cm in diameter) and the vials
were placed in a 1.5 Tesla MRI. Results for T2-weighted images of vial cross-sections
are shown in Fig. 1-11. Through careful selection of the TR and TE times, a relax-
ation series of curves was obtained and it was possible to arrive at an experimental
relationship between the transverse and longitudinal relaxation times of the ferrofluid
and the concentration of the ferrofluid in the vial. These results correspond to the
combined effects of water and ferrofluid relaxation, as given by Tlafter and T 2after of
18MSG W11 is a water-based ferrofluid available from Ferrotec Gmbh (Germany) containing 2.8%
to 3.5% magnetite by volume with an estimated mean core radius of 4.7 nm [44]. Further information
is at http://www.ferrofluidics.de/pdf/si/msgw11.en.pdf
Eqs. (1.15) and (1.16). The ferrofluid solution contained 2.75% magnetite by volume
but in order to generate MR images with meaningful SNR, it was necessary to dilute
the solution considerably as outlined in Table 1.2. The concentration dependence
was fitted to a power curve and resulting experimental fit led to Eqs (1.22) and (1.23)
where T1 and T2 have units of ms and q is the solid volume fraction of the solution.
Vial Solid Volume Fraction, ¢ T1 in ms T2 in ms
A 4.7 x 10-7  1706 265
B 1.15 x 10-6 1345 108
C 2.2 x 10-6  1009 74
D 2.75 x 10-  887 57
E 5.5 x 10- 6  - 27
F 1.4 x 10-5  - 20
Table 1.2: T1 and T2 results for various ferrofluid solid volume fractions, 4, of MSG
W11 supplied by Ferrotec. At very high concentrations (4 > 5 x 10-6), the SNR was
not sufficient to allow for the accurate determination of TI relaxation times.
T1 m 10.794 4-0.348 (1.22)
T2 x 0.00062 4-0.889 (1.23)
1.6.2 Significance of T1
The theoretical prediction of the total time constant for MSG W11 was obtained from
the right-hand side of Eqs. (1.15) and (1.16) where Tlbef,, and T2before correspond
to the longitudinal and transverse relaxation of pure water. The R C terms are as
predicted by the outer-sphere relaxation model (Eqs. 1.17 and 1.18) at a Larmor
frequency of 64 MHz (corresponding to 1.5 T, as given by w0 = 21r-yBo). The values
of Tlbefre and T 2befoe, due to pure water acting alone, are clearly independent of
ferrofluid concentration and in the most fundamental derivation would be derived
from Eqs. (2.28) and (2.29) of reference [34]. However, these expressions prove to be
over-complications for this purpose and experimental values for T1 and T2 of pure
water are used. The experimental data from Table 1.2 for T1 (in ms) is plotted in
Fig. 1-12 along with the experimental datapoints.
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Figure 1-12: Experimental results for T1 (given in ms) over a range of MSG W11
ferrofluid concentrations measured by the unitless fraction solid volume, 4.
It turns out that an accurate prediction of the theoretical T1 value from the
combination of T1 for pure water and the prediction of Eq (1.17) replicates the
experimental analysis when the T1 relaxation time for water is 2000 ms. This is the
value used in Figure 1-12. Since the T1 contribution from the ferrofluid grows rapidly
at reasonable imaging frequencies so as to soon become insignificant compared to the
contribution due to the intrinsic T1 from the water's dipole-dipole interactions (this
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is clearly seen from the plots of Fig. 1-9), T1 is of lesser interest when considering
ferrofluid as a contrast agent for MRI since the percentage change in T1 is modest
compared to the effect of the SPIO particles on T2 (as will be shown in Figure 1-13).
Nonetheless, the effect of T1 shortening, even for dilute solutions, is not negligible.
This is clearly seen from the results of Table 1.2 and in the plots of Figure 1-12.
However, since the effects on T2 are more pronounced (i.e., comparable to those
from pure water), superparamagnetic solutions are generally considered T2-contrast
agents.
1.6.3 Significance of T2 and Theoretical Approximations
T2 Experimental and Theoretical Results
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Figure 1-13: Comparison of the theoretical prediction for T2 at various superparamag-
netic particle radii with the experimental results over a range of MSG W11 ferrofluid
concentrations measured by the unitless fraction solid volume, 4.
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In estimating T2 from theoretical analysis, the relaxation contribution due to the
pure water acting alone was chosen to be 570 ms in accordance with our recorded
experimental result. The value for T2 due to the ferrofluid alone was calculated
over a range of particle radii and the combined result, as given by Eq. (1.16) is
plotted in Fig. 1-13 versus ferrofluid concentration. Also included in the figure are
the experimental values for T2 in the solution over the same concentration range
for an expected mean particle radius in the range of 2.2 to 6.2 nm as measured by
Elborai [44] and He [45] using transmission electron microscopy. From inspection of
Fig. 1-13, a number of observations are notable:
* The value for the particle radius from Figures 1-12 and 1-13 appears to agree
closely with the upper end of the particle radius range measured by Elborai and
He [44,45]. This is expected since it is the largest particles which will dominate
the T1 and T2 relaxation times. Larger particles tend to have shorter relaxation
times and hence, due to the parallel nature of the contributions from particles
of different radii, it is these shorter relaxation times which will dominate the
final T1 and T2 values. Indeed, T1 and T2 measurements would appear to be
a robust measure of the particle radius, R as evidenced by the results shown
here.
* The experimental result at a concentration of 1.4x 10- 5 would appear to be
somewhat outlying. This is to be expected since at very high concentrations
the ferrofluid image on the MRI appears so dark that accurate determination
of the mean signal intensity is difficult and the SNR suffers significantly.
* The values of theoretical T2 are found to have little frequency dependence at tra-
ditional Larmor imaging frequencies. This follows from Fig. 1-10 where, depend-
ing on particle radius, at Larmor frequencies beyond approximately 100 MHz,
the contribution to T2 due to the ferrofluid is almost independent of frequency.
Accordingly, it is sometimes deemed satisfactory [12] to ignore this frequency de-
pendence entirely and approximate T2 from the ferrofluid by the high-frequency
limit of Eq. (1.18) given by Eq. (1.24) where the Langevin function approaches
unity and all of the power spectral density functions approach zero except for
Jo(wo, -rd, + 00) which approaches unity. At 1.5 T, this is not an entirely
accurate approximation as can be seen from inspection of the plots of Fig. (1-
10), which are not quite independent of frequency at the corresponding Larmor
frequency.
1/T2 4x104r 2 NACp: 2 Wd (1.24)

Chapter 2
Transverse Field Excitation
The purpose of this chapter is to explore the feasibility of inducing spin-velocity in a
ferrofluid while in MRI. To do this, an external field, in addition to those currently
available in MRI, is introduced and its effect on the magnetization of the ferrofluid
is examined. The external field is transverse to the Bo field that characterizes MRI
systems.
2.1 Introduction
Fundamental to MRI are three applied magnetic flux densitites: a strong, homogenous
z-directed DC field, Bo; an RF field, B1; and spatially-varying encoding fields or
gradients, G. The Bo field (1.5 T or 3 T for the most common clinical systems) induces
polarization of nuclear spins, the much weaker (-0.01 mT) and transient ('ms)
B 1 field is used to drive the induced z-directed magnetization into a transverse xy
component for imaging, and the gradients (-10 mT/m) are DC fields used to spatially
encode the transverse magnetization during relaxation to a resting state (- 10ms).
Under the large Bo field of conventional clinical MRI systems, it is expected (based
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Figure 2-1: A planar ferrofluid layer between rigid walls at y = 0, d, is magnetically
stressed by a uniform DC z-directed magnetic field Ho, an x-directed magnetic field of
complex amplitude hx and a y-directed magnetic flux density of complex amplitude
by. The x and y components vary sinusoidally at frequency Q. The walls are of
infinite extent along the x and z axes and there is no ferrofluid outside the channel.
on Fig. 1-2) that the equilibrium magnetization of a water-based ferrofluid would
be saturated and virtually all the magnetic particles in the suspension would rigidly
align with Bo. However, low-field MRI platforms exist, typically employed for better
patient access or intervention by physicians during scanning. Commercial low-field
MRI scanners operate typically at 0.2 T or 0.35 T, and this is the field-range examined
in the work that follows. With this lower Bo, it is shown that ferrofluid saturation is
not complete as determined by the Langevin relation for magnetic suspensions [42]
and ferrofluid particle spin is indeed possible. In our analysis, we derive the expression
for the ferrofluid spin velocity, w induced by adding a fourth field component, Be,
to a conventional MRI. Here, we assume Be to be a rotating field applied in either
the transverse {xy} plane or the longitudinal { yz} plane such that one component of
the rotating field is collinear with the z-directed Bo. A simple but important channel
geometry introduced by Zahn and Greer [47] and shown in Fig. 2-1 is employed,
)
which allows for the imposition of boundary conditions on both magnetic fields and
fluid flow. For the first case to be considered in this chapter, both Be and B, are
transverse, rotating fields and the rotation frequency of B, is proportional to Bo as
given by (2.1), where y is the gyromagnetic ratio of the nucleus under study, which
for conventional MRI is the 'H proton with y = 42.58 MHz T- 1.
f,= -y Bo (2.1)
This work examines a wide range of rotation frequencies for Be including those
typical of fi in open MRI systems (8.5 MHz for 0.2 T and 14.9 MHz for 0.35 T).
However, the amplitude of Be is set between 1% and 10% of Bo, which is much larger
than typical B, amplitudes. Modulation of the transverse magnetization is achieved
by selecting the transverse Be excitation frequency, termed Q, to be of the same order
as the reciprocal of the ferrofluid relaxation time r. For typical SPIO nanoparticles,
r is on the order of 1 its, (see Fig. 1-2).
A novel linearization of the Langevin relation for magnetic fluid suspensions is
presented for small signal field variations around the operating point determined by
the Bo field. Having established this linearization, the scenario of a concurrent Bo
and transverse rotating Be field is examined. In addition to this relatively simple case
of magnetic field-driven spin-velocity, two flow-driven regimes for spin-velocity mod-
ulation are examined for the channel geometry shown in Fig. 2-1. The first considers
Couette-imposed flow [105] where the upper channel plate moves at a constant lin-
ear velocity Uc, transverse to Bo. The second regime is the more common Poiseuille
flow [105] where fluid flow is due to an x-directed pressure differential across the
channel. Two critical parameters of interest in the MRI environment are examined
in all cases. These are the ferrofluid spin-velocity in the channel and the resultant
modulation of the transverse fluid magnetization that arises in the channel due to
the simultaneous relaxation and realignment of the magnetic nanoparticles with the
applied transverse rotating field. Results for both quantities are examined over a wide
range of parameters for magnetic nanoparticles with physical characteristics typical
of SPIO agents used in MRI.
2.2 Theory
2.2.1 Governing Equations
The geometry shown in Fig. 2-1 follows the analysis of Zahn and Greer [47] and is
carefully selected to allow the imposition of fields along all three axes.
Magnetization Constitutive Law
The magnetization relaxation equation for a ferrofluid under the action of a rotat-
ing magnetic field, thereby undergoing simultaneous magnetization and reorientation
with the applied field, is given by (2.2). The fluid linear flow velocity vector is v, the
ferrofluid spin-velocity vector is w and the ferrofluid relaxation time [42] is 7.
BM + v. VM - w x M + (M - Meq)/7 = 0 (2.2)
For the planar geometry shown in Fig. 2-1, the flow velocity can only be x-directed
and the spin-velocity can only be z-directed. Both quantities may vary spatially along
y.= (y)i(2.3)
v = vx(y)ix (2.3)
w = w(y)z (2.4)
Magnetic Fields
This analysis assumes the magnetoquasistatic limit so that the displacement current
can be neglected. For typical poorly conducting fluids compared to typical metal
conductivities, conduction currents can also be neglected if the skin-depth is much
larger than a characteristic dimension of the ferrofluid. A water-based ferrofluid may
have a conductivity, a, of about 28 x 10-6 (~ m)- 1 [73]. Based on an excitation
frequency of 850 kHz and p = 2 po (both typical of the analysis which follows), the
skin depth, given by Eq. (2.5) is shown to be 2 orders of magnitude greater than any
length dimension characteristic of this analysis (where d is on the order of 4 cm).
6 1x102 m (2.5)
Under such conditions Ampere's Law approximately reduces to Eq. (2.6).
Vx H = 0 (2.6)
In this case, the magnetic field intensity can be rewritten [43] as the gradient of a
scalar potential, T, as in Eq. (2.7).
H= -V'I (2.7)
Gauss' Law, given in Eq. (2.8) requires the divergence of the magnetic flux density
to be identically zero.
V B = 0 (2.8)
The constitutive relation for a magnetizable material, such as ferrofluid or water,
is given by Eq. (2.9) where /to is the permeability of free space and has the value of
47r x 10- ' H-m - 1.
B = po(H + M) (2.9)
In water, which is diamagnetic and has a magnetic susceptibility of X = -9 x 10-6
at room temperature [93], it can be generally assumed that the magnetization vector,
M, is significantly smaller than the H field and the constitutive relation reduces to
Eq. (2.10).
B = poH (2.10)
Considering the geometric arrangement of Fig. 2-1, the imposed magnetic field
intensities along i, and iz are spatially uniform with corresponding zero spatial
derivatives. This follows from Ampere's Law which states that in the absence of
any conductive or displacement current densities, the curl of the magnetic field inten-
sity is necessarily zero, as given by (2.11). For the geometry of Fig. 2-1, this means
that both the x and z components of magnetic field intensity are uniform since Ho is
invariant in space and there is no imposed H field along the y axis (i.e., hy = 0) as
given in (2.11).
VxH=0
aHo A0, aHoOH O 0 - I =0
ay oz ay
Ohx OHo Oh~
-=0 • =0Oz Ox Oz
0 a =0 -hx 0 (2.11)ax ay ay
Similarly for the imposed magnetic flux density along iY since Gauss' Law states
that normal components of the B field are continuous, as given by (2.12). For Fig. 2-
1, this means that the components of B field along the y axis are continuous since
there are no imposed B components along x (i.e., b. = 0) and the main, z-directed
Bo field is invariant in space.
V-B= x+ + by = 0Ox Oy Oz
= = 0 since "x = 0 = 0 (2.12)
ay Ox az
In light of these observations, the total magnetic flux density B and the total
magnetic field H is given by (2.13) and (2.14) respectively where hx and h. are
now sinusoidally time-varying quantities and hh = 0. Complex notation is used
for convenience. The ^ symbol denotes a complex amplitude, Re signifies the real
component of a complex quantity, 2 is the frequency of excitation in rad-s- 1 and
3 = VT-. The relationship between B, H and M is given by the familiar expression
of (2.16).
B = Re{(b,(y)ix + •iy)e7fl + Boiz (2.13)
H = Re{(hxix + hv(y)iy)e 3 t } + Hoiz
M = Re{ (7ix(y)ix f+ r(y)iy)eJt} + Moiz (2.15)
B = po(H + M) (2.16)
The relationship between Mo and Ho, the z-directed components of magnetization
and magnetic field intensity respectively, has been established in (A.20). In seeking a
solution for the instantaneous magnetization, the imposed fields by and hx are assumed
known. This follows from (2.11) and (2.12), where normal components of the B field
and tangential components of the H field are continuous within the ferrofluid. The by
field might be imposed by means of a U-shaped electromagnet with its poles at y = 0
and y = d. The magnetic field, hX, might be imposed using planar current sheets at
the y = 0 and y = d (equal in magnitude and opposite in direction) where the surface
current density, K,, is given by Ampere's Law: V x H = K,.
Substituting for Mq from (A.17) through (A.20) and for M from (2.15) one can
rewrite the x and y (transverse) components of (2.2) using (2.16) as given by (2.17)
and (2.18).
Mo (j•r + 1 + Mo/Ho)hx - (w,zr)by/to
Ho (0lr + 1)(jR + 1 + Mo/Ho) + (w r)2
Mo (wzr)hx + (36jr + 1)b/o (2.18)
Ho (jQ• + 1) (jQ + 1 + Mo/Ho) + (w ')2
The only unknowns are the complex amplitudes of transverse magnetization rhx
(2.14)
and raz which are a function of the, yet undetermined, spin-velocity w,. The second
term of (2.2), v -VM, does not contribute any terms since the flow velocity is along
i, and all small signal terms can only vary with y. In the absence of a small signal
magnetic field along iz, the z-component of magnetization is constant and given by
the equilibrium value of Mo. The magnetization of the ferrofluid in the presence of
small-signal rotating magnetic fields gives rise to a torque which, in turn, is respon-
sible for fluid motion causing a non-zero value for spin-velocity w~ and flow velocity
v,. Non-zero w, and v, results in a changed fluid magnetization. Therefore, as well
as the ferrofluid relaxation, one should consider the mechanical equations of interest
to arrive at a consistent solution for riz, rhy and w,.
Fluid Mechanics
Applying the principles of conservation of linear and angular momentum to an in-
compressible ferrofluid leads to the simplified expressions of (2.19) and (2.21) respec-
tively [42,48] where p' is the modified pressure along the channel, given by (2.20), p
is the absolute pressure in Pa, g is the gravitational acceleration acting along iy in
m-s- 2, p is the ferrofluid mass density in kg-m - 3, ( is the ferrofluid vortex viscosity
in N-s-m - 2, q is the dynamic shear viscosity of the ferrofluid in N-s-m - 2 and Tm is
the magnetic torque density given by (2.22) in N-m - 2 . The expressions consider the
situation of sinusoidal steady state with viscous dominated flow conditions (so that
inertia is negligible) and the ferrofluid only responds to force and torque densities
which have a time-averaged, non-zero component. Also ignored are the coefficients
of shear and bulk viscosity (r'( and A') [42] discussed by Elborai [44] and He [45].
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-Vp' + Pto(M -V)H + 2(V x w + (( + rq)V 2v = 0
p' = p + pgy (2.20)
Tm + 2((V x v - 2w) = 0 (2.21)
Tm = po(M x H) (2.22)
Considering that, for the channel geometry of Fig. 2-1, fluid flow is only allowed
in the x direction, (2.21) can be simplified and rewritten in (2.23) where the only
non-zero components are along the z axis.
Tm,z + 2((- ) - 4(w = 0 (2.23)
After considering time averaging, denoted by ( ), the only remaining non-zero
component of magnetic torque density for the system, now expressed in terms of the
applied fields from (2.22), is given by (2.24) where * denotes the complex conjugate.
(Tm,z) = -ORe(hx h* - hx Sn) (2.24)
*2 ) h (2.24)
Considering (2.16), one can rewrite the time-averaged torque density in terms of
the imposed fields and the complex transverse magnetization amplitudes.
(Tm,z) = 2Re(n by* - po(hx + fnx) 1h) (2.25)
2Tnz = Y• n•b ~
(2.19)
Comparing (2.25) and (2.23), one can combine to find an expression that elimi-
nates Tm,z and is given by (2.26).
yv, 1
2( + 4(w, - Re(rii by - po(he + 7rh) ih*) = 0 (2.26)
Considering (2.19), one should note that the second non-zero term, Po(M V)H,
is the magnetic force density Fm associated with the ferrofluid. However for the
geometric arrangement of Fig. 2-1, the field components can only vary with y so
the only non-zero component of magnetic force density is y-directed and given by
(2.28). Again, only the non-zero, time-averaged terms are retained. As previously,
the~ symbol is used to denote the real-valued, time-varying, small signal field while
the * symbol indicates the complex, small-signal amplitude.
axaOy Za
8hh
S Fm,y= = Uo(mTy h)
ay
(Fm,y) = Re [, hy
by = /to (h, + (,)
= (Fm,y)= - Re[_ n (2.27)
2 the chain rule of differentiation, (2.27) ca  be expressedY as (2.28).
Considering the chain rule of differentiation, (2.27) can be expressed as (2.28).
(Fm,y)y (2.28)
In light of the simplification of (2.28) one might write the non-zero components
for (2.19) as given by (2.29) and (2.30). Conservation of linear momentum yields
components along both i. and iy, given by (2.29) and (2.30) respectively. There is
no component along iz.
P+ 2 + ( 2 + r) = 0 (2.29)
Ox + 9y +y 2
Oy 4 Oy
p + pgy +c- rn, 2 = constant (2.31)
Equations (2.17), (2.18), (2.26) and (2.29) now constitute a closed system of equa-
tions with 4 unknown quantities: spin-velocity, w,, flow velocity, vx, and the two com-
plex amplitudes of magnetization along ix and iy, denoted rAh and fhy, respectively.
It is again noted that by and hx are imposed uniform small-signal fields and therefore
known. While (2.31) is an additional equation of interest which accounts for changes
in fluid pressure, it does not govern fluid flow. However, (2.31) does provide a way to
measure A, from pressure measurements.
2.2.2 General Solutions
Field Driven Solution
Generalized analytical solutions are possible considering (2.17), (2.18), (2.26) and
(2.29) when boundary conditions are defined. When both plates in Fig. 2-1 are fixed,
the flow velocity is necessarily zero at the boundaries y = 0 and y = d.
From Maxwell's Equations, the relevant boundary conditions on the magnetic field
components are given by Eq. (2.32) and Eq. (2.33) where in is the unit vector normal
to the boundary in the second medium. K, is the boundary surface current density
in A-m - '. The magnetic flux density and magnetic field intensity, given by B1 and
H 1 respectively, correspond to the fields on the inside of the ferrofluid region (i.e.,
O < y < d) in the first medium while B2 and H2 correspond to the fields outside the
ferrofluid (i.e., y < 0 and y < d). The surface currents at y = 0 and y = d must
be opposite in direction (x-directed surface current to generate a uniform z-directed
field and z-directed surface current to generate a uniform x-directed field) so that the
fields outside the ferrofluid region are zero. For the y-directed B field, the field is
confined to the channel when the pole faces are located at y = 0 and y = d.
in -(BI - B2) = 0 (2.32)
i, x (H 1 - H 2) = K, (2.33)
In the absence of any imposed flow or pressure differential in the channel, the first
term of (2.29) is zero. It it is not necessary to define boundary conditions on w,.
vx(O) = vx(d) = 0 (2.34)
Additional boundary conditions for the field components follow the continuity
law of electromagnetics such that normal components of B are continuous at the
boundaries y = 0 and y = d, while the tangential components of H are determined
by the surface current densities at the boundaries y = 0 and y = d. Integrating
(2.29) with respect to y and some rearranging leads to (2.35) where C1 is a constant
of integration. For this solution, the pressure differential is not considered although
the cases of an applied pressure differential are considered later.
_v 1
- = - (Cl + 2(wz) (2.35)
y ( + rl
Substituting from (2.35) for the derivative of vx in (2.26) and solving for w, leads
to (2.36).
S+  e (2.36)CWZ= 8-C 1e(r b* - pio(hx + i) x ) + 2 (2.36)
Inspection of (2.36), where the expressions for ri and ^,Y can be substituted
from (2.17) and (2.18), shows no y dependence. It follows that wz is necessarily a
constant in space, thereby also setting the second term in (2.29) to zero. Solving the
remaining non-zero term of (2.29) by integration with respect to y (since ( and 77 are
both assumed non-zero) and applying the boundary conditions of (2.34) shows that
the flow velocity in the channel is zero. C2 and C3 are constants of integration.
82vx2 =y 0 (2.37)8y2
X = C2 (2.38)
vx(y) = C2Y + C3 (2.39)
vX(0) = vx(d) = 0 =* C2 = C3 = 0 = vx(y) = 0
Applying this result to (2.35), one can solve C1 = -2(wz and substituting for C1
in (2.36), the spin-velocity wz is given in terms of mx and M^ .
z = RJe(MAX by - po(he +  z) Ix) (2.41)
While (2.41), (2.17) and (2.18) do not facilitate closed form solutions for w,
mEz, and Mr, the equations were solved using Mathematica 5.2 (Wolfram Research,
Champaign, Illinois) and the results are included in the following section. It should
be clear from (2.41) that in the absence of one or other of the x and y components
of the applied small-signal magnetic field, the spin-velocity is zero.
Couette Flow Solution
The only difference between the case of an imposed Couette flow and the previous
solution is the changed boundary condition at y = d where vx(d) = U, and U, is
the imposed linear velocity of the upper plate in m-s- 1. In addition to the imposed
Couette flow, the applied rotating transverse field excitation remains present so that
the spin-velocity is due to a combination of the magnetic driving field and fluid flow.
There is no imposed pressure differential along i, so the analysis is identical up until
(2.35). However since the non-slip boundary condition at y = d requires v.(d) = U,
this leads to a solution with C3 = 0 and C2 = U,/d. Substituting into (2.35) one
finds the revised form of (2.41) for imposed Couette flow conditions, given in (2.42).
Uz = 8(e( X by - ,o(h + ) ) - (2.42)
=C - (L+
(2.40)
Similar to the no-flow solution, (2.42), (2.17) and (2.18) were solved using Math-
ematica 5.2 and the numerical results are presented.
Poiseuille Flow Solution
Poiseuille flow is achieved in the channel by means of an x-directed pressure differ-
ential which, in the absence of a magnetic torque density in the fluid, results in a
parabolic flow profile with y. The imposed flow is, again, in addition to the rotat-
ing transverse field excitation due to Be where Be is the amplitude (in Tesla) of the
rotating field excitation. This complicates the previous solution and leads to the ex-
pression of (2.48) after twice integrating (2.29) (repeated in (2.43)) with respect to y.
The expression for - is substituted from (2.25). Note that the first term of (2.29)
is now non-zero, corresponding to the pressure drive. K1 and K2 are constants of
integration while (T,,z) is still given by (2.25).
ap' _w_ 62 vx
-
+ 2 + (C + 7)Y = 0 (2.43)ax ay ay2
Op' ___ 24 1 9Tm,z 1 O2vUy ] 02vxU
-+ 2( + (_± + l)(( y2 = 0 (2.44)ax 4( ay 2 ay2 aY2
_p' 1 Tm,z 9 2vXS- + y = 0 (2.45)ax 2 ay By2
ap' 1 Tv =
py + 1(T,z) + + K' = 0 (2.46)
ax 2 9y
8p 1 Ov,
= L + (Tm,) + q-a-y + Kg = 0 (2.47)ax 2 19Y
p y2 1 pfY
--- 2 + -+2 (Tm,z)dy + Vx± + Kiy + K 2 = 0 (2.48)
Applying the non-slip boundary conditions on vx at y = 0 and d allows for the
solution of K1 and K 2.
vX(0) = 0 = K 2 = 0 (2.49)
d 8p' 1 od
v(d) = 0 K = Op - 1 (Tm,z)dy (2.50)2 ax 2d o
Substituting the results of (2.49) and (2.50) into (2.48) and rearranging one arrives
at (2.51).
&v y 1 Op' 1 1 d
a- = (2y - d) - (Tm,z) + (Tm,z)dy (2.51)ay 2,q ix 277 2d o
Substituting for the derivative of vx given by (2.51) into (2.48) and substituting
for K1 and K 2 leads to an expression for wz which is independent of vx and where
(Tm,z) is given by (2.25).
lp' a+( 1 dWz = (2y - d) + (Tm,z) (Tm,z)dy (2.52)
4 Ox 4(,q 4d Jo
While (2.52) is not solvable analytically, it can be solved numerically and the
results which follow use ComsolMultiphysics to do that. As an analytical check on
the numerical solutions, some simplifications were examined. The first limit is when
the pressure differential dominates and (Tm,z), the internal magnetic torque density
after time-averaging, is zero. In such a scenario, w, is a maximum or minimum at
y = {0, d}, where the sign depends on the direction of the pressure differential and
wz = 0 at y = d/2. For x-directed flow, the differential is negative and wz is a positive
maximum at y = 0 as given by (2.53).
(Tm,z) = 0
d 0p'
wz(Y = 0) = -wz(y = d) = (2.53)
Similarly for vx which has a maximum value at y = d/2 given by (2.54). In the
results which follow, this maximum velocity is denoted Up.
(Tm,z) = 0
d2 ap'
vX(d/2)= - - Up (2.54)
8r7 Ox
As with the field-driven and Couette-imposed flow conditions, spin-velocity and
transverse magnetization are solved and plotted under varying physical parameters
of interest.
2.3 Results
2.3.1 Physical Parameters
The physical ferrofluid parameters are selected for application of SPIO agents in a 0.1-
0.35 T MRI scanner with SPIO concentrations, ¢, varying between 3% and 0.003%.
This lower end value of ¢ = 0.003% is still over an order of magnitude beyond the
recommended dosage of Feridex, the only FDA-approved SPIO agent, after it becomes
diluted in the subject's bloodstream (see Table B.1 of Appendix B). The non-varying
parameters are included in Table 2.1. Nominal values are included for Bo, Be, f,
Table 2.1: Table of Nominal Physical Parameters
Symbol Value Quantity
Bo 0.2 Main Flux Density in T
Ho Bo/plo Main Field Intensity in water in A-m - 1
Be 5% of Bo = -_7by Rotating Flux Density Amplitude in T
He Be/lpo = h Rotating Field Intensity in water in A-m - 1
Po 4r x 10- 7  Permeability of free space in H-m - 1
R 4 x 10- ' Mean particle radius in m
V, 4/3 7rR 3  Magnetic particle volume in m3
f 1/(27r-7) Frequency of transverse Be field rotation in Hz
Q 27rf Frequency of magnetic field rotation rad-s- 1
0.03 Ferrofluid volume fraction of solids
ao Md Vp po Ho/(kT) Equilibrium Langevin Parameter
Mo Ms L(ao) Equilibrium Ferrofluid Magnetization in A-m - 1
Md 446 x 103  Single-domain magnetization (Fe30 4 ) in A-m - 1
M8  OMd Saturation magnetization of ferrofluid in A-m
- 1
T 10-6 Ferrofluid Time Constant in s
7 0.00202 Ferrofluid Kinematic Viscosity in Pa-s [44] [45]
1.5 1 Ferrofluid Vortex Viscosity in Pa-s [42]
T 295 Absolute temperature in K
k 1.381 x 10-23 Boltzmann Constant in JK - 1
d 0.005 Channel width in m
Uc 1 Top plate velocity (Couette flow) in m-s- 1
Up 1 Maximum flow velocity (Poiseuille flow) in m-s- 1
¢, Uc, and Up although the effect of varying these values is investigated. Uc denotes
the velocity of the upper plate under conditions of Couette flow while Up denotes the
maximum imposed inflow velocity under conditions of Poiseuille flow.
The main DC Bo field is directed along iz. A rotating field of angular frequency,
Q, and constant amplitude is generated in the transverse xy plane by setting hx = He
and by = jBe where Be and He are real-valued quantities. The resultant transverse
field rotates in an clockwise sense about the z axis. The magnetic particle properties
are typical of those used as superparamagnetic contrast agents in MRI [27], [59], [64].
The magnetic core is assumed to be magnetite (Fe 304). The frequency of excitation,
denoted R, of the transverse rotating field varies but is normalized with respect to
the ferrofluid time constant T, as is the spin-velocity wz in the resulting plots. The
ferrofluid kinematic viscosity, 77, is that recorded by He [45] using 3% solid volume
MSG- W 1 ferrofluid from the Ferrotec Corporation, Bedford, New Hampshire.
The effect of varying the physical system parameters is examined for the normal-
ized spin-velocity wr and the magnitude and lag angle (denoted phase) of the in-
stantaneous transverse magnetization IMtrans(t)l. Since the imposed transverse field
is circularly polarized in xy, one expects that the transverse magnetization will also
be circularly polarized in xy. Referring to (2.15) one can write Mtrans(t) as given by
(2.55). For non-dimensionalized plotting, the transverse magnetization is normalized
with respect to Be by dividing by Be/lpo.
Mtrans(t) = Re{(mix + fry(x)iy)eInt} (2.55)
For simplicity, the instantaneous magnitude is evaluated at time t = 0 so that
IMt,ans(0) is given by (2.56).
Mtrans(0)I = (e(R))z())+ 2  (2.56)
The phase, which represents the lag angle between the rotating transverse field
and the ferrofluid magnetization vectors is given by (2.57).
Phase of Mtran, = ArcTan e( (2.57)
2.3.2 Field-Driven Results
The conditions of field-driven excitation are simulated and the effect of changing Bo,
Be and q on both the normalized spin velocity wTr and the instantaneous transverse
magnetization, normalized with respect to Be are investigated. The results are shown
in Figs. 2-2 and 2-3 respectively. The plots are achieved using Mathematica 5.2
with reference to (2.17), (2.18) and (2.41). In all cases, the x-axis is the normalized
transverse rotating field frequency 2r.
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Figure 2-2: Frequency dependence of lwz|7 on (a) Bo (b) Be and (c) 0 is presented
in the presence of rotating field excitation and the absence of any imposed fluid flow.
Unless otherwise noted Bo = 0.2 T in (b) and (c), Be = 5% of Bo in (a) and (c), and
0 = 3% in (a) and (b). Note that for T = 1 ps, 1Q/(27r) - 160kHz.
2.3.3 Couette Flow Results
Couette flow is imposed by allowing the upper plate at y = d to move with linear
velocity U,. As for the previous case where the spin-velocity is due only to field-
driven excitation, the effect of changing Bo, Be and q on both wr and normalized
Mtran, is investigated and results are shown in Figs. 2-4 and 2-5 respectively. Now,
the spin-velocity is due to the combined effects of imposed field and flow on the
ferrofluid. The result of imposed Couette flow is a uniform, z-directed spin-velocity
Bo = 0.1 T
Bo = 0.2 T
Bo = 0.35 T ---
o.o02 Be = 1% of Bo
B, = 5% of Bo
002 Be = 10% of Bo ----
001.
0.010
cO O •
- . - - -
· · · ·k·l
I
in the channel. The resultant transverse magnetization is also uniform in space. The
effect of changing the maximum top-plate linear velocity, Uc, on w,- and normalized
Mtrans is investigated and the results are included in Figs. 2-4(d) and 2-5(g) and (h).
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Figure 2-3: Frequency dependence of normalized, instantaneous, transverse magneti-
zation, both magnitude and phase of Mtra,,,(0) at time t=0 on (a),(b) Bo (c),(d) Be
and (e),(f) 4 is presented in the presence of rotating field excitation and the absence
of any imposed fluid flow. Unless otherwise noted Bo = 0.2 T in (c)-(f), Be = 5% of
Bo in (a),(b),(e) and (f), and 4 = 3% in (a)-(d).
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2.3.4 Poiseuille Flow Results
For ease of comparison with the case of Couette flow, Poiseuille flow conditions are
implemented by means of an imposed parabolic flow profile on the left-most entry to
the channel of Fig. 2-1 rather than defining the imposed pressure differential across
the channel. This approach allowed the maximum flow velocity in the channel to
be defined in each case, Uc for Couette flow conditions and Up for Poiseuille flow
conditions. Finite element simulation and solution of the variables in the channel
is achieved using Comsol Multiphysics from Comsol Inc., Burlington, Massachusetts
where (2.17) through (2.22) are the equations of interest. Boundary conditions on the
upper and lower plates are given by (2.34) as is the case for no imposed flow. Inlet
flow (defined from the left side) is x-directed and defined by the parabolic distribution
of (2.58) where d is the channel width while the outlet boundary condition defines
the pressure p = 0.
Vin,x(y) = 4Upy(y-d) (2.58)d2
The result of the imposed parabolic flow profile in the channel is that the spin-velocity
is no longer spatially invariant as in the previous cases. The total spin-velocity in the
channel is now the sum of contributions from the Poiseuille imposed flow condition
and (Tm,z). Since the flow-induced spin-velocity changes sign as y varies from 0 to d
along the channel width, the two contributions will sum on one side of y = d/2 and
subtract on the other. At y = d/2, the spin-velocity is zero. For the geometry of
Fig. 2-1, where flow is directed along +ix, the contributions to w, from the imposed
rotating field, Be > 0, and that due to Poiseuille flow, add at the lower plate and
subtract at the top so that the maximum value of Iwz I occurs at y = 0. It is this lower
plate velocity which is plotted in the results of Fig. 2-6. Similarly, the instantaneous
transverse magnetization in the channel is no longer spatially invariant as in the prior
cases but varies with y. Again, the maximum instantaneous value is plotted in the
results of Fig. 2-7 and in all cases, the x-axis is the normalized transverse rotating
field frequency Q•. As for the previous cases, the effect of changing Bo, Be, 4, and
Up is investigated for both wz and normalized Mtra,n and the results are shown in
Figs. 2-6 and 2-7. Unlike the previous cases, analytical solutions are not possible so,
instead, numerical solutions are presented at discrete points along the Z7r axis. The
phase plots are not included but follow closely those for Couette flow.
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2.4 Discussion
2.4.1 Spin-velocity dependence on rotating field frequency Q
The dependence of the ferrofluid spin-velocity, w,, is closely related to the ferrofluid
time constant, 7, as should be expected from the expressions of (2.17) and (2.18)
since wr is a term that appears in both the numerator and denominator of each
expression. For low-frequencies where -r <« 1 and wr << 1, the effect of spin-
velocity on the ferrofluid's transverse magnetization is negligible. Physically this low-
frequency limit corresponds to a ferrofluid with a small-signal transverse susceptibility
given by Mo/Ho and the instantaneous transverse M and H vectors are collinear.
As Q-r approaches unity, the spin-velocity becomes increasingly significant. For
example, as seen in Fig 2-2(a), the value of w, is negligible until Tr a 1 and then
approaches a maximum of 1.4 x 103 rad/s for Bo = 0.35 T, at Qr = 1. This is because
the ferrofluid time constant 7 is no longer fast enough to allow the particles to reestab-
lish transverse equilibrium before the excitation changes direction, due to the rotating
transverse field. Instead, synchronism is maintained at a constant lag angle between
the transverse components of M and H for a particular rotating field frequency Qt.
The lag angle, plotted, in the absence of any imposed pressure differential, in Fig-
ures 2-3(b), (d), (f) and (h) for varying parameters, has a value of r/4 when 2 rT ; 1.
Mathematically, this is shown by the on-axis magnetization (both i~^ and r^,) given
by (2.17) and (2.18) becoming increasingly dependent on the orthogonal transverse
field component, h, for the case of ri, and by for the case of M^,. This cross-coupling
results in a non-symmetric, small-signal transverse susceptibility, which relates the
instantaneous transverse magnetization Mtran, to the applied transverse rotating field
due to h. and b6, denoted Htrans, causing Mtrans to lag Htras, as previously noted.
In the high-frequency limit, where -r >> 1, the lag angle between Mtran, and
Htran, approaches 7r/2, as plotted in Figure 2-3 and the denominators of (2.17) and
(2.18) become the dominant terms. The spin-velocity is less significant in the trans-
verse magnetization and in the limit of 2r >» 1, the transverse magnetization dis-
appears entirely so that the ferrofluid no longer appears magnetic in the transverse
xy plane. It is noted that this scenario is very difficult to achieve in reality since the
typical time constant of 1 ts requires Q/(21r) on the order of 0.1 MHz before 2r >» 1.
Even more critical is the note from Shliomis [48] that his formulation is no longer
valid in the frequency range of -Tr > 1, where for r P 1ps, f/(2r) approaches tens
of MHz. The plots should be treated with some skepticism beyond br - 1. The
z-directed magnetization is not frequency dependent as previously noted and is given
by (A.20) throughout.
2.4.2 Field-Driven Results
In the absence of externally imposed flow, the ferrofluid spin-velocity is spatially
constant in the channel of Fig. 2-1. As noted, the maximum spin-velocity occurs
when Qr = 1 and increases linearly with the main z-directed Bo field, as shown in
Fig. 2-2(a). The dependence on the rotating field amplitude Be, shown in Fig. 2-2(b) is
non-linear however. When Be is increased relative to Bo, the relationship between wz
and Be is approximately quadratic. Dependence of spin-velocity on percentage solid
volume 0, shown in Fig. 2-2(c), is minimal since spin-velocity is a volume-averaged
quantity. The maximum spin velocity occurs, as expected when Be is a maximum,
10% of Bo, although for none of the scenarios investigated does wzr approach unity.
The instantaneous magnetization shows similar dependence to Wz on Bo and Be,
as seen from Figs. 2-3(a) and (c) although the effect of 0, shown in Fig. 2-3(e), is
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pronounced where the normalized Mt,an, increases linearly with q. Throughout the
field-driven results, the value of transverse magnetization does not become comparable
to Be. Even for the conditions of Fig. 2-3(a) where Bo = 0.35 T and Be = 5% of Bo
the normalized magnetization is only 11% of Be for the low-frequency limit discussed
previously. This transverse magnetization decreases as ir approaches unity since the
increasing misalignment of the M and H fields is accompanied by a decrease in the
absolute magnitude of the transverse magnetization. This decrease results from the
dominance of the denominator in (2.17) and (2.18) as £2r increases.
2.4.3 Couette Flow Results
Imposing Couette flow conditions on the system of Fig. 2-1, the results of Fig. 2-4(a)
through (c) and Fig. 2-5(a) through (c) show remarkably little difference from the
prior case with no imposed flow although the top-plate of Fig. 2-1 now moves at 1 m/s
compared to the previous case where it is fixed. However, as shown in Fig. 2-4(d),
the top-plate velocity needs to be increased beyond 1 m/s before a perceptible change
is observed in the value of w_. Referring to (2.42) and noting that the channel width
d of Fig. 2-1 is 5 mm, it is noted that for Couette flow conditions to dominate the
internal magnetic torque density of (2.25), it is required that Uc/d exceed (Tm,z). As
shown in Fig. 2-5(g), this condition is not satisfied in the analysis above, even when
Uc = 10 m/s. Values beyond this were not considered physiologically relevant as the
maximum pulmonary flow velocity is approximately 1 m/s.
2.4.4 Poiseuille Flow Results
Imposing conditions of Poiseuille flow on the channel of Fig. 2-1 results in broadly
similar results for both w, and Mtra, as in the prior cases. Again, wJ shows linear
dependence on Bo, a quadratic dependence on Be and little change with the value of
€. Similar dependence is also observed for the instantaneous transverse magnetization
to both the previous cases. However, as clearly demonstrated by comparing Fig. 2-
4(d) with Fig. 2-6(d), the Couette flow regime has a more significant impact on wz
when the values of Uc and Up are equal. Setting Uc =10 m/s for the Couette flow
regime leads to a maximum value for w,r approaching 0.018 while setting Up =10 m/s
under Poiseuille flow conditions yields wr = 0.013. However since in neither case
the flow-induced spin-velocity is significant enough to exceed the internal magnetic
torque density, the values of Mta,,, shown in Figs. 2-5 and 2-7 are almost identical.
2.5 Conclusion
Current simulation results show that the ferrohydrodynamics of magnetite suspen-
sions may be a source of frequency-controlled ferrofluid magnetization in the presence
of a rotating magnetic field. This has important implications for MRI image contrast
since the local magnetization can have an enormous impact on the MR image inten-
sity (see chapter 25 of [35]). Foreseeable difficulties in the realization of this finding
are (i) the large rotating field amplitudes required to show an appreciable transverse
magnetization compared to the applied Be excitation, (ii) the high fraction solid con-
centration, 4, required to see the effect and (iii) the disappearance of the effect once
the rotating field is removed. However, in the event that these difficulties are over-
come, based on the work of this thesis, it is to be expected that any change in the
MRI phase measurement (the most convenient measure of changes in local field) will
be less than 5%, compared to the phase measured in the absence of the rotating field.
This estimate assumes a low-field MRI on the order of 0.2 T and a rotating field at
10% of Bo with particle concentrations on the order of 1 to 5% solid magnetic volume.
An independent transverse excitation field is required in addition to the current
B1 field, used for RF excitation, in order to see appreciable transverse magnetiza-
tion effects and the accompanying frequency dependence of the ferrofluid's transverse
susceptibility. This second transverse field would require significant input power for
fields on the order of 5% of Bo as well as a controllable frequency of excitation. This
means that demonstration of the effect is not feasible using the currently available B1
and gradient fields in a low-field, open MRI system. Concentrations of contrast agent
on the order of 3% solid volume are unlikely to be permitted in vivo. The recom-
mended contrast agent dosage for Feridex corresponds to approximately 1.3 x 10-4%
solid volume after dilution in the subject's bloodstream (see Table B.1 of Appendix
B). However, in the presence of suitable rotating field excitation, the effect may be
shown in vitro or in MRI animal studies with the development of appropriate custom
hardware. Finally, in order to maintain the effect on image contrast in MRI, the ro-
tating field would need to remain on during the duration of the image readout. This
is not true of the current B1 field which is usually off during the image readout.
A recent development [110] in ultra-low field (ULF) MRI offers a new imaging
method that uses SQUID sensors to measure the spatially encoded precession of pre-
polarized nuclear spin populations at a microtesla-range measurement field. ULF-
MRI is attracting increasing interest since it enables simultaneous MRI and magne-
toencephalography (MEG) imaging. The main Bo for Zotev's work has a value of
46 MT and a B1 field of 30 mT. Imaging results from [110] are shown in Figure 2-8.
The ultra-low field eliminates entirely any possibility of ferrofluid saturation and
represents an enormous advantage over the previously considered low-field MRI (Bo
between 0.1 T and 0.35 T). However, the Larmor frequency at Bo = 46 IT is 1940 Hz
which now lies below the range where 7r = 1 for particles with 7 on the order of
Y = 15 mm
V = rnmm Y= 0 mm Y =-5 mm
Ultra Low Field MRI
2.0 T MRI
Figure 2-8: Imaging results from [110] for preserved sheep brain acquired (top) by
3D Fourier transform from the ULF-MRI and (bottom) from a 2T MRI with slice
selection. Reproduced with the kind permission of Dr. Vadim Zotev, Los Alamos
National Laboratory.
1 aps. Larger particles would allow for longer values of -r but, ideally, the rotating field
source should be of variable frequency to demonstrate image contrast as a function
of frequency. This is not currently the case for Zotev's design. Notwithstanding this
fact, the design may represent the most promising means of demonstrating MR image
contrast due to the spin-velocity effects in ferrofluids due to a rotating magnetic field.
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Chapter 3
Longitudinal Field Excitation
3.1 Introduction
The previous chapter explores the impact of ferrofluid spin-velocity effects in the
presence of a rotating field excitation transverse to the main Bo field. This chapter
investigates the effect when the rotating field is no longer transverse to the main field
but one component lies collinear with the Bo field.
3.1.1 Governing Equations
As previously, the geometry shown in Fig. 2-1 is selected to allow the imposition of
fields along all three axes. In this case, the main Bo is y-directed while the rotating
field excitation responsible for the presence of a ferrofluid spin-velocity is in the xy
plane, such that one component is collinear with the main DC field. The situation is
shown in Fig. 3-1.
The geometry is consistent with the analysis of the preceding chapter although,
the DC field has been changed to point along the y axis. By convention, the main
bv = B + 9Ie{,jbe j w}
Ferrofluid
Ferrofluid
V
Figure 3-1: A planar ferrofluid layer between rigid walls is magnetically stressed by a
uniform DC y-directed magnetic flux density Bo, a complex x-directed magnetic field
of complex amplitude hx and a complex y-directed magnetic flux density of complex
amplitude by. The complex x and y components vary sinusoidally at frequency Q.
DC field in MRI is z-directed although in this chapter, it is written as y-directed for
convenience. As previously, the flow velocity can only be x-directed and the spin-
velocity may only be z-directed. Both quantities may vary spatially with y. The
transverse plane in this case refers to the plane orthogonal to the main Bo field,
which is the {xz} plane. There are no field components along iz so only the field
component along ix constitutes a transverse field component.
v = vX(Y)ix
w = Wz (y) iz
(3.1)
(3.2)
Again, the governing equation for relaxation of the ferrofluid magnetization, M,
is given by the expression of magnetic relaxation developed by Shliomis, in Eq. (2.2).
3.1.2 Magnetic Fields
Considering the geometric arrangement of Fig. 3-1, the imposed magnetic field in-
tensities along i, is spatially uniform and similarly for the imposed magnetic flux
density along i,. Gauss's Law for the magnetic flux density and Ampere's Law for
the magnetic field intensity require that this is the case. In light of this observation,
one might write the total magnetic flux density B and the total magnetic field H as
(3.3) and (3.4) respectively where h, and hy are now sinusoidally time-varying quan-
tities and h, = 0. As before, complex notation is used for convenience. The ^ symbol
denotes a complex amplitude, Re signifies the real component of a complex quantity,
Q2 is the frequency of excitation in rad-s- 1 and 3 = /--J. The relationship between
B, H and M is given by the familiar expression of (3.6).
B = Re{(bx(y)ix + byiy)e 7 t} + Boi, (3.3)
H = Re{(hXix + hy(y)iy)e't} + Ho(y)i, (3.4)
M = Rje{(rizx(yy)x + M (y)iy)eyt} + Mo(y)i- (3.5)
B = Io(H + M) (3.6)
The relationship between Mo and Ho, the y-directed components of DC magne-
tization and magnetic field intensity respectively, has been established in (A.20). In
seeking a solution for the instantaneous magnetization, the imposed fields by and hx
are assumed known. Substituting for Meq from (A.17) through (A.20) and for M
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from (3.5) one might rewrite the x and y components resulting from the Shliomis
Relaxation Equation using (3.6) as given by (3.7) and (3.8).
mX OHo H=Mo Ao (3.7)
(3fs2 + 1)(3~2r + 1 + + (wzr) 2
(w•)Moh, + (3Qr + • O 0 (3.8)
Y (3Q-r + 1)(3Qr + 1 + _• ) + (wz~) 2
The only unknowns are the complex amplitudes of transverse magnetization r$ix
and ýy which are a function of the yet undetermined spin-velocity wz. Also, as given
by Eq. (A.19), the y-directed small-signal magnetization, r', shows strong dependence
on the slope of the Langevin relation evaluated at the operating point established by
Bo, i.e., .MOHo
As previously, the second term of (2.2) does not contribute any terms to the
expressions of (3.7) and (3.8) since the flow velocity is along ix and can only vary
with y. The DC y-component of magnetization is given by the equilibrium value of
Mo. However, it is the small-signal magnetization in the ferrofluid that gives rise to a
torque which, in turn, is responsible for fluid motion causing a non-zero value for spin-
velocity w,. This w, changes the magnetization. However, unlike the previous case
when excitation was transverse to the main DC field, the transverse magnetization
will no longer be ecliptically polarized in the transverse plain.
3.1.3 Fluid Mechanics
As for the previous analysis, the principles of conservation of linear and angular
momentum are the equations of interest in defining a closed set of equations. These
expressions, given in (2.19) and (2.22) are repeated here for convenience in Eqs. (3.9)
through (3.12).
-Vp' + po(M -V)H + 2(V x w + ( + )V2v = 0 (3.9)
P' = p + pgy (3.10)
Tm + 2(V x v - 2w) = 0 (3.11)
Tm= •o(M x H) (3.12)
As before, these expressions represent simplifications of the more general expres-
sions of He [45] and Elborai [44] although they are more than sufficient for the analysis
which follows.
Beginning with the expression for the magnetic force density, Fm, given by
po(M -V)H in Eq. (3.13), this can be rewritten as follows in Eq. (3.13) for the field
expressions of Eqs. (3.3) through (3.5). Since the field variables only show a spatial
dependence in the y direction, then the force density only has a y component for the
geometry considered; Fm = Fm,yiy.
Fm,, = po[Re{r(f^e n t} + Mo ] [Ho + Re{hY eAtj}] (3.13)
Considering the x-directed H field to be spatially invariant and only considering the
time-averaged, non-zero components of force density, one finds the reduced expression
of Eq. (3.14).
h*_ (3.14)(Fm,y) = /o(e{r } + Mo (3.14)
Since the y-directed B field is invariant in space, the derivative of the H field with
respect y is equal and opposite to the derivative of the M field with respect to y.
Note that Mo is a real-valued expression so that it's complex conjugate is equal to
Mo.
M rh* M 9Mo
(Fm,) = yo(e({-reI- }-y Mo 0 ) (3.15)
The expression is further simplified by application of the product rule for derivatives.
As already noted in the case of a transverse rotating field, (3.17) only affects the
pressure distribution and the flow profile can be solved independently.
1 da h|2 10lM012(Fm,y) = •0o(~Re {- y} - ) (3.16)2 ay 2 ay
/io (9 1 12  IOM 2  (3.17)lM(Fm, ) = (3.17)( m 2 ay 2 ay
Considering Eq. (3.12), some considerable simplification is possible in the expres-
sion of the magnetic torque density, arising due to the omission of zero time-averaged
terms and the geometry presented in Figure 3-1. Considering only the time averaged
components, the expression of Eq. (3.12) can be rewritten as Eq. (3.18) where the
expressions for H and M are given by Eq. (3.4) and Eq. (3.5) respectively. The only
time-averaged, non-zero torque is z-directed, as expected.
Tm,z = Tm,ziz = *-oRe{(m(enh* - hxi;)}iz (3.18)
Time-averaging of a complex exponential requires the use of the complex con-
jugate, denoted by *. The expression of (3.18) contains no dependence on the DC
Ho field since there can be no non-zero, time-averaged component resulting from the
cross-product of a DC and an AC quantity. The dependence on the term hy is elim-
inated by reference to Eq. (3.6) leading to the final simplified expression given by
Eq. (3.20).
(Tm,z) = [to {(( - - hxm) } (3.19)
2 to
(Tm,z) = ,Re{jxb - pLo(7hi + hx) i} (3.20)
In light of the simplifications of (3.20) and (3.17), one might write the non-zero
components for (3.9) and (3.11) as given by (3.21) through (3.23). Conservation of
linear momentum yields components along both ix and i,, given by (3.21) and (3.22)
respectively. There is no component from the principle of conservation of linear
momentum along iz. Also, there are no components along ix or iY from the principle
of conservation of angular momentum and the z-component is given by (3.23).
(p+ 2( + ) = 0 (3.21)
avX 1
2( + 4(wz - 2e{e{Fnb - po(:ni + hx)mh} = 0 (3.23)
Similar to the previous chapter examining transverse rotating field excitation,
Eqs. (3.7), (3.8), (3.21) and (3.23) now constitute a closed system of equations with
4 unknown quantities: spin-velocity w,, flow velocity v. and the two complex ampli-
tudes of magnetization along is and iY denoted r^X and rth respectively. It is again
noted that by and hx are imposed fields and therefore known. While Eq. (3.22) is an
additional equation of interest, it only changes the pressure distribution and not flow.
3.1.4 General Solutions
Field Driven Solution
Generalized analytical solutions are possible considering (3.7), (3.8), (3.21) and (3.23)
when boundary conditions are defined. When both plates in Fig. 3-1 are fixed, the
flow velocity is necessarily zero at the boundaries y = 0 and y = d. In the absence
of any imposed flow or pressure differential in the channel, the first term of (3.21) is
zero. As in the previous case of a transverse applied field, it it is not necessary to
define boundary conditions on w,.
vx(O) = vx(d) = 0 (3.24)
As outlined previously, additional boundary conditions for the field components
follow the continuity law of electromagnetics such that normal components of B are
continuous and tangential components of H are determined by the surface current,
K,, at the boundaries y = 0 and y = d. Integrating (3.21) with respect to y and
some rearranging leads to (3.25) where C, is a constant of integration.
Ov, 1S- -- (C1 + 2(wz) (3.25)
Substituting this expression for he derivative of in (2.26) and solving for
Substituting this expression for the derivative of vx in (2.26) and solving for w,
leads to (3.26).
(3.26)z = 8 e( ^ bC - po(h + +) i-) 
After substituting the expressions for rix and ^r from (3.7) and (3.8), the expres-
sion for wz from (3.26) shows no y dependence. The spin-velocity, w,, is necessarily a
constant in space, thereby also setting the second term in (3.21) to zero. Solving the
remaining non-zero term of (3.21) by integration with respect to y (since C and iq are
both assumed non-zero) and applying the boundary conditions of (3.24) shows that
the flow velocity in the channel is zero. C2 and C3 are again constants of integration,
which are zero to satisfy the zero velocity boundary conditions at y = 0, d.
- 0
8y2
-v2
v = C2
Oy
(3.27)
(3.28)
(3.29)vx(y) = C2y + C3
v (O) = vx(d) = 0 = C2 = C3 = 0 = vx(y) = 0 (3.30)
Applying this result to (3.25), one can solve C1 = -2(w, and substituting for C1
in (3.25), the spin-velocity wz is given in terms of Mi and Th,.
W = 8(Re(Mix b• - po(fnx + h:) m~) (3.31)
While (3.31), (3.7) and (3.8) do not facilitate closed form solutions for wz, rM^ , and
rz, the equations were solved using Mathematica 5.2 (Wolfram Research, Champaign,
Illinois) and numerical results are included in the following section.
Couette Flow Solution
The only difference between the case of an imposed Couette flow and the previous
solution is the changed boundary condition at y = d where v (d) = U, and U, is
the imposed linear velocity of the upper plate in m-s- '. In addition to the imposed
Couette flow, the applied rotating transverse field excitation remains present so that
the spin-velocity is due to a combination of the magnetic driving field and fluid flow.
There is no imposed pressure differential along is so the analysis is identical up until
(3.25). However since the non-slip boundary condition at y = d requires v,(d) = U,
this leads to a solution with C3 = 0 and C2 = U/d. Substituting into (3.25) one
finds the revised form of (3.31) for imposed Couette flow conditions, given in (3.32).
8(= Re(Mx o) 2d (3.32)
Similarly to the no-flow solution, (3.32), (3.7) and (3.8) were solved using Mathe-
matica 5.2. Explicit results are not included since, as will be outlined in the following
discussion, these results will be coincident with the case of field-driven excitation in
all practically achievable circumstances.
Poiseuille Flow Solution
Poiseuille flow is achieved in the channel by means of an x-directed pressure differ-
ential which, in the absence of a magnetic torque density in the fluid, results in a
parabolic flow profile along iY. The imposed flow is, again, in addition to the rotating
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field excitation in the {xy} plane due to Be. This complicates the previous solution
and leads to the expression of (3.34) after twice integrating (3.21) with respect to
y. Note that the first term of (3.21) is now non-zero, K1 and K2 are constants of
integration while (T,z) is still given by (3.20).
Op 1 8v
-y + (TM,z) +,qy+ K = 0
Op y 2 1d JY
a+ 2IY + (Tm,z) dy + ?7vx + Ky + K2 = O
ax 2 2 0')
(3.33)
(3.34)
Applying the non-slip boundary conditions on vx at y = 0 and d allows for the
solution of K1 and K 2.
vx(0) = 0 4= K2 = 0 (3.35)
vx(d) = 0 =>. K1 =
Substituting the results of (3.35) and
at (3.37).
Ov, 1 pS (2y - d) -oBy 2,q ax
d p 1 d2 8 2 (Tm,z) dy2 Ox 2dJ (3.36)
(3.36) into (3.34) and rearranging, one arrives
1 jd(T2,q 2d?7 o (3.37)
Substituting for the derivative of v, given by (3.37) into (3.34) and substituting
for K1 and K2 leads to an expression for w, which is independent of v- and where
(Tm,z) is given by (3.20).
W l= p (2yd) 1-- (Tm,z) dyW 4 (2y - d)+ (Tm,z) 4,q 4 7 Jd (3.38)
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Simplification of (3.38) is possible in the limit where the pressure differential
dominates (Tm,z), the internal magnetic torque density after time-averaging. In such
a scenario wz is a maximum or minimum at y = {0, d}, where the sign depends on
the direction of the pressure differential and wz = 0 at y = d/2. For x-directed flow,
the differential is negative and wz is a positive maximum at y = 0 as given by (3.39).
d 8pwz(0, d) = Op (3.39)
Similarly for vx which has a maximum value at y = d/2 given by (3.40).
d2 pv (d/2) = (3.40)
As noted in the case of Couette flow and as will be outlined in the following
discussion, explicit results for the case of Pouseille flow-driven magnetization are not
included as it is shown that these will be coincident with the case of field-driven
excitation in all practically achievable circumstances.
3.2 Results
3.2.1 Physical Parameters
The physical ferrofluid parameters are again selected for application of SPIO agents
in low-field MRI scanners (0.1 T-0.3 T). The nominal values are identical to those in-
vestigated in the case of transverse rotating field excitation. The nominal parameters
are repeated in Table 3.1 for convenience.
The main DC Bo field is directed along i,. A rotating field of constant amplitude
is generated in the longitudinal xy plane by setting hx = He and by = jBe where
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Table 3.1: Table of Nominal Physical Parameters
Symbol Value Quantity
Bo 0.2 Main Flux Density in T
Ho Bo/to Main Field Intensity in water in A-m - 1
Be 5% of Bo = -3b, Rotating Flux Density Amplitude in T
He Be/Io = hx Rotating Field Intensity in water in A-m - 1
Ol 47r x 10-7 Permeability of free space in H-m - 1
R 4 x 10- 9  Mean particle radius in m
V, 4/3 7rR 3  Magnetic particle volume in m3
f 1/(2irr) Frequency of transverse Be field rotation in Hz
Q 24rf Frequency of electrical field rotation rad-s- 1
0.03 Ferrofluid volume fraction of solids
Oao Md V, io Ho/(kT) Equilibrium Langevin Parameter
Mo M, L(ao) Equilibrium Ferrofluid Magnetization in A-m- 1
Md 446 x 103 Single-domain magnetization (Fe3Oa4 ) in A-m- 1
M,  OMd Saturation magnetization of ferrofluid in A-m- 1
T 10-6 Ferrofluid Time Constant in s
7 0.00202 Ferrofluid Kinematic Viscosity in Pa-s [44] [45]
1.5 r7 Ferrofluid Vortex Viscosity in Pa-s [42]
T 295 Absolute temperature in K
k 1.381 x 10-23 Boltzmann Constant in JK- 1
d 0.005 Channel width in m
Uc 1 Top plate velocity (Couette flow) in m-s- 1
U, 1 Maximum flow velocity (Poiseuille flow) in m-s- 1
Be and He are real-valued quantities. The resultant field rotates in a clockwise sense
about the z axis. As before, the effect of varying the physical system parameters is
examined for the normalized spin-velocity wrT and the magnitude of the instantaneous
transverse magnetization IMt an,(t)l. It is noted that, unlike in Chapter 2 where the
applied rotating field was in the transverse plane so that both components contributed
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to IMtrans (t) 
, 
for the case of a longitudinal rotating field, only the x component
will contribute to the transverse magnetization (i.e., the magnetization component
perpendicular to the Bo field). The y component represents a small deviation from the
DC y-directed magnetization, denoted M0 and is not expected to have any appreciable
impact while Be < Bo. Accordingly, IMtran,(t)l is simply the instantaneous value of
the x-directed magnetization with associated complex amplitude frh. As in the case
of transverse field excitation, the transverse magnetization is normalized with respect
to Be by dividing by Be/po for non-dimensionalized plotting.
Mtrans(t) = Re{ (rzix)e&3 t} (3.41)
For simplicity, the instantaneous magnitude is evaluated at time t = 0 so that
Mtrans (0) 1 is given by (3.42).
IMtrans((0) = Re{ri}n (3.42)
A further notable difference is apparent between the cases of transverse and
longitudinal field excitation. While in the former case, the transverse magnetization is
an elliptically polarized magnetization, in the latter case, the transverse magnetization
will vary with time, since the orthogonal component responsible for the ferrofluid spin-
velocity no longer lies in the transverse plane but parallel to the Bo field along the iY
axis. To clarify this distinction, the instantaneous transverse magnetization is plotted
over an entire cycle of the electrical frequency, Q.
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3.2.2 Field-Driven Results
The conditions of longitudinal field-driven excitation are simulated using the nominal
values of Table 3.1 unless otherwise stated and the effect of changing Bo, Be, and 4
on both the normalized spin velocity wzT and the instantaneous transverse magne-
tization, normalized with respect to Be, are investigated. The results are shown in
Figs. 3-2 and 3-3 respectively. The plots are achieved using Mathematica 5.2 with
reference to (3.7), (3.8) and (3.31). In all cases, the x-axis is the normalized transverse
rotating field frequency r7.
The instantaneous transverse magnetization is plotted over an entire period of
electrical frequency excitation, and is shown in Figure 3-4. In this plot, Bo = 0.2 T,
Be = 5% of Bo and q = 3%. The excitation frequency varies as indicated.
3.3 Discussion
Many of the comments at the end of the preceding chapter are relevant to this dis-
cussion. These include the observation that for low-frequencies where 72T < 1, the
effect of spin-velocity on the ferrofluid's transverse magnetization is negligible and
war < 1. Physically this low-frequency limit corresponds to a ferrofluid with a small-
signal transverse susceptibility given by Mo/Ho and the instantaneous transverse M
and H vectors are collinear. This mimics the case of a transverse rotating field exci-
tation.
As before, when 2b7 approaches unity, the spin-velocity becomes increasingly sig-
nificant since the ferrofluid time constant 7 is no longer fast enough to allow the
particles to reestablish transverse equilibrium before the excitation, now due to the
rotating longitudinal field, changes direction. Instead, synchronism is maintained at
105
IRoe t Retleft U d AmI@lB,. m l3pb-vde*dy
10-9  10- 10- 1 10
V B, = 1% of Bo
o01 Be, = 5% of Bo -
B, = 10% of Bo 
- - - - - - -
0.010
10- 9- 1 10
at, Non(riandcitaimoFrapaPcy dflr.Nonamlizd tatienFrqaaey
(a) (b)
IZ
fr, Nodnied cSion Frapumcy
(c)
Figure 3-2: Frequency dependence of war on (a) Bo (b) Be and (c) q is presented
in the presence of longitudinal rotating field excitation and in the absence of any
imposed fluid flow. Unless otherwise noted Bo = 0.2 T, B,e = 5% of Bo and 4 = 3%.
a constant lag angle between the transverse components of M and H for a particular
rotating field frequency Q. Mathematically, this is shown by the on-axis magnetiza-
tion (both MS and rh,) given by (3.7) and (3.8) becoming increasingly dependent on
the orthogonal field component, hx for the case of $z and by for the case of iaz,. This
cross-coupling results in an instantaneous transverse magnetization Mtran, which lags
the applied transverse rotating field, denoted Htrans.
As already noted, the high-frequency limit, where r >» 1, is not acceptably
modeled by Shliomis' Relaxation Equation and the plots are only included for com-
106
_ I
10-' 10- 1 10
3
0.10 Bo = 0.1 T
Bo = 0.2T -
0.08. Bo = 0.35T ------
0
0.0
0.00
Ift-9 i- tn-1 
3
fl.t. Nonniahd Ecita Frequetcy W.z, Noamalid Emition Frqunacy
(a) (b)
1o-94 104 10- 1 10.07
0.06
'0.05
S0.04
0.03
0.02
0.01
0.00
- - --
-
f = 0.03%
f= 0.3%
= f3% -----
', , , _, i
10-" 10"6 10- 1 to,
r., Nolized xcitio Frequency
(c)
Figure 3-3: Frequency dependence of normalized, instantaneous, transverse magneti-
zation, Mtra,, on (a) Bo (b) Be and (c) 4 is presented in the presence of a longitudinal
rotating field excitation and in the absence of any imposed fluid flow. Again, unless
otherwise noted Bo = 0.2 T, Be = 5% of Bo and 4 = 3%.
pleteness. The y-directed DC magnetization, Mo, is not frequency dependent as
before and is given by (A.20) throughout.
3.3.1 Field-Driven Results
In the absence of externally imposed flow, the ferrofluid spin-velocity is spatially
constant in the channel of Fig. 2-1. As noted, the maximum spin-velocity occurs
when 7r = 1 and increases linearly with the main y-directed Bo field, as shown in
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Figure 3-4: Time variation of the normalized, instantaneous, transverse magnetiza-
tion, Mtrans is presented in the presence of a longitudinal rotating field excitation
and in the absence of any imposed fluid flow. Four different excitation frequencies
are examined: (i) Q~r = 0.01, (ii) fr = 1, (iii) Q2r = 5 and (iv) •ir = 10. The other
parameters are Bo = 0.2 T, Be = 5% of Bo and q = 3%.
Figure 3-2(a). However, the maximum value of the normalized spin velocity is reduced
almost by a factor of 2 compared to the case of transverse rotating field excitation.
This is because of the difference between the small-signal transverse and longitudinal
susceptibilities for a representative 4 nm radius magnetic particle. This low-frequency,
small-signal susceptibility in the transverse plane is given by Mo/Ho whereas the low-
frequency, small-signal susceptibility in the longitudinal plane is given by 9M. The
relationships are plotted in Figure A-1 of Appendix A for the values of Table 3.1 as
the main Bo field varies.
At a main field strength of 0.2 T, the difference between Mo/Ho and M is a factor
of 2 although this also depends on the particle radius. For this reason, the associated
spin-velocity is halved when the rotating field is swapped from the transverse to
longitudinal plane. This is seen by comparing Figures 2-2 and 3-2. The relative
dependencies on Bo, the rotating field amplitude Be and the ferrofluid solid volume
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percentage q correspond to the case where Be is transverse to the Bo field.
The instantaneous magnetization shows similar dependence of w, on Bo and Be to
the former case of transverse excitation, as seen from Figs. 3-3(a) and (b). However,
the value of the maximum transverse magnetization is significantly reduced when the
rotating field excitation is moved to the longitudinal plane, for the reason already out-
lined. This is not evident from comparison of Figures 2-3 and 3-3 because while the
transverse field excitation results in a constant-amplitude transverse magnetization,
the longitudinal rotating field excitation does not. Rather, it peaks once every cycle
at a maximum value that is equal to the constant value in the transverse excitation
case. Such a maximum occurs at time t = 0 and for this reason, the transverse mag-
netization does not appear significantly altered with the reorientation of the rotating
field. The new, time-dependence of the transverse magnetization is well described in
Figure 3-4. Also clearly visible in Figure 3-4 is the temporal phase shift associated
with the transverse magnetization as the value of Q is increased. At low-frequency,
where 2r <« 1 the transverse M and H fields are in phase but this is increasingly not
the case as 2-r increases towards unity.
3.3.2 Flow Driven Excitation and Longitudinal Fields
Imposing Couette or Poiseuille flow conditions on the system of Figure 3-1 results
in an additional source for the spin-velocity in the ferrofluid, as given by Eq. (3.32)
for Couette flow and Eq. (3.38) for Poiseuille flow. However, as noted for the case
of transverse rotating field excitation, it is very difficult to envisage a physically
realizable scenario in which the flow-induced contribution to spin-velocity may be
comparable or equal to the contribution from the magnetic torque density. While the
magnetic torque density is somewhat reduced by the reorientation of the rotating field
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to the longitudinal plane, it cannot be expected that this will result in any appre-
ciable change to the conclusion of the previous analysis for the transverse excitation.
Accordingly, the application of either Couette or Poiseuille flow is not pursued further
in this treatment.
3.4 Conclusion
In comparing the resulting spin-velocity and transverse magnetization in the two
orientations of applied rotating field excitation, a number of points are worth noting.
* The ferrofluid spin-velocity is approximately halved by the reorientation of the
applied rotating field from the transverse to longitudinal planes. This difference
corresponds to the difference between the values of Mo/Ho and 0M0 evaluatedOHo
at the operating point defined by the Bo field.
* The transverse magnetization is a constant-amplitude rotating field in the case
of a transverse rotating field excitation. However, in the case of longitudinal
rotating field excitation, the transverse magnetization is no longer constant in
amplitude but varies with time at the same frequency as the applied electrical
frequency, Q, since the x-directed component no longer lies in the longitudinal
rather than in the transverse plain.
* In order to see a more appreciable change in the transverse magnetization, it
appears that the transverse rotating field is a more attractive alternative. This
is because the value of the transverse magnetization in this case represents a
larger, and hence easier to detect, quantity relative to the amplitude of the
rotating field which causes it. However, in either case, the application of the
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ferrofluid spin-velocity as a source of image contrast in MRI would require the
use of custom hardware. Further experimental investigation was judged beyond
the scope of this work.
* The impact on MR image intensity in the presence of ferrofluid is expected
to be difficult to detect due to a rotating field with one component aligned
with Bo. This is because the change in magnetization is even smaller than
the case where the field rotates in a plane perpendicular to Bo since now one
component of the rotating field represents a deviation from the already partly-
saturated DC magnetization. The same comments regarding ULF-MRI apply
to this approach but the approach of Chapter 2 is recommended for any further
experimental work.
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Chapter 4
Spin Velocity and Mechanical
Rotation
4.1 Introduction
In addition to spin-velocity due to electrically rotating magnetic field excitation, the
phenomenon is also observed due to mechanical rotation of a ferrofluid sample [107-
109]. In particular, the arrangement of concentric cylinders has been investigated
since this readily facilitates Taylor-Couette flow where the inner cylinder is driven
by a mechanical rotation about its central axis and the outer cylinder is maintained
at rest. Under these conditions, the magnetization of the ferrofluid in the inner
cylinder is a function of the rotating frequency, the ferrofluid time constant and
the mechanical rotation frequency, as determined by Shliomis' Relaxation Equation,
repeated in Eq. (4.1)
aM
+ v. VM - w x M + (M - Meq)/r = 0 (4.1)Ot
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Figure 4-1: The arrangement to facilitate Taylor Couette flow in the inner cylinder
requires that the inner cylinder be rotated at an angular frequency of Q rad/s. For
the numerical results which follow, the gap approaches 0 and the ferrofluid container
radius is 1.2 cm.
4.2 Governing Equations
To investigate the feasibility of spin-velocity generation in the MRI environment by
means of mechanical rotation, the arrangement of Figure 4-1 was simulated in Comsol
Multiphysics. The main DC Bo field is z-directed and transverse to the cylinder's
axis of rotation, which is along ix. Many of the simplifications applied in the earlier
analysis of a simple channel geometry no longer apply and only a numerical solution
is possible. This is due to a non-zero spatial-derivative given by the second term
in Shliomis' Relaxation Equation. The value of Q which previously represented the
electrical frequency of excitation is now representative of the mechanical rotation
frequency of the inner cylinder.
In Chapters 2 and 3, the v -VM term was eliminated by means of the channel
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geometry previously employed to investigate the effect of electrical rotating fields.
However, in the presence of mechanical rotation with the arrangement of Figure 4-1,
this is no longer the case. A further complication is that it is no longer possible
to write an analytical expression for the ferrofluid susceptibility in the presence of
Taylor-Couette flow due to this spatial derivative. To avoid this problem, and without
undue loss of generality, the analysis which follows assumes a saturated ferrofluid
such that the equilibrium magnetization is z-directed and given by M,, the saturation
magnetization of the suspension in A-m- 1. As has been previously shown in Figure 1-
4, saturation is virtually assured in almost all common clinical MRI environments
(1.5 T and 3 T) and is only avoided in the case of low-field open MRI (0.1 T to
0.35 T). Furthermore, the assumption of magnetic saturation does not jeopardize
any resulting conclusions of the analysis which follow since the absence of saturation
simply adds a non-zero x-directed ferrofluid magnetization component in equilibrium.
Saturation also results in torque and force densities that are dominated by the field
in the ferrofluid rather than the flow. This means that the second term of Eq. (4.1)
has only limited impact on the ferrofluid spin-velocity.
In the presence of Taylor-Couette flow, the dominant flow direction will be parallel
to the cylinder wall in the same sense as the mechanical rotation. In cylindrical
coordinates, this corresponds to the negative 9 direction', and the azimuthal flow
velocity, ve is as indicated in Figure 4-1. Accordingly, it can be expected that the
spatial variations in the flow will be along the radial r axis and the induced spin-
velocity will be x-directed; w = w, i,.
In light of these simplifications, Eq. (4.1) may be rewritten in cylindrical coor-
'By convention, this direction is denoted 0 in cylindrical coordinates. However, to avoid confusion
with the ferrofluid solid volume concentration, 4, it is denoted 0 here. Also, in the orientation of
Figure 4-1, the x axis is left-handed with respect to the cylindrical unit vectors, i0 and i,.
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dinates, where Eq. (4.2) realates the radial components while Eq. (4.3) gives the
azimuthal directed components. The analysis assumes sinusoidal steady state.
OM, vo 8M, 1
t +  0 + 2~Me + (M, - MScos9) = 0 (4.2)&t r ae 7
0M e  v 9 _Me 1Sv - M + -(Me + MsinO) = 0 (4.3)&t r o0 7
In conjunction with Shliomis' Relaxation Equation, the principles of conservation
of linear and angular momentum are the governing mechanical equations. These are
identical to those given in Eqs. (2.19) and (2.21) although considerable simplification
results from the replacement of w with Q in the absence of any magnetic torque,
thus eliminating an unknown quantity in the case of mechanically-driven flow. The
construction of the differential equations for a cylindrical geometry follow the form
employed by He [45]. Following He's approach, only time-averaged quantities are con-
sidered, thus considerably reducing the numerical burden on the Comsol Multiphysics
software.
Another advantage of considering a saturated ferrofluid is that the magnetic field
inside the ferrofluid can be written directly, where the demagnetizing field, denoted
MD, in an infinitely long cylinder is given by half the magnetization in the direction
opposing the applied field outside the ferrofluid. Since the region outside the ferrofluid
is water, and the magnetization vector in this region is zero, the H field inside the
ferrofluid is given by Eq. (4.6) in cylindrical coordinates. For Figure 4-1, r < R1
corresponds to the region inside the gap while r > R 1 is that region outside the gap.
H(r < R 1) = Hoix - MDix (4.4)
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Figure 4-2: The time-averaged magnetization is plotted as Qr is increased for the
transverse and longitudinal magnetization components.
1
H(r < R1) = Hoi, - -Msi, (4.5)2
H(r < R 1) = (Hocos9 - cos9)ir + (-Hocos9 - -Msin9)io (4.6)2 2
The results of Figure 4-2 only show time-averaged magnetization components.
When ir <« 1, the time constant of the ferrofluid is sufficiently responsive to allow the
ferrofluid magnetization to never become misaligned with the applied B 0 field acting
along ix. The x-component of magnetization is given by the saturation magnetization
and there exists no appreciable magnetization component transverse to the B 0 field.
As •r approaches unity, the nanoparticles are no longer able to realign themselves
instantaneously with the B 0 field so a small transverse magnetization component
emerges. This component, My increases with Qr until Qr a 1. At this point, the
system enters a new domain of operation where the ferrofluid is no longer responsive
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to the Bo field and the magnetization instead follows the applied mechanical rotation.
The nanoparticles will rotate in unison with the applied rotation Q and no realignment
is possible with the Bo field. In these circumstances, the magnetization will be a
rotating vector at the same frequency as the applied mechanical rotation, Q and there
is zero time-averaged component of magnetization as QT is increased beyond unity. It
should be noted that it is extremely difficult to envisage a physical experiment where
this scenario is achievable since mechanical rotation on the order of 106 rpm would be
required for T = Ips. Nonetheless, the numerical simulation is instructive to validate
the outlined intuitive understanding. The Comsol results show the time-averaged
transverse and longitudinal magnetization components in Figure 4-2.
For the MRI environment, it is clearly shown that the ferrofluid magnetization
only shows dependence on the applied mechanical rotational frequency when Q-r r
1. Although some variation is seen from QT- 0.1, even this would necessitate an
applied rotation of 105 rpm for a particle with T - 10 ps. Such an experimental
scenario seems unlikely and therefore the concept of mechanical rotation as a means
for demonstration in the MRI environment is not pursued further in this thesis.
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Chapter 5
Experimental Imaging Results in
1.5 T and 3 T MRI
5.1 Introduction
In conjunction with the effect of rotational or spin velocity effects on ferrofluids in
the MRI environment, the passive characterization and the linear dynamics of su-
perparamagnetic nanoparticles have also been examined. This chapter is divided in
two sections; the first examines the passive characterization of the magnetization of
commercial MRI contrast agents at 3T. This includes a method to determine the
magnetization of the agents at this field strength using Bo phase maps in MRI. The
second section follows from the discussion in chapter 2 of Rosensweig's text [42] where
the stability criteria for magnetic nanoparticles are outlined. Two categories of sta-
bility are considered in this work. They are (i) the stability of the nanoparticles in a
magnetic field gradient and (ii) the stability against chaining in a high-field.
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5.2 Magnetization Characterization at 3 T
The goal of this portion of the work was to demonstrate the ability of MRI to ac-
curately measure the magnetization associated with two commercial MRI contrast
agents. These agents were Feridex (AMAG Pharmaceuticals, Cambridge, MA), a
superparamagnetic iron oxide suspension used primarily for liver imaging [59,62] and
Magnevist (Bayer HealthCare AG, Leverkausen, Germany) [61], a paramagnetic, Gd-
based compound used mainly as a gastrointestinal contrast agent to visualize the
bowel in MRI.
5.2.1 Phase and B0 Maps for Commercial Contrast Agents
To examine magnetic saturation effects in a commercial SPIO contrast agent, we took
a sample of Feridex MRI contrast agent and using a vibrating sample magnetometer,
measured the magnetic moment per unit volume. The result is shown in Figure 5-
1(a) where the units of magnetic moment are given as Am 2/kg of Fe. Feridex is the
only commercial SPIO contrast agent for use in clinical MRI which is FDA approved.
Feridex is a superparamagnetic agent which saturates at high field. The saturation
magnetization of the agent was estimated to be in the region of 84 Am 2/kg Fe. One
of the drawbacks of VSM and SQUID magnetometery is that the maximum field
strength is usually limited. For the Feridex VSM measurements shown in Figure 5-
1(a), there was no data beyond 1.2 T. Magnevist is a paramagnetic agent which
exhibits a linear magnetic susceptibility up to DC fields of 50 T [25]. The mass
susceptibility, Xm, was estimated by a linear curve fit to be 2.06x 10-6 m3/kg Gd
from the VSM measurements shown in Figure 5-1(b). Again, there was no available
data beyond 1.2 T.
In order to estimate the magnetization in MRI, B0 maps were obtained in a 3 T
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Figure 5-1: Measured magnetization using a VSM for (a) Feridex and (b) Magnevist
MRI contrast agents. The units of magnetic moment are (a) Am 2/kg Fe for Feridex
and (b) Am 2/kg Gd for Magnevist.
Siemens Trio MRI. The agent was placed in a long, narrow NMR tube: 10 cm in
length and 3.43 mm inside diameter. The walls of the tube were 0.41 mm thick.
The tube was fixed to lie horizontally in a water tank for imaging and positioned so
that the Bo field lay transverse to the tube's principle axis. The tube's center slice
was imaged at 3 T with an imaging resolution of 256x256 pixels, a 180mm FOV,
a slice thickness of 7 mm and a repetition time, TR = 100 ms. Using 10 averages,
the total scan time was 4.25 minutes. The phase maps and Bo maps are shown in
Figures 5-2 and 5-3 for the Feridex contrast agent, where TE = 2.83 ms for the phase
map and ATE = 0.9 ms for the Bo map. The Bo map was corrected for edge effects
and shimming by taking a second Bo map in the absence of the tube and identical
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imaging parameters including the same shimming fields. The second Bo map was then
subtracted from that due to the tube. The original result before correction is shown
in Figure 5-2 for the Feridex agent. The corrected Bo map is shown in Figure 5-3. An
identical procedure was employed to obtain a similar result for the Magnevist agent.
Figure 5-2: The phase map is shown for the center slice of a tube of Feridex agent
surrounded by water. The phase map only shows the net field component along the
z-axis, i.e., Bz. The Bo field is left to right and has a value of 3 T.
Next, the theoretical solution for the dipole field surrounding the tube was simu-
lated with the same geometric values using a 3D model in Comsol Multiphysics and
the results compared over the same frequency range as in Figure 5-3. The Comsol
result used a saturation magnetization of 74 Am 2/kg Fe, the result which most ac-
curately replicated the results from the MRI measurements. The resulting simulated
dipole distribution is shown in Figure 5-4(a). It should be noted that this represents
the change in the z component of the Bo field rather than the magnitude of the mag-
netic field. Therefore, the distribution is quadrapolar rather than dipolar as given
by Equation 5.3 for an infinite cylinder in an x-directed field following the example
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Figure 5-3: The Bo map is shown for the center slice of a tube of Feridex agent
surrounded by water. Edge and shim effects were eliminated by means of a subtraction
of the Bo maps measured in the absence of any tube.
of problem 5.32(c) in Zahn's text [43]. For the numerical results, the vial radius, a,
is 3.43 mm, corresponding to the inner diameter of the vials and r represents the
axial radius measured from the vial's center. The main field is denoted Ho i,, the
saturation magnetization (assumed x-directed for consistency with Zahn's solution)
has a value of M, and 0 = arctan(y/x).
Ms a2  Ma 2H(r > a) = (Ho + 2r 2 ) cosi, - (H -2r 2 ) sin i (5.1)
Ma2  M a 2H(r > a) = (Ho + 2M2 ) cos 20i. + 2 sin 20i, (5.2)
M, a2AHx(r > a) = 2r 2 cos 20 (5.3)
The experimental result of Figure 5-4(b) is the field map from Figure 5-3 after
windowing (140x 140 pixels) and adding a colormap in Matlab (Mathworks Corp.,
Natick MA). Clearly some phase wrapping occurs in the region around the tube as
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the field varies too rapidly to be captured accurately by the field map. This means
that the field immediately surrounding the tube itself is severely distorted from the
actual value. However, the dipole fields are closely matched in areas which do not
suffer from phase wrapping.
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Figure 5-4: Comparing (a) theoretical results from Comsol Multiphysics and (b) Bo
maps from the scanner at 3 T for Feridex contrast agent.
The results of Figure 5-4 were compared for the line of maximum field variation
along the x axis. The results are shown in Figure 5-5 where the black solid line indi-
cates the measured result for the change in local Larmor frequency using MRI, the red
line represents a least-squares fit of the MRI result assuming Ms =74 Am
2/kg Fe and
the blue line represents the result based on the VSM measurement of Ms =84 Am2/kg
Fe. We can compare these results with the only available similar analysis, as de-
tailed in [60]. Here, the magnetization of Feridex-like ferumoxides was estimated at
0.6 T and 5 T. The resulting mean value of the magnetization was measured to be
69.8 Am 2/kg Fe at 0.6 T and 93.6 Am 2/kg Fe at 5 T.
Using an identical procedure to that outlined to obtain the results of Figure 5-4,
the Bo and phase maps were obtained for the Gd-based contrast agent, Magnevist.
The theoretical results from Comsol (using a value for the susceptibility as estimated
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Figure 5-5: Comparing experimental results from the MRI (black), extrapolated re-
sults from the VSM at 1.2 T (blue) and theoretical results from Comsol Multiphysics
(red) based on a least-squares fit of the MRI data for the change in local Larmor
frequency due to the SPIO agent, Feridex.
from the VSM results) and Bo map at 3 T are shown in Figure 5-6. The results in
Figure 5-6 are compared along the line of maximum field variation along the x axis,
as was the case for the Feridex results. The results are shown in Figure 5-7 where
the black solid line indicates the measured result for the change in local Larmor
frequency using MRI, the red line represents a least-squares fit of the MRI result
assuming Xm = 1.8 x 10-6 m3/kg Gd and the blue line represents the result from
the VSM measurement of 2.06 x 10- 6 m3/kg Gd. It should be noted that the mass
susceptibility, X, in m3/kg, is related to the absolute susceptibility, X (unitless), by
the concentration of the magnetic material in the fluid in kg Gd/m 3 . For Magnevist
contrast agent, the supplied concentration [61] is 78 kg Gd/m3 although this is diluted
for clinical administration as indicated in Appendix B. Jung et al. [60] listed a mass
susceptibility for Magnevist of 2.72 x 10-2 cgs/mol or 2.13 x 10-6 m3/kg Gd which
is comparable to our results.
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Figure 5-6: Comparing (a) theoretical results from Comsol Multiphysics and (b) Bo
maps from the scanner at 3 T for Magnevist contrast agent.
For the VSM measurements, it is worth noting that the susceptibility of deionized
water was measured using the VSM to be -12 x 10-6. The recorded and accepted
result is -9 x 10-6 [93] indicating that there may be a small DC bias on the VSM
measurements tending to skew the results as indicated above. This is one plausible
source for the small error between the VSM measurements shown and the results
from the MRI at 3 T. Another source of error is possible misalignment between the
theoretical and experimental phase maps, resulting in the theoretical least-squares fit
not correlating to the exact same point along the x axis in the experimental results.
Conclusions
Table 5.1: Comparison of Feridex Results for M,
VSM Measurement Fitted MRI Result Published Result [60]
84 Am 2/kg Fe 74 Am2/kg Fe 93.6 Am 2/kg Fe
The results for the saturation magnetization of Feridex contrast agent is compared
in Table 5.1 using three different results. These are the VSM measurements which
yielded a result of 84 Am2 kg Fe at 1.2 T, the fitted MRI measurement which yielded
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Figure 5-7: Comparing experimental results from the MRI (black), extraopolated
results from the VSM at 1.2 T (blue) and theoretical results from Comsol Multiphysics
(red) based on a least-squares fit of the MRI data for the change in local Larmor
frequency due to the Gd-based contrast agent, Magnevist.
a value of 74 Am2 kg Fe at 3 T and the published result of Jung et al. who cite a
result of 93.6 Am 2 kg Fe at 5 T. One would expect that the results should increase
with increasing field. However, this is not the case indicating some discrepancy in the
results. As already noted, it was found that there was a slight DC bias on the VSM
which was thought to skew results. However, this is not sufficient to account for the
discrepancy. Therefore, it is most likely that some additional error is introduced in
the MRI. This might include an inaccurate fit of the experimental data (for example,
if datapoints closer the the vial tend to suffer more from uncompensated edge effects,
this is not reflected in the least-squares fit) and a misalignment between the Comsol
result and the MRI measurement (meaning that pixels were not exactly matched in
space and therefore introducing an error in the predicted value for the saturation
magnetization). However, it is also possible that there was some error associated
with the result of Jung [60]. The results are, at least, broadly similar, as is seen in
Figure 5-5 and the goal of the experiment, to show that MRI can be used to accurately
measure contrast agent magnetization, has been verified.
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The results for the mass susceptibility of Magnevist contrast agent is compared
in Table 5.2 using the same three methods and again, good agreement is found. The
comments of the previous paragraph are again applicable. Furthermore, the slight
variation in the results of Table 5.2 is difficult to see in the imaging results of Figure 5-
7.
Table 5.2: Comparison of Magnevist Results for Xm
VSM Measurement Fitted MRI Result Published Result [60]
2.06x10 - 6 m3/kg Gd 1.8x10 - 6 m3/kg Gd 2.13x10- 6 m3/kg Gd
5.3 Gradient Field Effects and Instability at 1.5 T
In examining the effect of the MRI's gradient fields at 1.5 T, it is worth noting that
several factors can influence the behavior of the fluid's magnetic nanoparticles. These
factors include the effect of the earth's gravitational field effects and van der Waals
attractive forces between the particles. Following the analysis of Rosensweig [42]
(pg. 36), the relative influence of gravity to magnetism is described by the ratio of
(5.4) where Ap is the difference in density between the fluid and the nanoparticles (x
4300 kg-m - 3 for magnetite particles [42]), g is acceleration due to gravity (9.8 m-s-1 ),
L is the characteristic dimension of the container in m, Po is magnetic permeability
of free space, M is the single domain magnetization of magnetite ( 446 x 103 A-m -1 )
and H is the local magnetic field in Am - 1.
GravitationalEnergy 
_ p g L (5.4)MagneticEnergy poMH
For pI-H = 1.5 T and a 5 cm container height, the ratio is 0.0025, indicating
that gravitational forces are less of a threat to segregation than is the magnetic
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field. The van der Waals forces arise spontaneously between neutral particles because
of the fluctuating electric dipole-dipole forces that are always present. This force is
inversely proportional to the seventh power of the radial distance, d, from the particle
(oc d-') and therefore is not as significant as the interparticle forces associated with
magnetic force of attraction which is proportional d- 3 [42], except when particles are
already in very close proximity. Therefore, this section focusses on effects which are
expected to be of relevance to MRI, namely the effects of the MRI gradient fields on
ferrofluid suspensions and the possibility of chaining and clustering of the magnetic
nanoparticles in MRI.
This section also analyzes the sensitivity of cylindrical vials of contrast agent to
transverse fields, where the vial is collinear to the Bo field. The purpose of this
investigation is to estimate at what point the transverse field begins to give rise
to a dipolar field pattern in the vicinity of the agent, as viewed using MRI. The
investigation takes place using a 1.5 T system but the results are more generally
applicable since the transverse field is normalized with respect to the effective Bo
field along the vial's axis.
5.3.1 Theory of Gradient Field Effects
The motion of a magnetic nanoparticle in a magnetic field is governed by the principle
of conservation of linear momentum, as given in Eq. (5.5), where p' is the modified
pressure, given by (2.20), p is the absolute pressure in Pa, g is the gravitational
acceleration in m*s- 2, p is the ferrofluid mass density in kg-m- 3 , C is the ferrofluid
vortex viscosity in N.s.m-2 and q is the dynamic shear viscosity of the ferrofluid in
N.s.m -2 . As noted previously, the expression considers the situation of sinusoidal
steady state with viscosity-dominated flow conditions (so that inertia is negligible)
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and the ferrofluid only responds to force and torque densities which have a time-
averaged, non-zero component.
-Vp' + po(M -V)H + 2(V x w + (( + q)V 2v = 0 (5.5)
Clearly, in the presence of a gradient in the magnetic field, the second term is non-
zero and there is a linear force density in the direction of the gradient. Since such a
gradient is the means by which the image is encoded in MRI, as outlined in Chapter
1, some order of magnitude calculations are undertaken here. Furthermore, should
the effect be significant enough to cause motion within the ferrofluid, there is the
potential to control such an effect by selecting the direction of the gradient [88-91].
5.3.2 Numerical Calculations
The force density term of Eq. (5.5), ~o(M -V)H, and the associated magnetic energy
density, Urn, become significant when they are comparable to the thermal energy
density, Ut = kT, such that the random thermal fluctuations are no longer dominant
over the gradient-directed magnetic force density. Therefore, when the ratio U,,/Ut
approaches unity, the effect of gradient field forces can be significant. The value of
U,r is the integral of the second term in Eq. (5.5) and is given in Eq. (5.11), where
x is the characteristic dimension over which the gradient is exerted. For an MRI
of human vasculature containing SPIO contrast agent, this is typically on the order
of centimeters. For simplicity, a linear flux density gradient, GX, is assumed, such
that G. has units of T-m- 1. As previously defined, Vp is the magnetic volume of the
particle, Md is the single domain magnetization of the particle, which for magnetite
has a value of 446 x 103 A-m- 1. It is also assumed that spatial variations in the
magnetic field intensity are dominated by the applied magnetic flux density gradient
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and any spatial variation in magnetization (associated with concentration gradients)
are not comparable (i.e., A -M ; A). The ratio of the magnetic and thermal energy
densities is finally given by Eq. (5.12)
Ut = kT (5.6)
Urn = JOVPM'x dx (5.7)
UVpMd B - M)dx (5.8)
Um Vp, Md x dx (5.9)
Um VpMdGxd (5.10)
Um - VpMdGxx (5.11)
Um VpMdG~z(5.12)
Ut kT
The ratio is plotted for a number of typical gradient fields in MRI. On the typical
1.5 T and 3 T MRI systems, the Siemens' gradient system allows for gradients up
to 40 mT.m- '. Typical particle radii are considered and the results are included in
Figures 5-8 and 5-9 for various gradients and particle radii. The energy density is
plotted versus the characteristic dimension in each case.
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Figure 5-8: Ratio of Magnetic to Thermal Energy Densities for particles of 10 nm
mean magnetic radius under varying gradient field conditions.
Inspection of Figures 5-8 and 5-9 shows that under no circumstances of realis-
tic particle radii or gradient field is the magnetic energy density associated with the
nanoparticles comparable to the thermal energy density, Ut. Accordingly, it is sup-
posed that particle movement can be discounted as a source of image contrast due to
the encoding gradient fields in MRI. However, this supposes that the particles remain
discrete in the MRI environment and, as outlined in the following paragraphs, this is
not necessarily the case due to chaining under conditions of high magnetic field. The
potential for particle chaining and clustering is assessed in the following paragraphs.
132
10-6 10-1
Z5 x 104
11 x 1O6S2Sx 10-
5. x10 -"
Gradient
G = 10 mT/m
G = 30 mT/m -------------------
G = 50 mT/m -----
Particle Radius 10nm
10- 10-"
rl----------·-- ---- t-- ·· '- -~^L" L
· · ·
r'
g
i
f
6 1'
i
I
I
8·
1 e 0 t Pf•tde Iati*s n eIqy sll"el4 ord,0- 1 3 10'-0O-
o.oooo12
000001
8.x10
s. x* to
4- x1,04
90
0- 1i0-5 10"4 too a00tI
Figure 5-9: Ratio of Magnetic to Thermal Energy Densities for particles of varying
magnetic radius in a magnetic flux density gradient of 30 mT-m-1 .
5.3.3 Clustering and Chaining Phenomena
Chaining of ferrofluids occurs when the dipole-dipole interaction between discrete
particles is sufficient to overcome the steric repulsion associated with the particle's
surfactant layer. The phenomena is more likely in strong external magnetic fields,
such as those typical of MRI and when chaining occurs, the nanoparticles form long
chains parallel to the applied field. Theoretical expressions, developed by de Gennes
and Pincus [92], predict the mean number of particles per chain, N, depending on
ferrofluid's concentration and physical parameters. The expression in the presence
of large DC magnetic fields (such that the suspension is assumed to be saturated) is
given by Eq. (5.13) where q is the percentage solid volume in the suspension, and A
is given by Eq. (5.14).
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/
N= (1 - e20A)-1; (5.13)
A = A0 Ma VP (5.14)24 k T
Typical contrast agents for MRI have values of ¢ in the range 10- 7 to 10- 5 in vivo
(see Table B.1 of Appendix B) so chaining can be expected for particle sizes with
magnetic radii in the range of 9 or 10 nm as predicted by Figure 5-10. Compartmen-
talization in vivo and improved steric hindrance may help alleviate chaining but this
is a topic that has not been previously examined in the context of superparamagnetic
contrast agents in MRI. The experimental results which follow this discussion use a
value of 4 = 0.004 indicating that chaining is expected for any particles exceeding
a magnetic radius of 6 or 7 nm. This value of € is still over 3 orders of magnitude
beyond the recommended dosage for Feridex, the only commercial SPIO agent, after
dilution in the subject's bloodstream (see Table B.1 of Appendix B).
As noted by Rosensweig on page 68 of his text [42], only values of A which ex-
ceed +1 are of physical significance. Chaining occurs very rapidly with increasing
particle concentration. For a saturated ferrofluid, theoretical chain length can ap-
proach infinity. This is obviously non-physical due to the container constraints and
compartmentalization that is inevitable in vivo.
5.3.4 Experimental work
While theoretical predications indicate that no individual particle motion is likely in
the presence of the gradients typical of the MRI environment, the inevitable pres-
ence of some chains in the suspension might still result in a non-negligible magnetic
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Figure 5-10: The dependence of mean number of particles per chain is shown for
various mean particle radii. With reference to Table B.1, typical SPIO contrast
agents (e.g., Feridex) for MRI have values of 0 in the range of 10-7 to 10- 5 in vivo.
The phenomenon of chaining occurs rapidly once particles of a given diameter are
concentrated over a certain threshold.
force density. Experimental SPIO contrast agent was obtained' with a characteristic
particle hydrodynamic radius of 10 nm and an estimated magnetic radius of 8 nm.
The concentration was 15 mg Fe per ml corresponding to a fraction solid volume
of approximately 0.004 when the particle volume is assumed to be 100% magnetite,
corresponding to a concentration which is over 3 orders of magnitude greater than the
recommended Feridex dosage after in vivo dilution (again, see Table B.1 of Appendix
B). Since the specific mass of the typically hydrogen atom-rich surfactant coating
used in the manufacture of SPIOs for MRI is about two orders of magnitude less
than that of Fe, this is adjudged an acceptable approximation.
In order to induce linear motion in the ferrofluid contrast agent, the MRI sequence
1Sincere thanks is due to Dr. Young Kim at the Martinos Center for Biomedical Imaging for the
use of his SPIO contrast agent.
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Figure 5-11: The timing diagram of the sequence used to investigate possible particle
motion due to gradient fields by means of a pre-crusher pulse. In this example, the
image is a sagittal slice so that the readout and pre-crusher are z-directed. The slice
selection is along x and y is the phase-encode axis.
shown in Figure 5-11 was employed. The purpose of this excitation was to begin the
movement of the nanoparticles in the ferrofluid prior to exciting the proton spins re-
sponsible for imaging. The "pre-crusher" was applied along the MRI readout direction
with an amplitude that was limited by the physical constraints of the Siemens system.
On the 1.5 T Siemens Trio, this is theoretically 40 mT.m- 1 although in reality, the
maximum used was 27 mT-m- 1 due to the - safety limits on the Siemens platform.
Although an arbitrarily long pre-crusher time is possible, a value of 1 second was used.
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Figure 5-12: The vial orientation is shown for (a) sagittal and (b) coronal imaging
positions.
After the end of the pre-crusher, a regular gradient-recalled echo (GRE) sequence was
employed where the readout gradient was in the same direction as the pre-crusher.
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Since the pre-crusher time is several orders of magnitude longer than the subsequent
GRE excitation, the pre-crusher time has been shortened relative to the duration of
the other gradients in the timing diagram of Figure 5-11 although a value of 1 s was
used in the experiment. The total TR time of the GRE was 1200 ms with a flip angle
of 150 and this was adjudged sufficient to allow sufficient relaxation of the imaging
protons in the water between excitations. Although a true T2-weighted image would
require TR»>T1~3 s for water, TR=1.2 s allows sufficient SNR to support the con-
clusions which follow. The resolution was 256x256 pixels with a symmetric field of
view of 300 mm. The readout bandwidth was 358 kHz (1400 Hz per pixel). The slice
thickness varied with either sagittal (5 mm thick) or coronal (3 mm thick) imaging
slices. The arrangement of long cylinders of ferrofluid in a water tank was employed
as shown in Figure 5-12 for (a) sagittal and (b) coronal imaging. The cylinders were
placed transverse to the Bo field thus allowing for imaging slice cross-sections in both
the coronal and sagittal orientations to investigate possible particle motion as out-
lined above. A control vial of water was placed adjacent to the ferrofluid vial in all
experiments. Although larger imaging slices are desirable since SNR increases linearly
with voxel size, a reduced slice thickness was used in coronal imaging to help mitigate
against edge effects parallel to the cylinder's long axis. Clearly, this is not as much
of a concern for sagittal imaging as the edge effects are due to the cylinder ends, and
if the slice is chosen to be at the center of the cylinder, these should be reduced. For
sagittal imaging, the readout and pre-crusher are z-directed. The slice selection is
along x and y is the phase-encode axis. The image is a cross-sectional slice along the
cylinder's short axis, transverse to the Bo field in the { yz) plane. In the following
sagittal images, the y axis is vertical, from bottom to top, and the z axis is horizontal,
from left to right. For the case of coronal imaging, slice selection is along the y axis,
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phase encoding is along the x axis and the readout and pre-crusher are z-directed.
The imaging slice is thus a cross-section along the cylinder's long axis, parallel to the
Bo field in the {xz} plane. It is thought that any particle motion effects would be
most evident in this orientation since the particles would have a longer characteristic
dimension over which to diffuse. For the coronal images which follow, the x axis is
vertical, from bottom to top, and the z axis is horizontal, from left to right.
In order to eliminate any confusion between effects due to inhomogeneities in
the main Bo field and effects due to the particle's motion, a so-called "Bo map" was
obtained using closely spaced TE times following the method described in Chapter 20
of Haacke's text [35]. The local resonant frequency, wo(x, y), is estimated by Eq. (5.15)
where ATE is given by the difference in the two TE times and AO is the associated
difference in the phase maps. In fact, the Bo map is a measure of the local resonant
frequency rather than the local B field in the absence of effects due to inhomogeneities
associated with B0 . However, the two measures only differ by the constant factor, y,
the gyromagnetic ratio for the 1H proton.
wo(x, y) A(5.15)ATE
This work uses consecutive TE times of 3.9 and 4 ms allowing a frequency band-
width of ±5 kHz in the Bo maps which follow. The phase maps show significant
"phase wrapping", as is evident in Figures 5-13 and 5-15. Phase wrapping is the
phenomenon where the frequency spectrum of the phase accumulated across the MRI
image exceeds the bandwidth associated with 1/ATE used to estimate the phase
map. When this occurs, phase wrapping results and the local phase shows discrete
jumps of 27r radians whereas the real accumulated phase is continuous. Unwrapping
these effects is an area of significant interest in MRI [35] but is not explored in any
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detail in this work.
5.3.5 Phase and Bo Maps
The phase maps of Figure 5-13 show sagittal slices for a center slice in both the control
vial of deionized water (left) and the ferrofluid (right). The control vial is not readily
visible since there is little or no phase shift associated with it. The left column shows
the phase accumulated at TE = 3.9 ms and the right shows phase at TE = 4.0 ms.
The top line is the phase in the absence of any pre-crusher. The middle line shows
phase with the application of a positive pre-crusher of 1 s duration and an amplitude
of 27 mT-m- 1. The bottom line of images is the phase with a negative pre-crusher
of the same amplitude. The resulting Bo maps, as derived by Eq. (5.15) are shown
in Figure 5-14 with a frequency scale of ±5 kHz corresponding to 1/ATE. Since the
pre-crusher is z-directed in the sagittal case, any particle motion is expected to be
manifested in a shifting of the ferrofluid's dephasing pattern, to the left in the case of
the positive crusher and to the right in the case of the negative crusher. No such shift
is apparent and it is therefore concluded that there is no perceptible particle motion
in the vial due to the MRI gradient fields. This result is in line with the predictions
of Figures 5-8 and 5-9 where the characteristic length of the vial is 1.2 cm.
The phase maps of Figure 5-15 show the 2 coronal cross-sectional slices. Again, the
left column shows the phase accumulated at TE = 3.9 ms and the right shows phase
at TE = 4.0 ms. The top line is the phase in the absence of any pre-crusher. The
middle line shows phase with the application of a positive pre-crusher of 1 s duration
and an amplitude of 27 mT.m- '. The bottom line of images is the phase with a
negative pre-crusher of the same amplitude. The resulting phase maps are shown in
Figure 5-16. Since, in this case, the pre-crusher is z-directed, any particle motion is
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Figure 5-13: Phase maps (in radians) for sagittal imaging slices. The z axis is hori-
zontal (left to right) and the y axis is vertical, from bottom to top. The pre-crusher
and readout gradient are both z-directed. To the left of each ferrofluid vial is a
control vial of deionized water. There is no perceptible change in the phase maps
in the presence of the crushers indicating no gradient-induced magnetic force on the
particles.
again expected to be seen in a shifting of the ferrofluid's dephasing pattern, to the left
in the case of the positive crusher and to the right in the case of the negative crusher.
As for the sagittal images, no such shift is apparent and it is therefore concluded that
there is no perceptible particle motion in the vial due to the MRI gradient fields.
Furthermore, while chaining may be present, it does not seem to represent a source
of particle motion in MRI gradient fields.
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Figure 5-14: Bo maps are shown for each of the three cases considered with a sagittal
viewing slice: (i) in the absence of a pre-crusher, (ii) in the presence of a positive
pre-crusher and (iii) in the presence of a negative pre-crusher. No perceptible change
was observed in the presence of the pre-crusher.
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Figure 5-15: Phase maps for coronal (xz) slice images. The z axis is horizontal (left
to right) and the x axis is vertical, from bottom to top. The pre-crusher and readout
gradient are both x-directed. The control vial of deionized water lies to the right of
the ferrofluid vial.
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Figure 5-16: Bo maps are shown for each of the three cases considered with a coronal
viewing slice: (i) in the absence of a pre-crusher, (ii) in the presence of a positive
pre-crusher and (iii) in the presence of a negative pre-crusher. The control vial of
deionized water lies to the right of the ferrofluid vial. As in the previous case, no
significant change in the Bo maps was observed due to the pre-crusher.
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5.3.6 Sensitivity to Transverse Fields
In order to estimate the sensitivity of the SPIO contrast agent to transverse magnetic
fields, a vial of agent was placed parallel with the main field at 1.5 T and a series of
experiments were undertaken. These involved positioning the vial at various angles
of inclination (denoted 0 where tan is the ratio of the transverse to longitudinal
components) to the main Bo field such that there exists components both parallel and
perpendicular to the vial's principal axis. The arrangement is simplified in Figure 5-17
where the vial is represented by an ideally infinite cylinder of radius R.
Water
B0
*ast Agent
Water
Y
Figure 5-17: The angle between the applied Bo field and vial's axis is denoted 0. Edge
effects are neglected by assuming that the vial is infinitely long.
Four different orientations were investigated, as noted in Table 5.3, where the ratio
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of the transverse to axial components is simply given by the tangent of the angle to
the Bo field.
Table 5.3: Table of Field Components as a Function of Angle, 0 to Bo
Angle to Bo in degrees Transverse to Longitudinal Field Ratio
00
5.8 0.102
12.8 0.227
17.8 0.321
In the MRI imaging results which follow, the parameters are given in Table 5.4,
except for the case where the angle of inclination is 00, the resolution is 128x72
and TR = 500 ms.
Table 5.4: Table of MRI Parameters for Bo experiments
Parameter Value
Resolution 128x84
Slice Thickness 10 mm
TR 100 ms
TE as indicated
Number of averages 1
Bandwidth per pixel 1955 Hz/Pixel
Flip Angle 250
FOV 183 mmx280 mm
In each case, the bandwidth was maximized to minimize the effect of Bo inho-
mogeneities. The low spatial resolution is a trade-off with short TE times, so the
slice thickness is increased in order to increase SNR. The presence of edge effects and
artifacts due to such a large slice thickness is subsequently accessed. A relatively low
flip angle allows for shorter TR times and there is no expectation that increasing TR
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Figure 5-18: Magnitude (a) and phase (b) images collected when the vial is parallel
to the main Bo field with a coronal imaging view.
beyond 100 ms would significantly improve SNR.
5.3.7 Fringing Fields and Edge Effects
To investigate the fringing fields associated with the ends of the vial and the edge
effects due to the surrounding walls of the water tank, the vial was imaged in a
coronal orientation such that the imaging slice was in the {xz} plane. The echo time
was allowed to run to 10 ms to exaggerate any effects due to either the edges or the
vial ends. The TR value is 100 ms and the field-of-view is 300 mm x 300 mm. The
spatial resolution is 128 x 128 with a sagittal slice thickness of 5 mm and a readout
bandwidth of 1955 Hz/pixel. The large readout bandwidth and short TE are used to
minimize Bo inhomogeneity effects from affecting the image. The resulting magnitude
and phase images are shown in Figure 5-18.
The magnitude plot of Figure 5-18(a) shows that there is little disturbance of
the image magnitude at the water vial, except due to edge effects from the perspex
container and the end clamps. The vial of contrast agent shows significant end effects
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at each end of the vial as expected but, again, the magnitude is largely unchanged at
the center of the vial. The phase plot of Figure 5-18(b) shows some end effects for the
water vial but nothing significant at the vial's center. The contrast agent vial shows
significant phase disturbance at the vial center with widespread "phase wrapping"
as evidenced by the alternating black, then white phase patterns as the phase flips
from -7r to +ir. The effect will be clearly seen regardless of how thin the transversal
imaging slice becomes due to the severity of the wrapping and this is confirmed in
the results of Figure 5-19 which follow.
5.3.8 Phase Maps and Bo Fields
A series of phase maps were collected and the associated Bo maps were estimated as
previously outlined. The phase maps were collected for various short TE values to
ensure a heavy T2* weighting in all the resultant images. The slice of most interest
is that at the vial's center with a transversal orientation, such that it is always or-
thogonal to the vial's principal axis. The theoretical solution for the magnetic field
and flux density inside and outside the vial is described below.
Theoretical Field Solutions
The problem under consideration is that of Figure 5-17. The main Bo field is inclined
at an angle 0 to the vial's axis such that there are components of the main field
applied along both the y and z axes given by Bo sin 0 and Bo cos 9 respectively. The
vial of contrast agent is assumed to be of infinite extent along z and the agent is
assumed saturated with a saturation magnetization of Mo in A/m aligned with the
Bo field where Mo is given by O1M, and M, is the saturation magnetization of the
magnetite. The percentage solid volume in the agent is denoted €. The condition of
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saturation is easily met when imaging at typical clinical fields of 1.5 and 3 T.
The resulting field solutions for the regions 0 < r < R and r > R where R is the
vial's radius and r is the radial distance from the center of the vial, is a combination
of the effects due to the transverse field along i, and the axial field along i,. The
axial solution is trivial and the z-components are given in Eq. (5.16) and (5.17) by
virtue of continuity of the tangential H field at r = R.
B Bocos + koMocos0 for O<r< R
Bo cos9 for r>R
B •cosO for O<r<R
Hz = O (5.17)
B cosO for r>R
The solutions for the y components are more involved. For an infinite vial,
simplification arises with the consideration of a cylindrical coordinate set and the
definition of a transverse magnetic potential which takes the form of Eq. (5.18)
for a non-conducting, uniformly magnetized medium. The expression follows from
VH = -VM which is identically zero when M is uniform in space. Under this
condition of uniform M, the expression of Eq. (5.18) is true where H = -VI.
V2T = 0 (5.18)
Eq. (5.18) has solutions in an azimuthal-symmetric geometry such as that of Fig-
ure 5-17 as given by Eq. (5.19) where A, B, C and D are constants to be evaluated
by means of boundary conditions at r = R and V! =H.
149
(Ar+-L)sinw for 0<r<R
(r, )= (Ar + )s f(5.19)
(Cr + 2) sinD for r>R
Since ' cannot yield infinite field solutions at r = 0, we conclude that B = 0.
Therefore, the y-component of H might be written using the del operator in cylindri-
cal coordinates, as in Eq. (5.20), where ir and i, are unit vectors in the cylindrical
coordinate system.
(rsin pi + Acos pi, for 0 <r < R
gy(r, (P)= -(5.20)
(C - 2) sin •i + (C - ) cos pi, for r > R
The y-component of the B field solutions are given by Eq. (5.21).
By(r7, 0)f= po(Hy(r, p) + My(r, p)) for 0 < r < R (5.21)
pIoHy(r, ý) for r > R
The constants are solved by considering the boundary conditions as follows where
By = Bo sin 0 and My = Mo sin 0.
* B(r = R-) = Br(r = R +)
SH,(r = R-) = H,(r = R+)
H(r -- oo) =B-i (sin Oir + cos OiW)
Applying these boundary conditions to Eqs. (5.20) and (5.21) yields the following
solutions for A through D as given by Eqs. (5.22) through (5.24).
A= By My (5.22)
Po 2
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C = By (5.23)
/to
D = (5.24)2
Substitution yields the complete solution for the H and B fields by combining
these solutions for the transverse fields with the solutions of Eqs. (5.16) and (5.17)
where By = Bo sin 0, My = Mo sin 9, Bý = Bo cos 0 and M, = Mo cos 0.
Bi +(2-- )i, for 0<r<R
H = i 2 o 14o (5.25)
'iz + + "i $ (sin(2ý)i, - cos(2W)iy) for r > R
(Bz + /oMz)iz + (By + Mf)i, for 0 <r <R
B = (5.26){B, iz + B 1i + •r (sin(2p)ix - cos(2cp)i,) for r > R
The solution is plotted for various values of p and the results are shown in the
plots which follow along with the accompanying experimental imaging results.
Experimental Imaging Results
When the vial is aligned with the Bo field, the image results are shown in Figure 5-
19. The images all capture the center of the vial with a transversal view, or the {xy}
plane in Figure 5-17. The phase map of Figure 5-19(a) shows significant shading
in the water region surrounding the vial of contrast agent (rightmost vial) which
is not present for the water vial. This is to be expected for a 10 mm slice given
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the pronounced edge effects shown in Figure 5-18. The Bo map of Figure 5-19(b)
shows some inhomogeneity to the right of the contrast agent but, on the whole, is
reasonably uniform in the water region surrounding the two vials. It is assumed
that any disturbance to the phase maps are due to susceptibility effects caused by
the contrast agent and not due to Bo inhomogeneities. The theoretical solution for
transverse magnetic flux density, plotted using Comsol Multiphysics and shown in
Figure 5-19(c) along iY, is zero when the vial is aligned with the Bo field.
In the MRI system, the vial is rotated to achieve the angle effect. At an angle
of 9 = 5.80, the imaging results are shown in Figure 5-19(d)-(f). This value of 0
corresponds to an applied transverse flux density which is 10.2% of the axial magnetic
flux density. As well as the previously noted shading, there appears a clear dipolar
phasing pattern around the vial of contrast agent in Figure 5-19(d). There is also
some evidence of phase wrapping as signified by abrupt change from -7r to +ir above
and below the vial of contrast agent. No such dipole pattern is evidenced around
the water vial, so it is assumed that the disturbance correlates to the theoretical
transverse dipolar field solution shown in Figure 5-19(f). Again, no significant Bo
inhomogeneity effects are found, as shown in the Bo map of Figure 5-19(e).
Increasing the angle 0 to 12.80, the imaging results, given by Figure 5-19(g)-(i)
show increased dipolar-shaped field disturbance due to the increased component of
Bo that lies perpendicular to the vial's principal axis. This value of 0 corresponds to
an applied transverse flux density which is 22.7% of the axial magnetic flux density.
The experimental imaging results of Figure 5-19(g) and the predicted theoretical
field pattern of Figure 5-19(i) correlate closely. Furthermore, the presence of Bo
inhomogeneities is again discounted as a source of dephasing as evidenced by Figure 5-
19(h).
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Figure 5-19: Phase Maps, (a),(d),(g) and (j), and Bo maps, (b),(e),(h) and (k),
collected when the vial is at various angles to the main Bo field. The theoretical
transverse magnetic flux density was plotted using Comsol and shown in (c),(f),(i)
and (1). The angle of inclination is 00 for (a)-(c), 5.80 for (d)-(f), 12.80 for (g)-(i) and
17..8 for (j)-(1). The phase maps only show changes parallel to the Bo field.
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Increasing 0 again, now to 17.80 results in a further increased dipolar pattern
around the vial of contrast agent. This value of 8 corresponds to an applied transverse
flux density which is 32.1% of the axial magnetic flux density. In addition to the lobes
above and below the vial in Figure 5-19(j), the lobes to the right and left are now
clearly visible also. Again the result is closely correlated to the theoretical solution in
Figure 5-19(1) with little or no Bo inhomogeneity effects as shown in Figure 5-19(k).
Comments on Sensitivity to Transverse Fields
The purpose of the preceding experiment was to evaluate the effects of a magnetic
field transverse to the vial's principal axis by tilting the vial in a 1.5 T MRI system.
Two principal conclusions were reached. Firstly, the presence of dephasing due to
edge effects is unavoidable with the current vial and test setup. This results in the
shading around the vial of contrast agent in a T2*-weighted image when the vial
is parallel to the Bo field. While this effect is eliminated by means of a spin-echo
experiment (see Chapter 1), it would also be alleviated with the use of vials of a
greater length:radius ratio and by thinner imaging slices. The second finding is that
sensitivity of the MR image intensity and phase in a gradient-recalled echo (GRE) to
a transverse field was only just visible when the field represented approximately 10%
of the field along the vial's axis. This finding has implications for any effort to use
the transverse concomitant fields as a source of increased sensitivity in contrast agent
detection. It is also worth noting that any approach that employs the transverse
fields due to concomitance in Maxwell's Equations will have to be used outside of the
saturation region of the agent, such that there exist some transverse component of
susceptibility in order to see an imaging effect. Physically, this means the experiment
would only be effective at modulating MR image intensity and phase at low-field open
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MRI systems which typically operate at 0.2 or 0.35 T.
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Chapter 6
Linear Forces on Magnetic Fluid
Flow in MRI
6.1 Introduction
With the development of high-field MRI (e.g., 3 T and 7 T human scanners), the
potential for significant magnetic forces on magnetic fluids in MRI has increased.
Prior work (Ch. 5) has assessed the force associated with the magnetic gradients in
MRI. The purpose of this chapter of the thesis was to assess the potential impact of
commercial gadolinium and SPIO contrast agents (Magnevist and Feridex) on in vivo
blood flow in the presence of the large fringing field associated with high field MRI.
The effects at both 3 T and 7 T systems were investigated using a flow phantom to
replicate in vivo flow. The investigations consider pressure-driven Poiseuille flow in a
long pipe. The flow velocity was examined in the presence and in the absence of the
Bo magnetic field for a variety of pressure conditions. The effect of varying contrast
agent concentration and Bo was also examined. The results show that neither agent
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present measurable magnetic forces on blood flow in vivo even when three times
the recommended dosage is administered (i.e., 0.3 mmol Gd/kg for Magnevist and
0.03 mmol Fe/kg for Feridex, as given in Appendix B).
6.2 Theory of Magnetic Fluid Flow in MRI
Magnetomotive forces in magnetic fluid flow are governed by Maxwell's Equations,
the conservation of linear momentum (6.1), and conservation of angular momentum
(6.2) [42,97] where p is the pressure in Pa, p is the fluid mass density in kg-m- 3, ( is
the fluid vortex viscosity in N.s.m - 2, q is the dynamic shear viscosity in N-s.m - 2, J is
the fluid's current density in A-m - 2 (for conductive fluids), I is the moment of inertia
per unit volume in kg-m- 1, M is the fluid's magnetization in A-m- 1, H its magnetic
field intensity in A-m - 1 and po the magnetic permeability of free space with a value
of 47r x 10- 7 H/m. The flow velocity, v, and so-called spin-velocity, w, depend on the
flow regime. In the linear limit, M and H are collinear and related, in the low field
limit, by the susceptibility where M = xH. Spin-velocity will exist for flows with
vorticity or when M and H become misaligned, resulting in a magnetic torque density
acting to realign the magnetization and the magnetic field [42,97]. For incompressible
flows, the divergence of the flow velocity is zero (i.e., V -v = 0).
-Vp+ io(M -V)H + 2V x w + (++ )V2v + toJ x H = p( + (v. V)v) (6.1)
po(M x H) + 2((Vxv-2w)= I( O + (v V)w) (6.2)
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Of particular interest are long cylindrical vessels, typical of the human leg vascu-
lature, where Poiseuille flow dominates. These vessels may be exposed to high VH
effects in the fringe fields of MRI since, in the course of a typical MRI scan of the
head or upper torso, the legs lie in the region of rapidly decreasing magnetic field
intensity. The situation is illustrated in Figure 6-1 for the 3 T and 7 T Siemens MRI
systems [104]. While Figure 6-1 shows the magnetic flux density, B (in Tesla) as a
function of space, the strength of the main field in MRI is such that, for all realistic
clinical scenarios, M < H where VB = /ioV(H + M) and, therefore, VB ; poVH.
Main Axial Fed
Distance from isocenter in meters
Figure 6-1: Fringing fields associated with the 3 T and 7 T Siemens MRI systems [104]
are plotted as a function of distance (in meters) from the isocenter of the MRI magnet.
For a typical MRI of the head, the subject (typically ; 1.7 m in length) is positioned
as shown with the head at the magnet's isocenter (z = 0) where the B0 field is most
uniform.
The work which follows assumes steady state conditions so that all time-varying
terms in (6.1) and (6.2) may be ignored. In addition, for z-directed pipe flow which
only varies spatially in the radial direction along the pipe, the convective effects on the
right hand side of (6.1) and (6.2) are zero. Under conditions of magnetic saturation,
M and H are almost colinear so that M x H in (6.2) is also zero for any conven-
tional MRI system (i.e., B0 > 1T). The spin-velocity only becomes comparable to
pressure differentials typical in vivo when either the vorticity effects are considerably
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increased or in the presence of a rotating magnetic field which might misalign the
vectors M and H [97]. Neither scenario is considered in this work. Therefore, the
spin-velocity is given by half the vorticity (i.e., w = !V x v). Contrast agents, as well
as human blood, do not have negligible conductivity [98] as is commonly assumed.
However, since the magnetic Reynolds' Number in this experiment [99] (given by
oajvl Z (10- 6)(/zo)(1)(1.8) ; 10-5 where 1 is the longest dimension of interest (pipe
length) and p is the magnetic permeability) is very small, J, the fluid's current den-
sity is also set to zero. Considering all these simplifications, (6.1) and (6.2) can be
combined into the single expression, given by (6.3).
-Vp + to(M -V)H + 7V2v = 0 (6.3)
Initially, the viscosity of the suspension was assumed to be given by the viscosity
of the solvent, taken to be pure water at 200C with a value of q = 0.001 N.s.m- 2
[105]. However, since the viscosity is a strong function of temperature, decreasing
to 0.0008 N-s*m- 2 [105] at 300C, these changes had to be subsequently considered in
the work since the temperature changed considerably (up to 80C or 100C depending
on the conditions) from inside to outside of the MRI field. This dependence led to
misinterpretation of early results although the anomaly was eventually resolved.
The flow was considered fully developed, laminar, Poiseuille flow in the z-direction
along the entire pipe. Since pressure increases in the positive z direction (i.e., > 0),
the flow was in the negative z direction, as indicated in Figure 6-2. The analytical
expression in the absence of the MRI field is given by (6.4) where r, is the pipe
radius [105] and r is the radial distance from the pipe's center.
_v( ) =2 1- ) (6.4)
4160z r
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For such flow, the average and maximum flow velocities are related by a factor of
2 [105], so that the average velocity, vav is given by (6.5)
2 Op
v, = (6.5)8r7 Oz
In the presence of a gradient in the magnetic field (as shown in Figure 6-2),
the solution is given by (6.6). Under virtually all conditions, PoM < Bo and the
expression reduces to (6.7). The velocity is negative since it flows in the negative z
direction. In each case, the value of M depends on the agent. For the recommended
Feridex dose, the effective in vivo magnetization is M = qMd = 1.115 A-m - 1, where
Md = 446 x 103 A/m and the unitless solid fraction, ¢ = 2.6 x 10-6 as given in
Table B.1.
r ( p  
_Ho
vav = - MpoM (6.6)
Vav a p -M (6.7)8q az (z9
As long as the Bo field is sufficiently large that the Feridex remains in magnetic
saturation, the magnetization is independent of field strength so that (6.7) can be
rewritten as (6.8) where the bracketed term represents the modified pressure in the
presence of the Bo field.
Vay 8 za - p + M Bo(z) (6.8)
For Gd agents, the magnetization, M, is given by XH , XBo/po. Since Bo is a
function of z, the magnetization is also a function of z for Gd agents. In this case,
(6.7) can again be rewritten as given in (6.9) where the bracketed term is the modified
fluid pressure due to the Gd contrast agent.
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6.2.1 Measuring Magnetization
In the presence of a known pressure differential driving the fluid flow, the only re-
maining unknown quantity required to determine the expected fluid flow velocity from
(6.3) is the magnitude of the contrast agent's magnetization, M. Gadolinium agents
remain magnetically unsaturated up to main fields of about 50 T [25] so that the
agent's magnetization is linearly proportional to the applied magnetic field intensity,
H with the constant of proportionality being the magnetic susceptibility. Assuming
that the agent's magnetization is significantly less than the strength of the main field
(M < Bo/po), then the Gd agent's magnetization is given by (6.10), where Cm is
the agent concentration in kg Gd/m3 of solvent and Xm is the mass susceptibility in
m3/kg.
BoM ; Xm C,m (6.10)
/to
The Magnevist's magnetization was investigated independently using a vibrat-
ing sample magnetometer (VSM) and MRI as detailed in Chapter 5 of this thesis.
The results were a mass susceptibility of 2.06x 10-6 m3/kg Gd from VSM compared
with 1.8x 10-6 m3 /kg Gd for MRI. The prescribed dosage for Magnevist is 0.1 mil-
limoles of agent per kg bodyweight [61]. However, recognizing that each mole of the
agent (which has the complex molecular composition C28H54GdN5020) corresponds
to approximately the same mass as six moles of Gd, the recommended dosage is 0.6
millimoles Gd per kg. After the agent is injected into the subject, it is diluted in the
subject's blood pool, which acts as the agent's solvent. For in vivo administration to a
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normal, healthy adult with a total blood volume of 79 ml per kg bodyweight [103], this
corresponds to 15.7 mg Gd in each 79 ml or C, = 201 kg Gd/m 3 . The corresponding
in vivo magnetization with the recommended dose of Magnevist is Bo-dependent as
given by (6.10).
For SPIO agents, it is easily shown by means of the well-known Langevin relation,
that superparamagnetic particles of 6 to 8 nm magnetic core diameter (typical values
for Feridex nanoparticles [59]) will be magnetically saturated at all common clinical
values of Bo (e.g., 1.5 T, 3 T and 7 T). Unlike Gd agents, whose concentration is
usually expressed in molarity, SPIO agents are defined by the Fe mass in the solution.
The typical clinical dosage of Feridex is 0.56 mg Fe per kg of patient weight. Given the
molecular composition of magnetite (Fe30 4), this corresponds to 0.77 mg Fe30 4 per kg
or 1 x 10-8 m3 Fe30 4 per kg assuming magnetite has a density of 5150 kg.m - 3 . After
the agent is injected into the subject, it is diluted in the subject's bloodflow, yielding
an effective value for € in vivo. For in vivo administration to a normal, healthy adult
with a total blood volume of 79 ml per kg bodyweight [103], this corresponds to a
fraction solid volume of ¢ P 2.5 x 10-6. The resultant in vivo magnetization is given
by qMd and has a value of 1.115 A-m - ' for the recommended dosage. It is noted
that, unlike Gd agents, the effective in vivo magnetization of SPIO agents is almost
entirely independent of Bo for typical MRI systems (Bo > 1 T). A full discussion of
the various concentration units for MRI contrast agents is outlined in Appendix B.
6.3 Experiments at 7T
An experimental setup was constructed consisting of an elevated cistern, connected
gate-valves and long (1.8 m), straight circular pipes, as shown in Figure 6-2. An
elevated cistern maintained an increased input pressure to the pipes which was reg-
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ulated by means of a manual gate-valve. Two pipes of diameters dl = 4.32 mm and
d2 = 6.35 mm were used and the effect of varying the input pressure, P1 was inves-
tigated by varying the open fraction of the valves. The other end of each pipe was
open, P2 = 0.
Main Axial Field
0.0 0.5 1.0 1.5 2.0
Distance from isocenter in meters
2.5
Figure 6-2: Schematic representation of the experimental setup used to investigate
the effect on contrast agents of the fringing fields at 3 T and 7 T.
To correlate the input pressure, P1 with the open valve fraction, f (f=-1 = open,
f=0 • closed), 4 liters of deionized water were added to the cistern and the valve
opened by varying fractions, f (0 < f < 1). The total flow volume was collected at
the other end of the pipe over a 3 minute time period and the average flow rate was
calculated based on the pipe diameter in the absence of any magnetic field. Every
attempt was made to minimize head losses in the cistern over this time by making
the cistern diameter (28 cm) much larger than the pipe diameters (dl = 4.32 mm and
d2 = 6.35 mm). However, it was found that as the gate valve was opened (f --+ 1), the
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inlet pressure P1 was increasingly a function of the changing pressure head and not
of the valve open fraction, f. This is an undesirable situation since the flow velocity
is no longer relatively constant over time but will vary the longer that the gate valve
allows flow. The flow time was selected as 3 minutes to increase the net mass flow
and, hence, minimize the variance due to experimental error.
A further complication is the presence of entrance effects at the gate valve. These
tend to cause the flow to be more turbulent near the valve and result in a slowing
of the average flow velocity compared to the case of fully developed laminar flow
throughout the pipe's length. Instead, the flow velocity at entry from the gate-valve
will be almost constant over the pipe's cross section. The velocity at the pipe wall,
however, is zero so that a thin boundary layer is formed round the pipe walls. The
thickness of this boundary layer increases downstream from the entry until it equals
the radius of the pipe. The pipe length at which this occurs, Le, has been found
empirically to be given by (6.11) where r, is the pipe radius [100].
Le = 0.115 r 2av (6.11)
It turns out that Le can be a significant fraction of the overall pipe length for
the work considered here. A corrected formulation for the relationship between va,
and the applied inlet pressure is now a discontinuous function [100] as given by the
expressions of (6.12) in the absence of a magnetic field where P(Le) is the pressure
at z = Le and p is the fluid density (assumed that of deionized water at room
temperature, p = 998 kg.m-3 ). The entrance effects give rise to an additional pressure
drop of P" between z = 0 and z = Le in addition to the pressure drop for fully-
developed laminar flow.
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+ for 0 < z < Le
z -Le - for 2L
Op _ P(Le) =8vav for z > Le (6.12)
Oz Le- L r
Deionized water was allowed to flow under a variety of inlet pressures by varying
f. The relationship between P1 and f was measured experimentally for various values
of f by measuring vav for deionized water flow in the absence of any magnetic field.
This was achieved by measuring the mass flow rate over a 3 minute time period and
estimating the corresponding average flow velocity from the pipe's cross-sectional
diameter. The experiment was repeated three times and the resultant mean velocity
measurements were used to estimate P1 for each value of f. The results were fitted
to the curve given by (6.12) and are shown in Figure 6-3. The plot also shows the
linear relationship between P1 and av, as given by (6.5), where no account is taken
for entrance effects and where it is assumed that ! = ~.
Average Flow Velocity for Delonized Water
0.8,
.5 0.6
> 0.4
<0.2 /
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Input Valve Pressure PI in Pa
Figure 6-3: Measured flow velocity for deionized water in pipes of diameters dl =
4.32 mm and d2 = 6.35 mm as a function of the inlet pressure, P1, is fitted to the
expressions of (6.12). The dashed lines show the linear relationship between P1 and
av, when no account is taken for the entrance effects as given by (6.4). Velocities are
plotted as positive values although the flow is in the negative z direction.
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The experiment was then repeated using Magnevist and Feridex dilutions instead
of deionized water. The recommended dosages (lx) of Magnevist and Feridex were
added to 4 liters of deionized water, representative of the dilution which takes place
when the contrast agents are administered in vivo. Two additional dosages of each
agent, at twice and three times the recommended dose (2x and 3x) were also prepared
in the same manner. Each of the six contrast agent solutions was subjected to the
same experiment as the deionized water solution in the absence of any magnetic field.
As might be expected, all the resultant measured flow velocities lay very close to the
results of Figure 6-3.
To investigate the effect on flow velocity in the presence of a magnetic field,
the experiment was moved into a 3 T Siemens Trio MRI scanner at the Athinoula
A. Martinos Center for Biomedical Imaging (Massachusetts General Hospital). The
profile of the main Bo field as a function of distance from the scanner's isocenter
at z = 0 is as shown in Figure 6-1 [104]. The pipe ends were positioned at the
isocenter of the scanner, where pressure P2 = 0. The other end of the pipe, where the
gate valve is located, were positioned 1.8 m away, such that the pipe's principal axis
ran parallel to the direction of the scanner's fringing field gradient. Again, the flow
velocity was measured for various input pressures P1, two different pipe diameters, d,
and d2, and each of the six dosages of contrast agent described above; lx Magnevist,
2x Magnevist, 3x Magnevist, 1x Feridex, 2x Feridex and 3x Feridex. The entire
procedure was repeated in a 7 T Siemens MRI scanner. In order to minimize the
effects of head losses previously described, the pressure were limited at the gate valve
where f - 0.1.
While initial results, such as the plots of Figure 6-4 (which shows the variation va,
as a function of magnetic field for various dosages of Magnevist agent) show significant
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dependence on the Bo field, it was subsequently found that these changes were due
primarily to viscosity changes due to increasing temperature in the MRI.
Averap Flow Vdoy for MagNevist Dosages
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Field Strength in Tela
Figure 6-4: The average flow velocity recorded by experiment is shown for pipe with
diameter d2 when the inlet pressure, P1 ; 250 Pa (as determined by (6.5) based on
the measurements in the absence of Bo) for various dosages of Magnevist as a function
of the magnetic field strength. Results for deionized water under the same field and
pressure conditions are shown. It was subsequently found that these results could be
accounted for by changes in the fluid viscosity due to changes in temperature rather
than by the effet of the magnetic field.
Results shown in Figure 6-5 and Figure 6-6 show that the effects cease to be appar-
ent when the effects of viscosity changes with temperature are considered. Changes
in viscosity were accounted for by scaling the measured velocity by the appropriate
temperature-dependent viscosity [105]. In general, results recorded outside of the
MRI were recorded at 190C where w? : 0.00105 N.s.m - 2 while the temperature in the
7 T scanner approached 280 C where q77 0.00081 N-s-m - 2 [105]. Since viscosity is
inversely proportional to fluid flow velocity in the pipe, this effect was found to be
dominant over that of the magnetic field for the results of Figure 6-4.
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Figure 6-5: The average flow velocity from experiment at 7 T is shown for a pipe
with diameter d2 as a function of inlet pressure, P1 . Results for 3x Magnevist at 7T
are shown by the purple squares. The solid line joins the blue datapoints, recorded
for deionized water at 7T.
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Figure 6-6: The average flow velocity from experiment at 7 T is shown for a pipe
with diameter d2 as a function of inlet pressure, P1 . Results for 3x Feridex at 7T are
shown by the purple squares. The solid line joins the blue datapoints, recorded for
deionized water at 7T.
6.4 Conclusions of Flow Experiments
As can be seen from Figure 6-3, the actual flow velocity varies significantly from
that predicted for fully-developed flow when the pressure is increased. Therefore, the169
* Deionized Water
a 3x Magnevist
* Deionized Water
a 3x Feridex
0.0 0.2 0.4 0.6 0.8 1.0 1.2
p0H in Tesia
Figure 6-7: The measured M-H curves using vibrating sample magnetometry for
deionized water, undiluted Magnevist and a 3x dosage of Magnevist diluted in deion-
ized water.
after Dilution with Feridex
Undiluted Feridex
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Figure 6-8: The measured M-H curves using VSM for deionized water, undiluted
Feridex and a 3x dosage of Feridex diluted in deionized water.
additional experiments focussed on the low-pressure flow domain so that the magnetic
forces would not be dominated by the pressure differential in the system. However,
as shown in Figures 6-5 and 6-6, the results for the contrast agents and those for
deionized water tend to be very similar even at 3x the recommended dosage and in
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a 7T MRI field. Accordingly, it was concluded that contrast agents administered in
vivo are unlikely to have any appreciable impact on the blood flow velocity due to the
magnetic particles in the suspension being pulled into the region of strongest field.
To confirm this conclusion, the magnetization of 3x dosages of both Magnevist and
Feridex contrast agents were measured in the VSM for field strengths up to 1.2 T. The
results are shown in Figures 6-7 and 6-8. Also included in these plots are the measured
magnetization for deionized water and for the undiluted agent, as indicated on the
plot. Since these measurements are beyond the threshold for which the instrument
can be relied upon to provide accurate measurements, a quantitative interpretation is
inexact. However, it is qualitatively apparent that the magnetization associated with
both the Gd-based Magnevist and the SPIO Feridex is due to the combined effects of
the diamagnetic deionized water and the (super)paramagnetic contrast agent. In both
cases, the net result is that the diluted agent has a net diamagnetic magnetization,
albeit less than that of deionized water. This evidence complimented the experimental
results of Figures 6-5 and 6-6, clarifying why the contrast agents exert little or no force
on the fluid flow for the dosages examined in this work. It remains to be seen if this
result is true for higher dosages or for deoxygenated blood flow where deoxygenated
blood has a diamagnetic susceptibility of -7.9x 106 [93] compared to -9 x 106 for pure
water.
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Chapter 7
Heating with Contrast Agents in
MRI
The Food and Drug Administration (FDA), who regulate MRI in the US, outlines
four areas of safety concern in MRI [111]:
* Force and torque on magnetic materials due to the static magnetic field
* Heating caused by the RF magnetic fields
* Subject nerve stimulation due to the gradient magnetic fields used for spatial
encoding
* Risks associated with implanted medical devices in conjunction with all of the
above [112]
The proposals of Chapters 2 and 3 of this thesis propose the introduction of an
additional RF excitation source in the MRI system. The goal of this additional
source is to modify, as a function of excitation frequency, the local magnetization in
the presence of magnetic nanoparticles. However, not considered is the considerable
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heating associated with magnetic fluids in this field, in particular the non-ohmic
heating that results when magnetic fluids interact with a rotating field. This is the
primary concern of this chapter.
7.1 RF Heating due to Eddy Currents in MRI
The FDA stipulates that the "normal mode limit" (i.e., suitable for all patients)
for whole-body heating due to RF in MRI is 0.50 C or 2 W/kg of bodyweight. This
increases to P1C or 4 W/kg under the "first level controlled mode" (i.e., under medical
supervision). For human head scans in the normal mode limit, the temperature is
not to exceed 380 C or 3.2 W/kg averaged over the head mass. However, in MRI,
this heating effect is usually entirely due to the effect of eddy currents circulating in
the subject. The effect is most pronounced where the electrical conductivity, a, is
significant, such as in the eyes, and where charge tends to accumulate (e.g., the tip
of the nose). However, since the conductivity of both ferrofluids and MRI contrast
agents is so small (a ;: 28 x 10-6 [73]) that the contrast agent has little or no effect
on SAR due to eddy currents as discussed in various publications [76-79].
7.2 RF Heating due to Rotational Relaxation of
Magnetic Nanoparticles in MRI
In the presence of sinusoidal or rotating magnetic fields, magnetic nanoparticles will
act to realign their magnetization with the applied rotating field. The realignment
is characterized by the time constant r, as given by Eq. (1.1) and shown in Fig. 1-2.
When the sinusoidal or rotating field frequency Q is such that Q2r approaches unity,
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the magnetization associated with the particles and the applied magnetic field are no
longer collinear. When this occurs, there is power dissipation which results in the
heating of the magnetic particles [42, 113]. This phenomenon has given rise to an
entire field of research dedicated to the treatment of cancer patients, based on the
localized heating effects of magnetic nanoparticles in vivo [80, 81,83]. Treatment falls
under one of two categories, hyperthermia and thermoablation.
7.2.1 Hyperthermia and Thermoablation
In hyperthermia, the target area is subjected to a local temperature in the range of
42°C to 450C for periods of up to a few hours [80]. The end result is usually not
sufficient to eradicate all the cancerous cells and is coupled with other techniques
such as irradiation or chemotherapy [83]. Thermoablation aims at creating in vivo
temperatures in excess of 50' in the tumor region and exposure time is limited to
just minutes. Although this approach would appear preferred, there are concerns
regarding the physiological effects of such a rapid, localized heating effect [82]. To
date, particles that have been used are either injected in situ or are designed to bind
selectively to cancerous cells. The majority of investigations use superparamagnetic
magnetite or maghemite (y-Fe20 3) in water based suspensions since these are well
metabolized. Creating in vivo concentration to allow for sufficient heating is a major
challenge due to heat conduction away from the target area as well as blood perfusion
around the tumor [80]. A second significant challenge is the undesired heating as-
sociated with eddy currents in surrounding healthy tissue [85]. Brezovich [85] found
that subjects had a sensation of warmth but were able to withstand the treatment
for more than an hour when the product of the field amplitude He and the frequency
f = Q/(27r) did not exceed 4.85 x108 (A/m)/s. Superparamagnetic particles of mag-
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netite and maghemite have been the preferred nanoparticle to date [81] but recent
developments such as FeCo particles [70] would offer significant advantage due to the
increased magnetic moment per particle if concerns regarding biocomparability can
be overcome.
7.2.2 Heating in Superparamagnetic Fluids
Rosensweig [113] has examined the effect of RF fields on superparamagnetic fluid sus-
pensions. His work develops dissipation relationships based on the rotational relax-
ation of single-domain magnetic nanoparticles dispersed in a solvent due to sinusoidal
magnetic fields. Eddy current heating is assumed to be negligible due to the small
size of the particles (< 15 nm core diameter). Rosensweig showed volumetric power
dissipation was closely related to the solution of Shlimois' Relaxation Equation [48].
This present work follows Rosensweig's approach and introduces two significant de-
velopments: (i) the analysis is revised for the presence of rotating as well as sinusoidal
magnetic fields and (ii) the analysis is examined in the MRI environment where, it is
expected that the heating effect will be limited due to the large Bo field.
7.2.3 Theory
This analysis is based on the channel geometry shown in Figure 2-1, where a planar
ferrofluid layer between rigid walls at y = 0, d, is magnetically stressed by a uniform
DC z-directed magnetic field Ho, an alternating x-directed magnetic field of complex
amplitude h., and an alternating y-directed magnetic flux density of complex ampli-
tude by. The x and y components vary sinusoidally at frequency Q. The walls are of
infinite extent along the z axis and there is no ferrofluid outside the channel. It has
been shown in Chapter 2 that in the absence of any applied pressure differential or
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imposed linear flow, the solutions for the x and y directed magnetization components,
associated with the applied transverse rotating field are given by (2.17) and (2.18),
repeated for convenience in (7.1) and (7.2).
Mo (3•r + 1 + Mo/Ho)hx - (wzr)bv/lyo
Ho (307 + 1)(30-r + 1 + Mo/Ho) + (W.7)2
= Mo (wzr)h + (3f2 + 1)b/o (7.2)g Ho (3Q7 + 1)(3Qir + 1 + Mo/Ho) + (wzr)2
The associated spin-velocity is z-directed and given by (2.41), repeated in (7.3)
W = Re(,R b, - Mo(he + Mn) ;*) (7.3)
From the first law of thermodynamics, the differential internal heat density, dU
for a closed system of constant density is given by (7.4) where SQ is the differential
energy input and 6W is the differential work done by the system.
dU = 6Q - 6W (7.4)
For an adiabatic process, it can be assumed that JQ is zero so that all generated
heat remains within the system. This ignores, for example, blood perfusion. The
internal energy is then given by -3W, which, for a magnetic fluid with negligible
conductivity is given by (7.5) where H and B are the magnetic field intensity and
magnetic flux density respectively.
JW = -H dB (7.5)
Simplification is possible using the relationship between B, H and M.
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B = po(H + M)
:= 6W = -P~(H dH + H dM) (7.6)
Rosensweig has shown [113] that integration by parts then yields the expression
of (7.7) for the cyclic increase in work done, AW, which is the negative of the cyclic
increase in internal energy per unit volume, AU.
SAU = -AW = - W = o (MdH) (7.7)
As noted by Rosensweig [113], AU is positive in a ferrofluid solution where M
lags behind H as occurs when the rotating field is at sufficiently high frequency. The
solution is expressed in terms of one complete time cycle, of period T = 27r/Q, in
(7.8). It is noted that the partial time derivative of (7.8) is correct for a stationary
medium. For moving media, the convective derivative should be employed.
AU = -Po (M. )dt (7.8)
The expression of (7.8) is evaluated where M is the vector whose components are
the complex amplitudes, h^, and r^~Y, given by (7.1) and (7.2). The time derivative
of the H field is first evaluated in (7.10) where H is given by (7.9).
H = Re (eýit(,i + hiy)) (7.9)
& = Re (QeP (hi, + hiy) (7.10)
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= Re lJe3'(hxi, + (by/go 
- ^)iy) (7.11)
Substituting the expression of (7.11) into (7.8) eventually yields (7.16).
AU = -Po T(M. (Re(fent(hxi + (by/lo - rY)iy))dt (7.12)
AU = -poe (jT, ix + riz)ent . fent(hxix + (by//po - yrn)iy)dt (7.13)
AU= -oRe (j 2Zx(3hx)* + ((b/p -( ))* dt) (7.14)
AU = -yoke T 2 (-3xh( ) + ^aY(-Q(b /Ao - A;)))dt (7.15)
The last term of (7.15) has %A, multiplied by its complex conjugate (purely real)
which is then multiplied by jmath so this term is purely imaginary and thus has no
real part. It is eliminated from the expression.
AU= -Poe - h 2 mV(b;/Po) T (7.16)
The period T, is given by 27r/O so further simplification is possible.
Au = poRe (3l( + y(b /Po))) (7.17)
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Substituting for h, = He and by = JBe where He and Be are real-valued quantities
leads to (7.18), generating a rotating field in the transverse xy plane. For the analysis
which follows Be and He are related by Be = CoHe and po = 47r x 10- 7, the magnetic
permeability of free space.
AU = oRe (jr(^ He + Vh(-IBe/Io)) (7.18)
The volumetric power dissipation, P,, in W/m 3 is then given by f = Q/(27r)
times the expression in (7.18), as in (7.19). This expression equals equation (6) of
Rosensweig's work [113] when Be is zero and the spin velocity in (7.1) and (7.2) is
ignored.
P, = po~e ( ^( He + 7(H-Be/Po)) (7.19)
While Rosensweig related this expression to the rate of temperature rise, the
specific absorption rate (SAR) is the conventional measure of heating effects in human
tissue. SAR is given by the volumetric power dissipation divided by the mass density,
Pm, in kg/m 3 , as in (7.20). As noted by Andra et al. [84], the value of Pm should be
given by the mass of magnetic nanoparticles per unit mass of tissue rather than the
value of the tissue mass density.
SAR = Pl/p = MoRe (Q(fxHe + %(-jBe/lo)) (7.20)
The relation between SAR and temperature rise in vivo has been evaluated by
Andra [84] for the particular case of small, spherical tumors in relatively homogenous
tissue with low blood perfusion (e.g., muscle tissue or fat). The situation is approx-
imately realized in breast carcinomas. While the full expressions [84] relate SAR
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to spatial and temporal variations, the steady-state temperature rise above ambient
temperature in a spherical tumor of radius, R, is given by (7.21) where A is the heat
conductivity of tissue with an approximate value of 0.64 W-K-1'm - 1.
SAR -R2  PVR2
AT (7.21)3p,A 3A
The variation of the SAR and steady-state temperature rise is investigated for a
number of cases of interest. The work represents two significant developments over
that of Rosensweig [113]. Firstly, the case of rotating rather than purely sinusoidal
magnetic field excitation is investigated. Secondly, the effect of excitation, with both
sinusoidal and rotating fields, is investigated in the presence of a low-field MRI system
(Bo varying from 0.1 T to 0.35 T) as has been proposed in Chapter 2 of this work.
The rotating and sinusoidal fields are applied orthogonal to the DC Bo field. In each
case, the effect of variation in (i) particle radius, r, (ii) field excitation frequency, Q,
(iii) field amplitude, He = Be/Io, (iv) Bo field strength and (v) solid magnetic volume
fraction q is investigated. In estimating AT, the magnetic mass density is given by
Pm, = PFeso 4 where the density of magnetite, PFe3 4, has a value of 5180 kg/m 3 [113].
It is noted that while the results of Chapters 2 and 3 examined the variation of various
parameters as the dimensionless product R- varied, this chapter explicitly plots the
results versus particle radius since, as will be apparent, heating due to nanoparticle
rotation is most pronounced at -r = 1 only when the particles are close to magnetic
saturation. However, since it is very difficult to manufacture a ferrofluid/SPIO sus-
pension with a single characteristic radius (and hence characteristic time constant),
showing results versus particle radius seems a more realistic scenario.
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7.2.4 Sinusoidal Field Excitation in the absence of Bo
This section examines heating in the absence of MRI with a sinusoidal magnetic field
excitation. Following the analysis of Rosensweig, spin-velocity is ignored (i.e., w, = 0)
in the case of a sinusoidal driving magnetic field. This leads to a simplification in
the expressions for r7h and Thy as given by (7.22) and (7.23) where the sinusoidal
excitation has amplitude He and is applied along the x direction. The orthogonal
field component, with amplitude Be, is set to zero.
m = X + ) (7.22)
7y, = 0 (7.23)
The low-frequency limit of susceptibility, given by Mo/Ho in the presence of the
Bo field characteristic of MRI, reduces to a simple susceptibility when Bo is zero.
This susceptibility, denoted X, is given by (7.25) [42]. This expression for X is the
chord susceptibility employed by Rosensweig and written in terms of the full Langevin
equation (see (1.5)) in the absence of any Bo field. Approaching zero field, the chord
susceptibility is zero as a, given by (7.24) also approaches zero.
Md Vp po IHo
a = (7.24)kT
S= •oMVp 3 coth(a) - 1/a (7.25)
The chord susceptibility is plotted in Figure 7-1 as a function of particle radius
for various values of field strength, denoted He, in units of A/m. Clearly, as particle
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Figure 7-1: The effect of particle radius on the chord susceptibility, given by (7.25),
is examined for three magnetic fields of interest: /o0He = 10 mT, 20 mT and 30 mT.
radius increases, the slope of the Langevin relation, and hence the chord susceptibil-
ity, increases. This is also apparent from Figure 1-4 in Chapter 1, which shows the
Langevin relation, plotted in the presence of increasing Bo. For the chord suscepti-
bility, the dependence is not on Bo (which is zero for now) but on the amplitude of
the rotating field, He. As He increases, the slope of the Langevin curve, and hence
chord susceptibility, decreases as the fluid slowly approaches magnetic saturation due
to He. This is apparent in Figure 7-1 where, for any particular particle radius, an in-
creasing He field results in increased susceptibility. The unitless Langevin parameter
is ao = IVPMdH in this case and all other quantities are as noted in relation to (1.5)
of Chapter 1.
The results for SAR and AT, the change in temperature, are shown in Figure 7-2.
The tissue was assumed to have the same mass density as water at room temperature
(998 kg/m 3 ) and, unlike in Rosensweig's approach, the ferrofluid/SPIO solution was
assumed water-based. The surfactant thickness was taken as 2nm throughout and the
time constant's dependence on r is as plotted in Figure 1-2. All remaining parameters
(field amplitude He, field frequency, Q and particle concentration q) were varied as
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noted in the results of Figure 7-2. In the plots of AT, the tumor radius, R, is assumed
to be 1 cm.
7.2.5 Rotating Field Excitation in the absence of Bo
This section examines heating due to a rotating magnetic field in the absence of the
MRI's Bo field. For a rotating field, the expressions for the complex magnetization
amplitudes are now given, once again, by (7.1) and (7.2) where Mo/Ho is again
replaced by X, as given by (7.25). The y-directed component of field excitation, with
complex amplitude given by JBe is now non-zero. All other parameters are unchanged
from the prior case. The resulting variation in SAR and AT is shown in Figure 7-4,
for varying parameters of interest. It is noted again that the x and y components of
field excitation are related by IoHI = Be. As before, for the plots of AT, the tumor
radius is assumed to be 1 cm.
7.2.6 Sinusoidal Field Excitation in the presence of Bo
This section examines the effect of heating due to a sinusoidal magnetic field in
the presence of the Bo field of MRI. In the MRI, the large, z-directed, Bo field is
applied in addition to the transverse x-directed sinusoidal magnetic field. The primary
effect of B0 on the SPIO magnetization is that the saturation of the nanoparticles
is determined primarily by Bo when Bo >> o0He. Since physically achievable AC
rotating fields are unlikely to exceed 10 mT [80] due to power requirements, the
assumption that saturation is determined by B0 is reasonable for B0 in the range
of 0.1 T to 0.35 T. The expressions for the complex magnetization amplitudes mix
and izy are identical to that of (7.22) and (7.23) where w_ = 0 in the absence of a y
component of magnetic field. Also, X is replaced by Mo/Ho and Mo is given by (A.20)
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while Ho is approximately equal to Bo/Po for the Bo fields considered in this work.
The ratio of Mo/Ho is plotted in Figure 7-3 versus the particle radius for three values
of B0 which are of interest. Clearly, as B0 increases, the ratio of Mo/Ho decreases in
value.
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Figure 7-2: The effect on SAR and AT are shown for changing particle radius with
varying (a) and (b) magnetic solid volume fraction, ¢ while Q = 1.88 x 106 rad/s and
o0He = 10 mT, (c) and (d) magnetic field amplitude while Q = 1.88 x 106 rad/s and
-= 0.002, and, (e) and (f), magnetic field frequency while poHe = 20 mT and 4 =
0.002. The excitation takes the form of a sinusoidally varying waveform and there is
no DC MRI field, Bo.
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Figure 7-3: The effect of changing particle radius on the ratio of Mo to Ho is shown
for increasing values of Bo, 0.1 T, 0.2 T and 0.35 T. The ratio saturates at large
values of r as might be expected since the onset of magnetic saturation is earlier with
increasing particle size. For this result, ¢ = 0.002.
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Figure 7-4: The effect on SAR and AT are shown for changing particle radius with
varying (a) and (b) magnetic solid volume fraction, q while Q = 1.88 x 106 rad/s and
Be = 10 mT, (c) and (d) magnetic field amplitude while 0 = 1.88 x 106 rad/s and ¢
= 0.002, and, (e) and (f), magnetic field frequency while Be = 20 mT and 4 = 0.002.
In this case, the excitation takes the form of a rotating waveform and there is no DC
MRI field, B 0.
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The effect on SAR and steady state temperature rise, AT, in a tumor of 1 cm
radius is plotted for changing values of particle concentration q, field amplitude, He,
field frequency, Q, and main field strength, Bo and the results are shown in in Figure 7-
5 for a sinusoidal field transverse to Bo. It is noted that the sinusoidal field could also
be added in the z direction such that the X is then replaced by the derivative of the
Langevin function evaluated at Bo (i.e, ). However, as shown in Figure A-1, the
value of OMO is less than Mo/Ho for all values of Bo except in the very low field limitOHo
(Bo -+ 0 T), where the two are approximately equal.
7.2.7 Rotating Field Excitation in the presence of Bo
The sinusoidal field is now replaced by a rotating field of amplitude He and frequency
2 while the Bo field is maintained and the results with varying parameters of interest
are shown in Figure 7-6. Again, in calculating AT, the tumor radius is assumed to
be 1 cm. The expressions for the transverse complex magnetization amplitudes are
identically (7.1) and (7.2) where it is assumed that saturation is determined primarily
by the Bo field and not the transverse rotating field amplitude.
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Figure 7-5: The effect on SAR and AT are shown for changing particle radius with
varying (a) and (b) magnetic solid volume fraction, 0 while 0 = 1.88 x 106 rad/s,
Be = 10 mT and Bo = 0.2 T; (c) and (d) magnetic field amplitude while Q =
1.88 x 106 rad/s, q = 0.002 and and Bo = 0.2 T; (e) and (f), magnetic field frequency
while Be = 20 mT, q = 0.002 and Bo = 0.2 T and; (g) and (h), main field strength
with Q = 1.88 x 106 rad/s, Be = 20 mT and q = 0.002. The excitation takes the
form of a sinusoidal, x-directed waveform and the Bo field is assumed orthogonal
(z-directed).
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Figure 7-6: The effect on SAR and AT are shown for changing particle radius with
varying (a) and (b) magnetic solid volume fraction, ¢ while Q = 1.88 x 106 rad/s,
Be = 10 mT and Bo = 0.2 T; (c) and (d) magnetic field amplitude while Q2 =
1.88 x 106 rad/s, 4 = 0.002 and and Bo = 0.2 T; (e) and (f), magnetic field frequency
while Be = 20 mT, € = 0.002 and Bo = 0.2 T and; (g) and (h), main field strength
while Q2 = 1.88 x 106 rad/s, Be = 20 mT and q = 0.002. The excitation takes the form
of a rotating, transverse xy field and the Bo field is assumed orthogonal (z-directed).
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7.2.8 Discussion
Sinusoidal Field Excitation in the absence of B0
The results of Figure 7-2 compliment those of Rosensweig although the solution is now
a water-based rather than an oil-based solution [113]. As is evident from Figure 7-
2(a) and (b), the SAR and temperature rise are a maximum at a particle radius
of approximately 7nm for a rotating field frequency of 300 kHz. While one might
suspect that this is where the product of Q-r approaches unity, this is only true in
the case where the chord susceptibility, X, is non-variant with particle radius, as is
the case when the fluid approaches saturation. Otherwise, the dependence of SAR,
and hence the change in temperature, is a non-linear function of the particle radius
where the chord susceptibility tends to shift the peak value of SAR to the right of
where i-r = 1. For an excitation frequency of 1.9 x 106 rad/s (;300 kHz), Figure 1-2
shows that the particle radius is approximately 4 nm when fTr = 1. Clearly, this does
not correspond to the peaks of Figure 7-2, although as the sinusoidal field amplitude
increases in Figure 7-2(c) and (d), the peak is seen to shift towards Q~7 = 1 as one
would expect due to the increasingly saturated fluid.
The dependence of SAR on particle concentration, is linear, as shown in Figure 7-
2(a) and (b), This is expected since the magnetization, on which SAR is linearly
dependent, increases linearly with chord susceptibility and hence, on particle concen-
tration, ¢. However, the temperature change, AT, increases with the square of the
particle concentration as is obvious from (7.21), which introduces a second ¢ factor
in addition to that due to the chord susceptibility. These dependencies are clear in
Figure 7-2(a) and (b).
SAR depends in a non-linear fashion on the sinusoidal field amplitude He, as
shown in Figure 7-2(c) and (d). This relation is expected due to the non-linear
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dependence of chord susceptibility on the field amplitude. However, with increasing
He, the chord susceptibility becomes increasingly non-variant with particle radius, as
has already been noted for the case of a fluid approaching saturation. As the fluid
approaches saturation, the SAR shows a square dependence on He and this relation
is visible in later plots with the addition of the Bo field, where the fluid is increasingly
saturated. Saturation is not achieved in the case of a sinusoidal field excitation with
M~He < 30mT as is the case here.
The variation of the applied field frequency, R, has two effects on SAR and AT.
Firstly, the peak value tends to shift to lower values of particle radius as 0 increases.
This is because, as 2 increases the maximum of the expression in (7.22) tends to shift
to the left, corresponding to the peak of Qr shifting with changing Q. As already
noted, the peaks are not centered on Qr = 1 while the chord susceptibility remains
a function of r. The second effect is that, for any one value of r, both SAR and AT
increase non-linearly with 2. This is due to two competing terms: (i) from (7.19)
and (7.20), SAR will increase linearly with 0 while (ii) SAR decreases with 0 due
to the 27r term in the denominator of (7.22). The first of the two effects dominates,
resulting in increasing SAR and AT with increasing 2. For 2r > 1 or 2r <« 1, the
second effect disappears and SAR (and AT) increase linearly with Q. This is the
reason why workers [80,81,83] developing hyperthermia systems seek to maximize 0
within physiological limits.
Rotating Field Excitation in the absence of Bo
With the addition of a second orthogonal (y-directed) component, which is a quarter
cycle temporally displaced from the x-directed field (i.e., 90' phase difference), a
rotating field is created. This action doubles the magnitude squared of the applied
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field, thereby doubling the power dissipated and is seen in the resulting increase in
SAR. From the expression of (7.19), the addition of this second component (i.e., a
non-zero Be) adds an approximate factor of two increase in SAR and AT. This is
shown in the results of Figure 7-4(a) through (f). All other comments of the prior
paragraphs remain true.
Sinusoidal Field Excitation in the presence of Bo
After the addition of the B0 field which characterizes MRI, the most striking result is
the large decrease in both SAR and AT. This decrease is greater as Bo increases. The
presence of Bo causes the fluid to approach saturation far more rapidly than occurs
in the presence of the rotating field. Saturation impedes nanoparticle rotation, and
hence, heat generation, since one can imagine a larger fraction of the nanoparticles
remain saturated, collinear with Bo, and do not respond to the sinusoidal field exci-
tation orthogonal to B0o, along the x axis. This result is supported by comparing the
resulting AT from Figures 7-2, where there is no B0 field and 7-5, where the B0 field
is present. Since the DC Bo field itself does not add or subtract heat from the fluid,
the dramatic change in heating can only be accounted for by the partial magnetic
saturation which occurs in its presence. Furthermore, with this increase in saturation
of the fluid, the SAR dependence on particle radius is determined primarily by the
denominators of (7.1) and (7.2) rather than the ratio of Mo/Ho which tends to be
invariant with r as field strength increases. For this reason, the peak SAR and AT
tends to be much sharper than in the absence of B0 . Also, the peak is now increas-
ingly centered around R• = 1, and the peak tends to be closer to -7T = 1 as Bo
increases (thereby causing more saturation for any given particle radius).
SAR and AT still increase linearly in the presence of Bo (see Figure 7-5(a) and (b))
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although the dependence on He is approximately square so that when He is doubled,
SAR quadruples etc. The relation is not perfect since there is still some dependence
of Mo/Ho on the particle radius. Finally, the relation to excitation frequency, 0, is
approximately linear, as expected from (7.20) although there is some influence from
the Or term in the denominator of the magnetization expressions, as described in the
previous sections.
Rotating Field Excitation in the presence of Bo
The results for a rotating field in addition to the B0 field are easily reconciled with
the previous results. A factor of two increase in SAR and AT is recorded compared
to the case of a sinusoidal waveform. All other notes from the prior paragraph remain
valid.
7.3 Conclusions
SAR and AT are increased by a factor of two in the presence of a rotating magnetic
field compared to a purely sinusoidal magnetic field. This is not a scenario that has
previously been examined in the context of hyperthermia and thermoablation and
may be of interest to the reader. More relevant to this thesis is the finding that,
in the presence of the B0 field characteristic of open MRI systems (where Bo might
vary between 0.1 T and 0.35 T), SAR is reduced significantly although appreciable
changes in temperature are still envisaged. The results of Figure 7-6 suggest that the
proposal of Chapter 2 (the application of rotating field transverse to Bo to generated
modulated magnetic fluid magnetization) be coupled to the application of magnetic
nanoparticles in hyperthermia treatment.
195
196
Chapter 8
Summary and Future Work
8.1 Summary of Thesis Contributions
This thesis represents the first attempt to integrate the fields of MRI and the dynamic
behavior of magnetic fluids, in particular, the unusual properties of magnetic fluids
in rotating magnetic fields. The novel contributions from the thesis are summarized
here.
* The strong dependence of T1 and T2 relaxation times on the superparamag-
netic nanoparticle radius has been demonstrated (Ch. 1). By comparison with
transmission electron microscopy, it has been shown that, with knowledge of the
water's relaxation time constants, an accurate prediction of the particle radius
can be made based on the measured T1 and T2 times for the suspension.
* It has been demonstrated that MRI can be used to accurately quantify mag-
netization due to MRI contrast agents (Ch 5). This was accomplished using a
3T MRI system for two types of contrast agent: paramagnetic Gd-based Mag-
nevist and superparamagnetic SPIO-based Feridex. The results closely agreed
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with measurements made using vibrating sample magnetometery.
* The work presented, for the first time, a modified Langevin relation for non-
saturated superparamagnetic suspensions in MRI (Ch 1, App. A) . This was
achieved by means of a small-signal linearization about the operating point, de-
termined by the Bo field of the MRI, where the AC rotating field was represented
as small-signal perturbations about the operating point.
* The change in magnetic fluid magnetization was simulated in the presence of
magnetic particle spin in MRI. The spin was achieved by a rotating magnetic
field (Ch. 2). The effect of flow and the field's orientation were investigated
(Ch. 3).
* The non-ohmic heating associated with superparamagnetic fluid suspensions
due to a rotating field was investigated for the first time by means of numerical
simulation and theoretical analysis (Ch. 7). The analysis was extended to find
the effect of the MRI's Bo field.
* The presence of linear magnetic forces on magnetic fluid flow in MRI was in-
vestigated for the typical dosages of commercial contrast agents at 3 T and 7 T
MRI (Ch. 6). The forces were not found to be significant compared to typical
in vivo pressure drives.
8.2 Proposals for Future Work
The proposals for future work are divided into three distinct categories: (i) a proposal
for a coupled MRI-hyperthermia system using magnetic nanoparticles for selective
heating, (ii) demonstration of nanoparticle spin using ultra-low field MRI and (iii)
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design of in vivo ferrofluid pumping techniques for targeted drug delivery.
8.2.1 Coupling MRI and Hyperthermia with Magnetic Nanopar-
ticles
As shown in the analysis and results of Chapter 7, the heating effects of magnetic
nanoparticles due to rotating magnetic fields is considerable even in low-field MRI.
This result suggests a combination of low-field MRI, which could be used for diagnostic
purposes, and the use of magnetic nanoparticles for selective hyperthermia in cancer
therapy. Much analysis remains undone in this area, particularly with respect to the
nanoparticles' behavior. It would be of use to examine the effects of blood perfusion
on the expected in vivo temperature rise as well as expanding the tissue conduction
work of Andra [84]. Currently, the analysis uses the evaluated SAR to calculate
the expected rise in temperature. However, since the SAR is determined assuming
an adiabatic process, it seems that that a more rigorous examination based on the
laws of thermodynamics is in order. Also worth examining is the effect of smart
nanoparticles (those agents which can intelligently bond to selective tissue types in
vivo [1, 2]) so that clinicians can accurately predict what concentration of magnetic
material is available at the tumor site for hyperthermia.
8.2.2 Nanoparticle Spin using Ultra-low Field MRI
Based on the analysis of Chapters 2 and 3, it should be of significant experimental
interest to determine if magnetic nanoparticle spin can be used to change image
intensity in MRI. This work suggests that this is best achieved at very low DC field
so that the rotating magnetic field can be used to arbitrarily rotate the magnetic
nanoparticles, unencumbered by magnetic saturation effects. As noted in Ch. 3, the
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use of ultra-low field MRI has been demonstrated as a feasible imaging technique for
clinical applications with a main field strength in the range of AT [110]. Adding a
rotating field on the order of mT to such a system, which would allow interaction with
the magnetic nanoparticles, presents one possible scenario of investigating ferrofluid
spin in the MRI environment.
8.2.3 Ferrofluid Pumping for Targeted Drug Delivery
This is not a new proposal but, since the theoretical basis rests heavily on the work
of chapters 2 and 3 of this thesis, the author believes that this may represent the
most promising avenue for clinical application of magnetic nanoparticles in MRI.
Using the nanoparticles as a passive contrast agent (as shown in Ch. 1), the position
of the magnetic nanoparticles could be predicted in vivo. Applied standing waves
cause the nanoparticles to move towards the target area [114, 115]. Obviously, the
technique is most suited to applications where the vasculature is close to the skin
surface (e.g., in the leg or arm) and one critical goal of the work would be to determine
the required nanoparticle concentration in vivo, necessary to successfully move the
magnetic nanoparticles, and thereby the nanoparticle-bound drug, to the subject's
target area.
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Appendix A
Linearization of the Langevin
Function
A.1 Introduction
The Langevin relation relates the ratio of the magnetic to thermal energy densities
in a ferrofluid [42]. It takes the form of (A.1) and L(a) describes the portion of the
magnetic nanoparticles in the ferrofluid that align with a constant, external, magnetic
field, of magnitude IHI. The Langevin parameter, a, is a function of the magnetic
field magnitude IHI within the ferrofluid, as given by (A.2) where Md is the single
domain magnetization of the particle (assumed magnetite), V, is the particle magnetic
volume, po is the permeability of free space, k is Boltzmann's constant and T is the
absolute temperature. The ferrofluid saturation magnetization M, is related to Md
by the fraction solid volume in the suspension, denoted by 0 where M, = OMd.
Meq = M8 L(a) = M,(coth(a) - 1/a) (A.1)
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A.2 Linearization of the Langevin Relation
Linearization of the Langevin function can be performed about a DC operating point
defined by the DC magnetic field intensity Ho. It is assumed that there are no large-
signal DC components directed along i, or i4, which are unit vectors along the x and
y axes respectively, so that Ho is directed along iz, the unit vector along z. Additional
small-signal perturbations about that operating point along i,, iY and i, are denoted
by hX, hy and hz respectively leading to the expression in (A.4).
H = hxix + hyiy + hziz (A.3)
H = h ix + hy iY + (Ho + h,) iz (A.4)
Similarly for the associated equilibrium magnetization vector, M,, where the compo-
nents of magnetization due to the perturbations along ix, i4 and iz are denoted ihxo,
miyo and m 0zo respectively.
Meq = mx i + my i + mziz (A.5)
Meq = filxo ix + fryo i + (Mo + frhzo) iz (A.6)
Under equilibrium conditions, the magnetic field and the magnetization vectors
will be colinear. Therefore H and Meq are collinear and (A.6) can be written in terms
of (A.4).
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M - ML(a) hx ix + h, iY + (Ho + z) iz (A.7)
() 2 + (h) 2 + (Ho + hz) 2
Considering a first-order Binomial expansion of the denominator of (A.7), one can
rewrite the expression for Meq as (A.8).
Meq, ML(a) h, i , + h4 iY + (Ho + hz) i(1- h (A8)
Ho  Ho
The Langevin parameter a is written as the linear sum of contributions due to the
Langevin function evaluated at the operating point (denoted ao) and the contribution
due to the small-signal perturbations (denoted a'). The terms ao and a' are evaluated
by a first-order Binomial expansion of (A.2) where IHI is given by (A.4) to yield (A.12)
and (A.13).
a = ao + a' (A.9)
a MdVp 110 (A.10)
a = kT ()2 + ( 2 + (H + )2 ( .10)
a Md V O Ho(1 + h) (A.11)
kT Ho
MdV po HoSV o = Ho (A.12)Sa = kT
= a' = a0H (A.13)Ho
Simplifying L(a) using a first-order Taylor Series expansion, leads to (A.16).
1
L(a) = coth(ao + a') - (A.14)
ao + a'
8L(a)L(a) a L(ao) + aa =~aOa' (A.15)
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1 a' a'
L(a) , coth(ao) - + (A.16)
ao sinh2(ao) • 0
Substituting for L(a) in (A.8) allows the constituent components of M,, to be
expressed as follows and the component due to the DC Ho field, which is z-directed,
is given by (A.20).
hx M (A.17)
fLyo 0- M, L(ao) (A.17)
fnyo , M, L(ao) -- h  (A.18)
-ao 1 )hz Mo
hzo ; M, ( a + --1 a o z  (A.19)
sinh2a o  ao Ho 8Ho
Mo = M, L(ao) (A.20)
The expressions of (A.17) through (A.20) show that for z-directed perturbations,
the relationship between the small signal magnetic field and the resultant magnetiza-
tion is due to the slope of the Langevin relation evaluated at the DC operating point
defined by Ho. When the perturbations are either x or y-directed, the relationship be-
tween the small signal magnetic field and the resultant magnetization is related by the
ratio Mo/Ho. Comparing these two relations, it is easily shown that the two relations
are approximately equal in the low-field limit, when the DC field determining the
operating point becomes comparable with the small-signal perturbations, as shown
in Fig. A-1 for the typical numerical values of magnetic particle radii (4 nm). As
the Bo field increases, the value of Mo/Ho exceeds the slope of the Langevin function
evaluated at the operating point for all values of DC field, as shown in Figure A-1.
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Figure A-1: The values of Mo/Ho and 8MO are plotted for the parameters of Table 3.1
including a particle core radius of 4 nm. As expected, the values converge in the low-
field limit.
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Appendix B
Defining Contrast Agent
Concentration
Throughout this thesis, every effort has been made to maintain consistent units of
contrast agent concentration. However, in light of the many formulations that appear
in the literature, a number of clarifying comments are offered.
B.1 Ferrofluids and SPIO Contrast Agents
In general, workers in the traditional applications of ferrofluids will use the solid
volume fraction to define concentration [42, 47,48,90]. The fraction indicates the
volume of magnetic nanoparticles as a fraction of the total volume of solution and is
usually denoted as €. This is the approach applied for all of the work in this thesis
unless otherwise stated.
However, in MRI, it makes little sense to speak in terms of 0 since the total volume
of the solution is often unknown or indeterminate (e.g., the total blood volume of the
patient to whom the agent is being administered). Therefore, SPIO contrast agents
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Figure B-1: In vivo magnetization is plotted in units of A-m - 1, for a person of 70 kg
with a total blood volume of 4 liters, as a function of the administered dose of Feridex.
The recommended dosage is 0.56 mg Fe/kg.
are commonly referred to in terms of their recommended dosage in mg of Fe per kg
of bodyweight. The majority of SPIO agents are comprised of magnetite (Fe30 4)
[59]. As of February 2008, the sole FDA-approved SPIO agent available in the US is
Feridex [59], manufactured by AMAG Pharmaceuticals, Cambridge, Massachusetts.
The recommended dosage for Feridex is 0.56 mg Fe per kg. For a human weighing
70kg, this corresponds to a total dosage of 39.2 mg Fe or, given the molar composition
of magnetite, 54.14 mg of Fe30 4. Magnetite has a density of 5210 kg-m - 3 [42],
yielding a total in vivo solid volume of 1 x 10- 8 m3 Fe30 4. Considering the total in
vivo blood volume to be 4 liters [103], this corresponds to an in vivo value for €, after
administration of the recommended dosage of Feridex, of 2.6x 10-6.
An additional source of confusion is due to the nomenclature arising in theoretical
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studies of T1 and T2 relaxation time. In the works of Gillis et al. [8, 10-13, 16], a
third terminology is employed. Here, the preferred unit of concentration is the molar
concentration in moles of Fe per liter, usually denoted C (see Eqs. (1.17) and (1.18)
of Chapter 1). The liter arises due to the use of cgs units. In addition, the unit is
often written [8,12,16] as "mM" which corresponds to millimoles of Fe per liter of
solution. The reference to Fe or to the control volume is seldom included. Since one
mole of Fe corresponds to 56 grams, the recommended dosage of Feridex, corresponds
to an in vivo value of C = 1.75x 10- 4 moles Fe per liter. Again, the in vivo blood
volume is considered to be 4 liters.
Table B.1 lists factors of the recommended dosage for Feridex SPIO contrast agent
and each of the corresponding units of concentration described above. As well as the
molar concentration, C, the mass concentration, C, in mg Fe per liter is also included.
Feridex dose Feridex dose In vivo In vivo C, In vivo C
in mg Fe/kg in mol Fe/kg in mg Fe per liter in mol Fe per liter
0.28 5x10- 6  1.3x10 -6  4.93 0.88x10- 4
0.56 10x10 - 6  2.6x10-6  9.86 1.75x10 - 4
1.12 20x10- 6  5.2x10 -6  19.6 3.5x10-4
1.68 30x10- 6  7.8x10 -6  29.6 5.25x10- 4
Table B.1: Units of in vivo concentration for Feridex using all units of concentration
found in the literature. The in vivo values assume a human bodyweight of 70 kg and a
total in vivo blood volume of 4 liters. Fe has a molar mass of 56 g. The recommended
(lx) dosage is 0.56 mg Fe/kg bodyweight.
While insightful, the concentration of the agent in vivo gives no indication of the in
vivo magnetization associated with the SPIO agent. To quantify this magnetization,
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one needs to make some assumptions regarding the saturation of the agent in vivo.
The agent saturation is determined by the Langevin relation (see Fig. 1-4). However,
as this figure clearly represents, all SPIO agents of realistic particle size will be fully
saturated at clinical MRI strengths beyond 1 T. Therefore, the in vivo magnetization,
M, is simply given by M = CMd where Md is the single-domain magnetization of
magnetite, with a value of 446x103 A-m- 1. The resulting in vivo magnetization is
plotted in Fig. B-1, again for a person of 70 kg with a total blood volume of 4 liters.
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B.2 Gd Contrast Agents
Unlike SPIO contrast agents, Gd agents are complex molecular structures which con-
tain long chains of bonding atoms around the Gd ion (Gd3+). The agent considered
in this work is Magnevist, with a molecular structure of C28H54GdN5 O20. The recom-
mended dosage is expressed in molarity rather than in mass, as is the case for Feridex.
The prescribed dosage for Magnevist is 0.1 millimoles of agent per kg bodyweight.
However, recognizing that each mole of the agent corresponds to approximately 6
moles of Gd, the recommended dosage is 0.6 millimoles Gd per kg. After the agent
is injected into the subject, it is diluted in the subject's bloodflow, which acts as
the agent's solvent. For in vivo administration to a normal, healthy adult with a
total blood volume 4 liters [103], this corresponds to an in vivo Gd concentration
C = 10.43 mM Gd (i.e., millimoles of Gd per liter of blood volume in vivo). The
various possible concentration units for Magnevist for recommended dosages and in
vivo concentration are shown in Table B.2.
Magnevist dose Magnevist dose In vivo q In vivo Cm In vivo C
in mg Gd/kg in mol Gd/kg in mg Gd per liter in mol Gd per liter
7.85 0.5 x 10-  - 820 5.22x10 - 3
15.7 1 x 10-  - 1639 10.43 x 10
31.4 2 x 10-  - 3278 20.86 x10 -
47.1 3 x 10- 4  - 5067 31.29x 10- 3
Table B.2: Units of in vivo concentration for Magnevist using all units of concentra-
tion found in the literature. The in vivo values assume a human bodyweight of 70 kg
and a total in vivo blood volume of 4 liters. The solid fraction volume is a meaningless
parameter for Gd agents since much of the particle mass is non-magnetic. Gd has a
molar mass of 157 g. The recommended (lx) dosage is 15.7 mg Gd/kg bodyweight.
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Gadolinium agents remain magnetically unsaturated up to main fields of about
50 T [9] so that the agent's magnetization is linearly proportional to the applied
magnetic field intensity, H, with the constant of proportionality being the magnetic
susceptibility. The results of Chapter 5 yielded a value for Xm, the mass susceptibility,
of 1.8x 10-6 m3/kg Gd as measured by MRI. Assuming that the agent's magnetization
is significantly less than the strength of the main field (M <K Bo/llo), then the Gd
agent's in vivo magnetization is given by (B.1), where Cm is the mass concentration
in mg Gd/liter and the mass susceptibility is expressed in liters/mg Gd. For the value
from the MRI measurement, this is equivalent to 1.8x 10-9 liters/mg Gd. The in vivo
magnetization is plotted for Bo = 1.5 T, 3 T and 7 T in Fig. B-2 as a function of the
dosage in mmol of agent per kg bodyweight. As already noted, the magnetization
is a function of field since the Gd agent is not magnetically saturated. Also, the
recommended dosage (usually expressed in units of moles of agent rather moles of
Gd) is 0.1 mmol/kg which corresponds to 0.6 mmol Gd/kg.
Bo
M I Xm -C (B.1)Po
Comparing Figs. B-1 and B-2 it is clear that the in vivo magnetization is increased
using Gd compared to SPIO agents. This is somewhat counter-intuitive since Gd is
a paramagnetic species and significantly less magnetic than the superparamagnetic
nanoparticles. However, the concentrations administered as recommended dosages
ensure that there is such an abundance of Gd ions per unit blood volume, that
the Gd agent has more appreciable net effect than the SPIO agent on the in vivo
magnetization.
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Figure B-2: In vivo magnetization is plotted in units of A-m -1 , for a person of
70 kg with a total blood volume of 4 liters, as a function of the administered dose of
Magnevist in mmol/kg. The recommended dosage is 0.1 mmol/kg.
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Appendix C
Prior Work on T1 and T2
Characterization
Preliminary investigations were undertaken by Professor Adalsteinsson to characterize
the T1 and T2 relaxation times associated with dilutions of MSG-W11 ferrofluid with
distilled water at Bo = 1.5 T. These investigations, led to the results of Fig. C-1 and
provided the impetus for the work of this thesis. The ferrofluid was diluted by three
different amounts, q1 = 2.75 x 10- 2, 02 = 2.75 x 10-6 and 03 = 2.75 x 10- 8. A control
sample of distilled water was also used. For each sample, the corresponding T1 and
T2 times were characterized.
C.1 Experiments
A series of spin-echo MR images were acquired with increasing repetition times (TR),
but with a fixed, short echo time (TE=14 ms). These data were used to estimate
T1, since the amount of signal recorded for each vial is exponentially related to T1,
as given by Eq. (C.1). The signal is also weighted by T2 due to the echo time, TE,
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but this weighting is constant for each solution and does not interfere with the T1
estimate. The values investigated for TR were 83, 167, 500, 600 and 2000 ms. The
results are shown in Figure C-l.
S(t) o 1 - e T (C.1)
A second data set with increasing echo times (TE) at a fixed, long repetition
rate (TR = 5000 ms) was acquired to estimate T2, since the signal, in this case, is
exponentially weighted by TE. When T1 is a significant fraction of TR (as is the
case for the distilled water solution), a better model for the recorded signal requires
knowledge of T1, as given by Eq. (C.2). The value of TE was varied between 0 and
800 ms and the results are shown in Figure C-1.
TR TR-TE/2 TE
S(t) cx (1 - e T1 - 2e Ti )e T2 (C.2)
A single slice through the center of the vials was used for analysis. A rectangular
area within each vial was used to estimate mean and standard deviation for the T1 and
T2 data sets. A nonlinear, least-squares fit to the increase in signal due to increased
TR was used to estimate T1 whereas the signal decay as a function of increasing echo
time was used to estimate T2 by including the prior estimates of T1. In all cases,
the image acquisition consisted of six contiguous, coronal slices, 8 mm thick, with
256x 160 pixels over a 16 cm field-of-view.
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Figure C-1: The insert shows the layout of four vials in the MRI phantom constructed
to evaluate the relaxation properties of diluted solutions of water-based ferrofluid.
The upper left quadrant has q1 = 2.75 x 10- 4 dilution and by its signal void shows
that the ferrofluid is a strong negative T2 contrast agent. Left: Decay of MR-visible
signal with increasing TE with TR=5s. The 02 = 2.75 x 10-6 solution clearly has a
dramatically shorter T2 than the distilled water and the 03 = 2.75 x 10-' solution.
Right: Signal recovery with increasing TR for TE=14 ms with substantial shortening
of T1 for the 02 vial of ferrofluid.
C.2 Results
Based on the results shown in Fig. C-1, the 41 dilution was too highly concentrated
to yield any significant SNR at 1.5 T. This is seen by the top-left image in the insert
of Fig. C-1, where the vial is indistinguishable from the background noise. However,
the 02 and O3 dilutions yield much-improved SNR.
The values of T1 and T2 were estimated based on an exponential curve fit of the
plots in Fig. C-1. This yields a T1 value for the 02 dilution of 260 ms while the value
for ¢3 dilution was 3000 ms. Similarly, the T2 relaxation times was estimated for
each concentration and for 02, the value was 11 ms. This value increased to 470 ms
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for 0 3 . For the distilled water, the values of T1 and T2 were estimated as 3200 ms
and 570 ms respectively.
It should be noted that the estimate of T2 for long T2 species is not thought to be
accurate. This is due to both T1 effects (T1 is substantial compared to TR), as well
as imaging artifacts at the very late echo times. The T2 measurement of the current
reference solution could be improved by lengthening TR or by applying an alternate
T2 measurement methodology (e.g., "T2 preparation" sequences as are used in flow-
independent MR angiography). The T2 estimates of the reference solution could also
be improved by doping them to reduce T1 and T2 to a few hundred milliseconds.
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